CN1768141A - Pantolactone hydrolase - Google Patents
Pantolactone hydrolase Download PDFInfo
- Publication number
- CN1768141A CN1768141A CNA2004800085042A CN200480008504A CN1768141A CN 1768141 A CN1768141 A CN 1768141A CN A2004800085042 A CNA2004800085042 A CN A2004800085042A CN 200480008504 A CN200480008504 A CN 200480008504A CN 1768141 A CN1768141 A CN 1768141A
- Authority
- CN
- China
- Prior art keywords
- leu
- gly
- asp
- ala
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940115458 pantolactone Drugs 0.000 title claims abstract description 70
- SIEVQTNTRMBCHO-UHFFFAOYSA-N pantolactone Natural products CC1(C)OC(=O)CC1O SIEVQTNTRMBCHO-UHFFFAOYSA-N 0.000 title claims abstract description 53
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 72
- 239000002773 nucleotide Substances 0.000 claims abstract description 45
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 37
- 108020004414 DNA Proteins 0.000 claims description 112
- 241000228245 Aspergillus niger Species 0.000 claims description 97
- 108090000604 Hydrolases Proteins 0.000 claims description 42
- 102000004157 Hydrolases Human genes 0.000 claims description 41
- 241000283073 Equus caballus Species 0.000 claims description 29
- 210000004185 liver Anatomy 0.000 claims description 24
- 235000020054 awamori Nutrition 0.000 claims description 17
- 239000013604 expression vector Substances 0.000 claims description 14
- 230000000692 anti-sense effect Effects 0.000 claims description 13
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 11
- 230000007062 hydrolysis Effects 0.000 claims description 10
- 238000006460 hydrolysis reaction Methods 0.000 claims description 10
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 9
- 244000063299 Bacillus subtilis Species 0.000 claims description 9
- 102000053602 DNA Human genes 0.000 claims description 8
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 6
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 238000012408 PCR amplification Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 108090000790 Enzymes Proteins 0.000 description 52
- 102000004190 Enzymes Human genes 0.000 description 50
- 150000001413 amino acids Chemical class 0.000 description 50
- 108090000765 processed proteins & peptides Proteins 0.000 description 50
- 229940088598 enzyme Drugs 0.000 description 45
- SERHXTVXHNVDKA-UHFFFAOYSA-N pantolactone Chemical compound CC1(C)COC(=O)C1O SERHXTVXHNVDKA-UHFFFAOYSA-N 0.000 description 40
- 241000282326 Felis catus Species 0.000 description 34
- 102000004169 proteins and genes Human genes 0.000 description 34
- 235000018102 proteins Nutrition 0.000 description 33
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 32
- 241000588724 Escherichia coli Species 0.000 description 31
- 230000000694 effects Effects 0.000 description 30
- 108010050848 glycylleucine Proteins 0.000 description 30
- 235000001014 amino acid Nutrition 0.000 description 29
- 229940024606 amino acid Drugs 0.000 description 29
- 239000000499 gel Substances 0.000 description 29
- 102000004196 processed proteins & peptides Human genes 0.000 description 27
- 239000000047 product Substances 0.000 description 27
- 101000693619 Starmerella bombicola Lactone esterase Proteins 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 23
- 239000007853 buffer solution Substances 0.000 description 22
- 239000000203 mixture Substances 0.000 description 22
- 229920001184 polypeptide Polymers 0.000 description 22
- 108010009298 lysylglutamic acid Proteins 0.000 description 21
- 102000039446 nucleic acids Human genes 0.000 description 21
- 108020004707 nucleic acids Proteins 0.000 description 21
- 150000007523 nucleic acids Chemical class 0.000 description 21
- 229940115459 (r)- pantolactone Drugs 0.000 description 20
- 108091034117 Oligonucleotide Proteins 0.000 description 20
- 108010092114 histidylphenylalanine Proteins 0.000 description 20
- SERHXTVXHNVDKA-BYPYZUCNSA-N (R)-pantolactone Chemical compound CC1(C)COC(=O)[C@@H]1O SERHXTVXHNVDKA-BYPYZUCNSA-N 0.000 description 19
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 19
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 19
- 239000012634 fragment Substances 0.000 description 18
- 238000009396 hybridization Methods 0.000 description 18
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 17
- 108010087924 alanylproline Proteins 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 108010057821 leucylproline Proteins 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- HQUXQAMSWFIRET-AVGNSLFASA-N Leu-Glu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HQUXQAMSWFIRET-AVGNSLFASA-N 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- 230000014509 gene expression Effects 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- 108010026333 seryl-proline Proteins 0.000 description 15
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 15
- VYZBPPBKFCHCIS-WPRPVWTQSA-N Arg-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N VYZBPPBKFCHCIS-WPRPVWTQSA-N 0.000 description 14
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000000523 sample Substances 0.000 description 14
- RGKKALNPOYURGE-ZKWXMUAHSA-N Asp-Ala-Val Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O RGKKALNPOYURGE-ZKWXMUAHSA-N 0.000 description 13
- PWPBLZXWFXJFHE-RHYQMDGZSA-N Leu-Pro-Thr Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O PWPBLZXWFXJFHE-RHYQMDGZSA-N 0.000 description 13
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 13
- RTJPAGFXOWEBAI-SRVKXCTJSA-N Val-Val-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N RTJPAGFXOWEBAI-SRVKXCTJSA-N 0.000 description 13
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 13
- 108010029020 prolylglycine Proteins 0.000 description 13
- YBMUFUWSMIKJQA-GUBZILKMSA-N Asp-Gln-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N YBMUFUWSMIKJQA-GUBZILKMSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- SWQALSGKVLYKDT-ZKWXMUAHSA-N Gly-Ile-Ala Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SWQALSGKVLYKDT-ZKWXMUAHSA-N 0.000 description 12
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 12
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 12
- HQPWNHXERZCIHP-PMVMPFDFSA-N Phe-Leu-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 HQPWNHXERZCIHP-PMVMPFDFSA-N 0.000 description 12
- XYHMFGGWNOFUOU-QXEWZRGKSA-N Pro-Ile-Gly Chemical compound OC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 XYHMFGGWNOFUOU-QXEWZRGKSA-N 0.000 description 12
- 108091028664 Ribonucleotide Proteins 0.000 description 12
- KHTIUAKJRUIEMA-HOUAVDHOSA-N Thr-Trp-Asp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O)=CNC2=C1 KHTIUAKJRUIEMA-HOUAVDHOSA-N 0.000 description 12
- 108010076718 lysyl-glutamyl-tryptophan Proteins 0.000 description 12
- 239000002336 ribonucleotide Substances 0.000 description 12
- 125000002652 ribonucleotide group Chemical group 0.000 description 12
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 11
- BIGRHVNFFJTHEB-UBHSHLNASA-N Asn-Trp-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(O)=O BIGRHVNFFJTHEB-UBHSHLNASA-N 0.000 description 11
- DWOGMPWRQQWPPF-GUBZILKMSA-N Asp-Leu-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O DWOGMPWRQQWPPF-GUBZILKMSA-N 0.000 description 11
- 108020004705 Codon Proteins 0.000 description 11
- XEKAJTCACGEBOK-KKUMJFAQSA-N Glu-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XEKAJTCACGEBOK-KKUMJFAQSA-N 0.000 description 11
- RJIVPOXLQFJRTG-LURJTMIESA-N Gly-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N RJIVPOXLQFJRTG-LURJTMIESA-N 0.000 description 11
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 11
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 11
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 11
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 11
- GTNCSPKYWCJZAC-XIRDDKMYSA-N Trp-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N GTNCSPKYWCJZAC-XIRDDKMYSA-N 0.000 description 11
- 108010047495 alanylglycine Proteins 0.000 description 11
- 108010047857 aspartylglycine Proteins 0.000 description 11
- 108010037850 glycylvaline Proteins 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 108091033319 polynucleotide Proteins 0.000 description 11
- 102000040430 polynucleotide Human genes 0.000 description 11
- 239000002157 polynucleotide Substances 0.000 description 11
- WCFCYFDBMNFSPA-ACZMJKKPSA-N Asp-Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O WCFCYFDBMNFSPA-ACZMJKKPSA-N 0.000 description 10
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 10
- WGNOPSQMIQERPK-UHFFFAOYSA-N Leu-Asn-Pro Natural products CC(C)CC(N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)O WGNOPSQMIQERPK-UHFFFAOYSA-N 0.000 description 10
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 10
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 10
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 108010053725 prolylvaline Proteins 0.000 description 10
- 108010061238 threonyl-glycine Proteins 0.000 description 10
- 108010076441 Ala-His-His Proteins 0.000 description 9
- UAOSDDXCTBIPCA-QXEWZRGKSA-N Arg-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UAOSDDXCTBIPCA-QXEWZRGKSA-N 0.000 description 9
- DDBMKOCQWNFDBH-RHYQMDGZSA-N Arg-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O DDBMKOCQWNFDBH-RHYQMDGZSA-N 0.000 description 9
- JYHIVHINLJUIEG-BVSLBCMMSA-N Arg-Tyr-Trp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O JYHIVHINLJUIEG-BVSLBCMMSA-N 0.000 description 9
- VCJCPARXDBEGNE-GUBZILKMSA-N Asn-Pro-Pro Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 VCJCPARXDBEGNE-GUBZILKMSA-N 0.000 description 9
- JILRMFFFCHUUTJ-ACZMJKKPSA-N Gln-Ser-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O JILRMFFFCHUUTJ-ACZMJKKPSA-N 0.000 description 9
- OEIDWQHTRYEYGG-QEJZJMRPSA-N Gln-Trp-Asp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N OEIDWQHTRYEYGG-QEJZJMRPSA-N 0.000 description 9
- KCCNSVHJSMMGFS-NRPADANISA-N Glu-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N KCCNSVHJSMMGFS-NRPADANISA-N 0.000 description 9
- DHDOADIPGZTAHT-YUMQZZPRSA-N Gly-Glu-Arg Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DHDOADIPGZTAHT-YUMQZZPRSA-N 0.000 description 9
- FQKKPCWTZZEDIC-XPUUQOCRSA-N Gly-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 FQKKPCWTZZEDIC-XPUUQOCRSA-N 0.000 description 9
- LLZXNUUIBOALNY-QWRGUYRKSA-N Gly-Leu-Lys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN LLZXNUUIBOALNY-QWRGUYRKSA-N 0.000 description 9
- IGOYNRWLWHWAQO-JTQLQIEISA-N Gly-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IGOYNRWLWHWAQO-JTQLQIEISA-N 0.000 description 9
- YPWHUFAAMNHMGS-QSFUFRPTSA-N Ile-Ala-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N YPWHUFAAMNHMGS-QSFUFRPTSA-N 0.000 description 9
- JRYQSFOFUFXPTB-RWRJDSDZSA-N Ile-Gln-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N JRYQSFOFUFXPTB-RWRJDSDZSA-N 0.000 description 9
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 9
- BJEYSVHMGIJORT-NHCYSSNCSA-N Phe-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BJEYSVHMGIJORT-NHCYSSNCSA-N 0.000 description 9
- ULIWFCCJIOEHMU-BQBZGAKWSA-N Pro-Gly-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 ULIWFCCJIOEHMU-BQBZGAKWSA-N 0.000 description 9
- JMGJDTNUMAZNLX-RWRJDSDZSA-N Thr-Glu-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JMGJDTNUMAZNLX-RWRJDSDZSA-N 0.000 description 9
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 9
- 230000002255 enzymatic effect Effects 0.000 description 9
- 108010064235 lysylglycine Proteins 0.000 description 9
- 108010084932 tryptophyl-proline Proteins 0.000 description 9
- PLNJUJGNLDSFOP-UWJYBYFXSA-N Asp-Tyr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O PLNJUJGNLDSFOP-UWJYBYFXSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- AFYGNOJUTMXQIG-FXQIFTODSA-N Cys-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)N AFYGNOJUTMXQIG-FXQIFTODSA-N 0.000 description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
- RWQCWSGOOOEGPB-FXQIFTODSA-N Gln-Ser-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O RWQCWSGOOOEGPB-FXQIFTODSA-N 0.000 description 8
- KLJMRPIBBLTDGE-ACZMJKKPSA-N Glu-Cys-Asn Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O KLJMRPIBBLTDGE-ACZMJKKPSA-N 0.000 description 8
- VJVAQZYGLMJPTK-QEJZJMRPSA-N Glu-Trp-Asp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N VJVAQZYGLMJPTK-QEJZJMRPSA-N 0.000 description 8
- XOEKMEAOMXMURD-JYJNAYRXSA-N Glu-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O XOEKMEAOMXMURD-JYJNAYRXSA-N 0.000 description 8
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 8
- CTJHHEQNUNIYNN-SRVKXCTJSA-N His-His-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O CTJHHEQNUNIYNN-SRVKXCTJSA-N 0.000 description 8
- AOFYPTOHESIBFZ-KKUMJFAQSA-N Leu-His-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O AOFYPTOHESIBFZ-KKUMJFAQSA-N 0.000 description 8
- ZDJQVSIPFLMNOX-RHYQMDGZSA-N Leu-Thr-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZDJQVSIPFLMNOX-RHYQMDGZSA-N 0.000 description 8
- LECIJRIRMVOFMH-ULQDDVLXSA-N Lys-Pro-Phe Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 LECIJRIRMVOFMH-ULQDDVLXSA-N 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- YRKFKTQRVBJYLT-CQDKDKBSSA-N Phe-Ala-His Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=CC=C1 YRKFKTQRVBJYLT-CQDKDKBSSA-N 0.000 description 8
- WGXOKDLDIWSOCV-MELADBBJSA-N Phe-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O WGXOKDLDIWSOCV-MELADBBJSA-N 0.000 description 8
- GCFNFKNPCMBHNT-IRXDYDNUSA-N Phe-Tyr-Gly Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)NCC(=O)O)N GCFNFKNPCMBHNT-IRXDYDNUSA-N 0.000 description 8
- RUDOLGWDSKQQFF-DCAQKATOSA-N Pro-Leu-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O RUDOLGWDSKQQFF-DCAQKATOSA-N 0.000 description 8
- NDXSOKGYKCGYKT-VEVYYDQMSA-N Thr-Pro-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O NDXSOKGYKCGYKT-VEVYYDQMSA-N 0.000 description 8
- 239000007983 Tris buffer Substances 0.000 description 8
- RPVDDQYNBOVWLR-HOCLYGCPSA-N Trp-Gly-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O RPVDDQYNBOVWLR-HOCLYGCPSA-N 0.000 description 8
- IEWKKXZRJLTIOV-AVGNSLFASA-N Tyr-Ser-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O IEWKKXZRJLTIOV-AVGNSLFASA-N 0.000 description 8
- QPZMOUMNTGTEFR-ZKWXMUAHSA-N Val-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N QPZMOUMNTGTEFR-ZKWXMUAHSA-N 0.000 description 8
- DAVNYIUELQBTAP-XUXIUFHCSA-N Val-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N DAVNYIUELQBTAP-XUXIUFHCSA-N 0.000 description 8
- VIKZGAUAKQZDOF-NRPADANISA-N Val-Ser-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O VIKZGAUAKQZDOF-NRPADANISA-N 0.000 description 8
- 238000000246 agarose gel electrophoresis Methods 0.000 description 8
- 108010068265 aspartyltyrosine Proteins 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 108010028295 histidylhistidine Proteins 0.000 description 8
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 8
- SERHXTVXHNVDKA-SCSAIBSYSA-N (3s)-3-hydroxy-4,4-dimethyloxolan-2-one Chemical compound CC1(C)COC(=O)[C@H]1O SERHXTVXHNVDKA-SCSAIBSYSA-N 0.000 description 7
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 7
- MFMDKJIPHSWSBM-GUBZILKMSA-N Ala-Lys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFMDKJIPHSWSBM-GUBZILKMSA-N 0.000 description 7
- IPZQNYYAYVRKKK-FXQIFTODSA-N Ala-Pro-Ala Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IPZQNYYAYVRKKK-FXQIFTODSA-N 0.000 description 7
- NKNILFJYKKHBKE-WPRPVWTQSA-N Arg-Gly-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NKNILFJYKKHBKE-WPRPVWTQSA-N 0.000 description 7
- RAKKBBHMTJSXOY-XVYDVKMFSA-N Asn-His-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O RAKKBBHMTJSXOY-XVYDVKMFSA-N 0.000 description 7
- VITDJIPIJZAVGC-VEVYYDQMSA-N Asn-Met-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VITDJIPIJZAVGC-VEVYYDQMSA-N 0.000 description 7
- SBHUBSDEZQFJHJ-CIUDSAMLSA-N Asp-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O SBHUBSDEZQFJHJ-CIUDSAMLSA-N 0.000 description 7
- GHODABZPVZMWCE-FXQIFTODSA-N Asp-Glu-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O GHODABZPVZMWCE-FXQIFTODSA-N 0.000 description 7
- BWJZSLQJNBSUPM-FXQIFTODSA-N Asp-Pro-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O BWJZSLQJNBSUPM-FXQIFTODSA-N 0.000 description 7
- UMZHHILWZBFPGL-LOKLDPHHSA-N Glu-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O UMZHHILWZBFPGL-LOKLDPHHSA-N 0.000 description 7
- RWIKBYVJQAJYDP-BJDJZHNGSA-N Ile-Ala-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RWIKBYVJQAJYDP-BJDJZHNGSA-N 0.000 description 7
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 7
- YFQSSOAGMZGXFT-MEYUZBJRSA-N Lys-Thr-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YFQSSOAGMZGXFT-MEYUZBJRSA-N 0.000 description 7
- VHGIWFGJIHTASW-FXQIFTODSA-N Met-Ala-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O VHGIWFGJIHTASW-FXQIFTODSA-N 0.000 description 7
- HFZNNDWPHBRNPV-KZVJFYERSA-N Pro-Ala-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HFZNNDWPHBRNPV-KZVJFYERSA-N 0.000 description 7
- WVOXLKUUVCCCSU-ZPFDUUQYSA-N Pro-Glu-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WVOXLKUUVCCCSU-ZPFDUUQYSA-N 0.000 description 7
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 7
- BUYHXYIUQUBEQP-AVGNSLFASA-N Ser-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CO)N BUYHXYIUQUBEQP-AVGNSLFASA-N 0.000 description 7
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 7
- NZRUWPIYECBYRK-HTUGSXCWSA-N Thr-Phe-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O NZRUWPIYECBYRK-HTUGSXCWSA-N 0.000 description 7
- KLOZTPOXVVRVAQ-DZKIICNBSA-N Tyr-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 KLOZTPOXVVRVAQ-DZKIICNBSA-N 0.000 description 7
- UEOOXDLMQZBPFR-ZKWXMUAHSA-N Val-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N UEOOXDLMQZBPFR-ZKWXMUAHSA-N 0.000 description 7
- LHADRQBREKTRLR-DCAQKATOSA-N Val-Cys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)N LHADRQBREKTRLR-DCAQKATOSA-N 0.000 description 7
- PMKQKNBISAOSRI-XHSDSOJGSA-N Val-Tyr-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N PMKQKNBISAOSRI-XHSDSOJGSA-N 0.000 description 7
- 108010093581 aspartyl-proline Proteins 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 108010078274 isoleucylvaline Proteins 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 239000000377 silicon dioxide Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WDIYWDJLXOCGRW-ACZMJKKPSA-N Ala-Asp-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WDIYWDJLXOCGRW-ACZMJKKPSA-N 0.000 description 6
- BFMIRJBURUXDRG-DLOVCJGASA-N Ala-Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 BFMIRJBURUXDRG-DLOVCJGASA-N 0.000 description 6
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 6
- GRRXPUAICOGISM-RWMBFGLXSA-N Arg-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O GRRXPUAICOGISM-RWMBFGLXSA-N 0.000 description 6
- FXGMURPOWCKNAZ-JYJNAYRXSA-N Arg-Val-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FXGMURPOWCKNAZ-JYJNAYRXSA-N 0.000 description 6
- XYOVHPDDWCEUDY-CIUDSAMLSA-N Asn-Ala-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O XYOVHPDDWCEUDY-CIUDSAMLSA-N 0.000 description 6
- DCXGXDGGXVZVMY-GHCJXIJMSA-N Cys-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CS DCXGXDGGXVZVMY-GHCJXIJMSA-N 0.000 description 6
- 241000287828 Gallus gallus Species 0.000 description 6
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 6
- BCYGDJXHAGZNPQ-DCAQKATOSA-N Glu-Lys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O BCYGDJXHAGZNPQ-DCAQKATOSA-N 0.000 description 6
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 6
- ULZCYBYDTUMHNF-IUCAKERBSA-N Gly-Leu-Glu Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ULZCYBYDTUMHNF-IUCAKERBSA-N 0.000 description 6
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 6
- MAABHGXCIBEYQR-XVYDVKMFSA-N His-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N MAABHGXCIBEYQR-XVYDVKMFSA-N 0.000 description 6
- IOVUXUSIGXCREV-DKIMLUQUSA-N Ile-Leu-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IOVUXUSIGXCREV-DKIMLUQUSA-N 0.000 description 6
- FJUKMPUELVROGK-IHRRRGAJSA-N Leu-Arg-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N FJUKMPUELVROGK-IHRRRGAJSA-N 0.000 description 6
- KVMULWOHPPMHHE-DCAQKATOSA-N Leu-Glu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KVMULWOHPPMHHE-DCAQKATOSA-N 0.000 description 6
- KOSWSHVQIVTVQF-ZPFDUUQYSA-N Leu-Ile-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O KOSWSHVQIVTVQF-ZPFDUUQYSA-N 0.000 description 6
- DRWMRVFCKKXHCH-BZSNNMDCSA-N Leu-Phe-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CC=CC=C1 DRWMRVFCKKXHCH-BZSNNMDCSA-N 0.000 description 6
- DTUZCYRNEJDKSR-NHCYSSNCSA-N Lys-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN DTUZCYRNEJDKSR-NHCYSSNCSA-N 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- ZENDEDYRYVHBEG-SRVKXCTJSA-N Phe-Asp-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 ZENDEDYRYVHBEG-SRVKXCTJSA-N 0.000 description 6
- LWPMGKSZPKFKJD-DZKIICNBSA-N Phe-Glu-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O LWPMGKSZPKFKJD-DZKIICNBSA-N 0.000 description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 description 6
- FUVBEZJCRMHWEM-FXQIFTODSA-N Pro-Asn-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O FUVBEZJCRMHWEM-FXQIFTODSA-N 0.000 description 6
- XKHCJJPNXFBADI-DCAQKATOSA-N Pro-Asp-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O XKHCJJPNXFBADI-DCAQKATOSA-N 0.000 description 6
- PVDTYLHUWAEYGY-CIUDSAMLSA-N Ser-Glu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PVDTYLHUWAEYGY-CIUDSAMLSA-N 0.000 description 6
- 108091081024 Start codon Proteins 0.000 description 6
- HIINQLBHPIQYHN-JTQLQIEISA-N Tyr-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HIINQLBHPIQYHN-JTQLQIEISA-N 0.000 description 6
- ARSHSYUZHSIYKR-ACRUOGEOSA-N Tyr-His-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ARSHSYUZHSIYKR-ACRUOGEOSA-N 0.000 description 6
- VXFXIBCCVLJCJT-JYJNAYRXSA-N Tyr-Pro-Pro Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O VXFXIBCCVLJCJT-JYJNAYRXSA-N 0.000 description 6
- ZXAGTABZUOMUDO-GVXVVHGQSA-N Val-Glu-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N ZXAGTABZUOMUDO-GVXVVHGQSA-N 0.000 description 6
- 108010011559 alanylphenylalanine Proteins 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 6
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 description 6
- 238000010008 shearing Methods 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 108010011619 6-Phytase Proteins 0.000 description 5
- GRIFPSOFWFIICX-GOPGUHFVSA-N Ala-His-Trp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O GRIFPSOFWFIICX-GOPGUHFVSA-N 0.000 description 5
- WOPFJPHVBWKZJH-SRVKXCTJSA-N Arg-Arg-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O WOPFJPHVBWKZJH-SRVKXCTJSA-N 0.000 description 5
- AZHXYLJRGVMQKW-UMPQAUOISA-N Arg-Trp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCCN=C(N)N)N)O AZHXYLJRGVMQKW-UMPQAUOISA-N 0.000 description 5
- KEUNWIXNKVWCFL-FXQIFTODSA-N Asn-Met-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(O)=O KEUNWIXNKVWCFL-FXQIFTODSA-N 0.000 description 5
- XMHFCUKJRCQXGI-CIUDSAMLSA-N Asn-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O XMHFCUKJRCQXGI-CIUDSAMLSA-N 0.000 description 5
- XTMZYFMTYJNABC-ZLUOBGJFSA-N Asn-Ser-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N XTMZYFMTYJNABC-ZLUOBGJFSA-N 0.000 description 5
- VFUXXFVCYZPOQG-WDSKDSINSA-N Asp-Glu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VFUXXFVCYZPOQG-WDSKDSINSA-N 0.000 description 5
- HOBNTSHITVVNBN-ZPFDUUQYSA-N Asp-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N HOBNTSHITVVNBN-ZPFDUUQYSA-N 0.000 description 5
- 241000228212 Aspergillus Species 0.000 description 5
- 241001513093 Aspergillus awamori Species 0.000 description 5
- 102000000584 Calmodulin Human genes 0.000 description 5
- 108010041952 Calmodulin Proteins 0.000 description 5
- SSNJZBGOMNLSLA-CIUDSAMLSA-N Cys-Leu-Asn Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O SSNJZBGOMNLSLA-CIUDSAMLSA-N 0.000 description 5
- ILGFBUGLBSAQQB-GUBZILKMSA-N Glu-Glu-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ILGFBUGLBSAQQB-GUBZILKMSA-N 0.000 description 5
- XZRZILPOZBVTDB-GJZGRUSLSA-N Gly-Arg-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN)C(O)=O)=CNC2=C1 XZRZILPOZBVTDB-GJZGRUSLSA-N 0.000 description 5
- SBVMXEZQJVUARN-XPUUQOCRSA-N Gly-Val-Ser Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O SBVMXEZQJVUARN-XPUUQOCRSA-N 0.000 description 5
- DCRODRAURLJOFY-XPUUQOCRSA-N His-Ala-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)NCC(O)=O DCRODRAURLJOFY-XPUUQOCRSA-N 0.000 description 5
- OZBDSFBWIDPVDA-BZSNNMDCSA-N His-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CN=CN3)N OZBDSFBWIDPVDA-BZSNNMDCSA-N 0.000 description 5
- MQFGXJNSUJTXDT-QSFUFRPTSA-N Ile-Gly-Ile Chemical compound N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)O MQFGXJNSUJTXDT-QSFUFRPTSA-N 0.000 description 5
- WGNOPSQMIQERPK-GARJFASQSA-N Leu-Asn-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N WGNOPSQMIQERPK-GARJFASQSA-N 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 5
- 108010076504 Protein Sorting Signals Proteins 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- IXUGADGDCQDLSA-FXQIFTODSA-N Ser-Gln-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N IXUGADGDCQDLSA-FXQIFTODSA-N 0.000 description 5
- DINQYZRMXGWWTG-GUBZILKMSA-N Ser-Pro-Pro Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DINQYZRMXGWWTG-GUBZILKMSA-N 0.000 description 5
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 5
- PKXHGEXFMIZSER-QTKMDUPCSA-N Thr-Arg-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O PKXHGEXFMIZSER-QTKMDUPCSA-N 0.000 description 5
- VEIKMWOMUYMMMK-FCLVOEFKSA-N Thr-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 VEIKMWOMUYMMMK-FCLVOEFKSA-N 0.000 description 5
- ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 description 5
- XTAUQCGQFJQGEJ-NHCYSSNCSA-N Val-Gln-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XTAUQCGQFJQGEJ-NHCYSSNCSA-N 0.000 description 5
- SYSWVVCYSXBVJG-RHYQMDGZSA-N Val-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N)O SYSWVVCYSXBVJG-RHYQMDGZSA-N 0.000 description 5
- PHZGFLFMGLXCFG-FHWLQOOXSA-N Val-Lys-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N PHZGFLFMGLXCFG-FHWLQOOXSA-N 0.000 description 5
- UOUIMEGEPSBZIV-ULQDDVLXSA-N Val-Lys-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UOUIMEGEPSBZIV-ULQDDVLXSA-N 0.000 description 5
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 5
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 5
- 125000000539 amino acid group Chemical group 0.000 description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- 108010068380 arginylarginine Proteins 0.000 description 5
- 239000011942 biocatalyst Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000013467 fragmentation Methods 0.000 description 5
- 238000006062 fragmentation reaction Methods 0.000 description 5
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 5
- 239000011654 magnesium acetate Substances 0.000 description 5
- 235000011285 magnesium acetate Nutrition 0.000 description 5
- 229940069446 magnesium acetate Drugs 0.000 description 5
- 239000012460 protein solution Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- WGDNWOMKBUXFHR-BQBZGAKWSA-N Ala-Gly-Arg Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N WGDNWOMKBUXFHR-BQBZGAKWSA-N 0.000 description 4
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 4
- LTSBJNNXPBBNDT-HGNGGELXSA-N Ala-His-Gln Chemical compound N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(=O)O LTSBJNNXPBBNDT-HGNGGELXSA-N 0.000 description 4
- ATAKEVCGTRZKLI-UWJYBYFXSA-N Ala-His-His Chemical compound C([C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 ATAKEVCGTRZKLI-UWJYBYFXSA-N 0.000 description 4
- FFZJHQODAYHGPO-KZVJFYERSA-N Ala-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N FFZJHQODAYHGPO-KZVJFYERSA-N 0.000 description 4
- WOZDCBHUGJVJPL-AVGNSLFASA-N Arg-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WOZDCBHUGJVJPL-AVGNSLFASA-N 0.000 description 4
- DXQOQMCLWWADMU-ACZMJKKPSA-N Asp-Gln-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O DXQOQMCLWWADMU-ACZMJKKPSA-N 0.000 description 4
- QCVXMEHGFUMKCO-YUMQZZPRSA-N Asp-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O QCVXMEHGFUMKCO-YUMQZZPRSA-N 0.000 description 4
- IVPNEDNYYYFAGI-GARJFASQSA-N Asp-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N IVPNEDNYYYFAGI-GARJFASQSA-N 0.000 description 4
- UZFHNLYQWMGUHU-DCAQKATOSA-N Asp-Lys-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UZFHNLYQWMGUHU-DCAQKATOSA-N 0.000 description 4
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 4
- GIKOVDMXBAFXDF-NHCYSSNCSA-N Asp-Val-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GIKOVDMXBAFXDF-NHCYSSNCSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- FIADUEYFRSCCIK-CIUDSAMLSA-N Cys-Glu-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FIADUEYFRSCCIK-CIUDSAMLSA-N 0.000 description 4
- HQZGVYJBRSISDT-BQBZGAKWSA-N Cys-Gly-Arg Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O HQZGVYJBRSISDT-BQBZGAKWSA-N 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- FQCILXROGNOZON-YUMQZZPRSA-N Gln-Pro-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O FQCILXROGNOZON-YUMQZZPRSA-N 0.000 description 4
- MKRDNSWGJWTBKZ-GVXVVHGQSA-N Gln-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N MKRDNSWGJWTBKZ-GVXVVHGQSA-N 0.000 description 4
- DYFJZDDQPNIPAB-NHCYSSNCSA-N Glu-Arg-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O DYFJZDDQPNIPAB-NHCYSSNCSA-N 0.000 description 4
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 4
- QXDXIXFSFHUYAX-MNXVOIDGSA-N Glu-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O QXDXIXFSFHUYAX-MNXVOIDGSA-N 0.000 description 4
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 4
- QRWPTXLWHHTOCO-DZKIICNBSA-N Glu-Val-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QRWPTXLWHHTOCO-DZKIICNBSA-N 0.000 description 4
- KFMBRBPXHVMDFN-UWVGGRQHSA-N Gly-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCNC(N)=N KFMBRBPXHVMDFN-UWVGGRQHSA-N 0.000 description 4
- AFMOTCMSEBITOE-YEPSODPASA-N Gly-Val-Thr Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AFMOTCMSEBITOE-YEPSODPASA-N 0.000 description 4
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 4
- KWBISLAEQZUYIC-UWJYBYFXSA-N His-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CN=CN2)N KWBISLAEQZUYIC-UWJYBYFXSA-N 0.000 description 4
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 4
- ORZGPQXISSXQGW-IHRRRGAJSA-N His-His-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(O)=O ORZGPQXISSXQGW-IHRRRGAJSA-N 0.000 description 4
- PUFNQIPSRXVLQJ-IHRRRGAJSA-N His-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N PUFNQIPSRXVLQJ-IHRRRGAJSA-N 0.000 description 4
- WXLYNEHOGRYNFU-URLPEUOOSA-N Ile-Thr-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N WXLYNEHOGRYNFU-URLPEUOOSA-N 0.000 description 4
- 241000880493 Leptailurus serval Species 0.000 description 4
- BAJIJEGGUYXZGC-CIUDSAMLSA-N Leu-Asn-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N BAJIJEGGUYXZGC-CIUDSAMLSA-N 0.000 description 4
- QPXBPQUGXHURGP-UWVGGRQHSA-N Leu-Gly-Met Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)O)N QPXBPQUGXHURGP-UWVGGRQHSA-N 0.000 description 4
- HVHRPWQEQHIQJF-AVGNSLFASA-N Leu-Lys-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HVHRPWQEQHIQJF-AVGNSLFASA-N 0.000 description 4
- YUAXTFMFMOIMAM-QWRGUYRKSA-N Lys-Lys-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O YUAXTFMFMOIMAM-QWRGUYRKSA-N 0.000 description 4
- QGQGAIBGTUJRBR-NAKRPEOUSA-N Met-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC QGQGAIBGTUJRBR-NAKRPEOUSA-N 0.000 description 4
- DSWOTZCVCBEPOU-IUCAKERBSA-N Met-Arg-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CCCNC(N)=N DSWOTZCVCBEPOU-IUCAKERBSA-N 0.000 description 4
- GRVMHFCZUIYNKQ-UFYCRDLUSA-N Phe-Phe-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O GRVMHFCZUIYNKQ-UFYCRDLUSA-N 0.000 description 4
- IEIFEYBAYFSRBQ-IHRRRGAJSA-N Phe-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N IEIFEYBAYFSRBQ-IHRRRGAJSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- GFHOSBYCLACKEK-GUBZILKMSA-N Pro-Pro-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O GFHOSBYCLACKEK-GUBZILKMSA-N 0.000 description 4
- IMNVAOPEMFDAQD-NHCYSSNCSA-N Pro-Val-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IMNVAOPEMFDAQD-NHCYSSNCSA-N 0.000 description 4
- IOVBCLGAJJXOHK-SRVKXCTJSA-N Ser-His-His Chemical compound C([C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 IOVBCLGAJJXOHK-SRVKXCTJSA-N 0.000 description 4
- FZXOPYUEQGDGMS-ACZMJKKPSA-N Ser-Ser-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O FZXOPYUEQGDGMS-ACZMJKKPSA-N 0.000 description 4
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 108010006785 Taq Polymerase Proteins 0.000 description 4
- 108020005038 Terminator Codon Proteins 0.000 description 4
- NYQIZWROIMIQSL-VEVYYDQMSA-N Thr-Pro-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O NYQIZWROIMIQSL-VEVYYDQMSA-N 0.000 description 4
- BZTSQFWJNJYZSX-JRQIVUDYSA-N Thr-Tyr-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O BZTSQFWJNJYZSX-JRQIVUDYSA-N 0.000 description 4
- IQGJAHMZWBTRIF-UBHSHLNASA-N Trp-Asp-Asn Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N IQGJAHMZWBTRIF-UBHSHLNASA-N 0.000 description 4
- LGEYOIQBBIPHQN-UWJYBYFXSA-N Tyr-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 LGEYOIQBBIPHQN-UWJYBYFXSA-N 0.000 description 4
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 4
- BZDGLJPROOOUOZ-XGEHTFHBSA-N Val-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N)O BZDGLJPROOOUOZ-XGEHTFHBSA-N 0.000 description 4
- 239000008351 acetate buffer Substances 0.000 description 4
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 4
- 108010038633 aspartylglutamate Proteins 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 108091036078 conserved sequence Proteins 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 4
- 108010020688 glycylhistidine Proteins 0.000 description 4
- 108010073101 phenylalanylleucine Proteins 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 108010015796 prolylisoleucine Proteins 0.000 description 4
- 238000000197 pyrolysis Methods 0.000 description 4
- 235000012239 silicon dioxide Nutrition 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- 108010073969 valyllysine Proteins 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- SIGTYDNEPYEXGK-ZANVPECISA-N Ala-Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CNC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 SIGTYDNEPYEXGK-ZANVPECISA-N 0.000 description 3
- SYIFFFHSXBNPMC-UWJYBYFXSA-N Ala-Ser-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N SYIFFFHSXBNPMC-UWJYBYFXSA-N 0.000 description 3
- CVKOQHYVDVYJSI-QTKMDUPCSA-N Arg-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCN=C(N)N)N)O CVKOQHYVDVYJSI-QTKMDUPCSA-N 0.000 description 3
- LYJXHXGPWDTLKW-HJGDQZAQSA-N Arg-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O LYJXHXGPWDTLKW-HJGDQZAQSA-N 0.000 description 3
- YNDLOUMBVDVALC-ZLUOBGJFSA-N Asn-Ala-Ala Chemical compound C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(=O)N)N YNDLOUMBVDVALC-ZLUOBGJFSA-N 0.000 description 3
- NUHQMYUWLUSRJX-BIIVOSGPSA-N Asn-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N NUHQMYUWLUSRJX-BIIVOSGPSA-N 0.000 description 3
- GMRGSBAMMMVDGG-GUBZILKMSA-N Asn-Arg-Arg Chemical compound C(C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N GMRGSBAMMMVDGG-GUBZILKMSA-N 0.000 description 3
- IBLAOXSULLECQZ-IUKAMOBKSA-N Asn-Ile-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC(N)=O IBLAOXSULLECQZ-IUKAMOBKSA-N 0.000 description 3
- GVPSCJQLUGIKAM-GUBZILKMSA-N Asp-Arg-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GVPSCJQLUGIKAM-GUBZILKMSA-N 0.000 description 3
- LKIYSIYBKYLKPU-BIIVOSGPSA-N Asp-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O LKIYSIYBKYLKPU-BIIVOSGPSA-N 0.000 description 3
- PXLNPFOJZQMXAT-BYULHYEWSA-N Asp-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O PXLNPFOJZQMXAT-BYULHYEWSA-N 0.000 description 3
- AHWRSSLYSGLBGD-CIUDSAMLSA-N Asp-Pro-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AHWRSSLYSGLBGD-CIUDSAMLSA-N 0.000 description 3
- FOXXZZGDIAQPQI-XKNYDFJKSA-N Asp-Pro-Ser-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O FOXXZZGDIAQPQI-XKNYDFJKSA-N 0.000 description 3
- 241000228257 Aspergillus sp. Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- DTMLKCYOQKZXKZ-HJGDQZAQSA-N Gln-Arg-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DTMLKCYOQKZXKZ-HJGDQZAQSA-N 0.000 description 3
- XFKUFUJECJUQTQ-CIUDSAMLSA-N Gln-Gln-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XFKUFUJECJUQTQ-CIUDSAMLSA-N 0.000 description 3
- RBWKVOSARCFSQQ-FXQIFTODSA-N Gln-Gln-Ser Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O RBWKVOSARCFSQQ-FXQIFTODSA-N 0.000 description 3
- PXAFHUATEHLECW-GUBZILKMSA-N Gln-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N PXAFHUATEHLECW-GUBZILKMSA-N 0.000 description 3
- ININBLZFFVOQIO-JHEQGTHGSA-N Gln-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N)O ININBLZFFVOQIO-JHEQGTHGSA-N 0.000 description 3
- LGYZYFFDELZWRS-DCAQKATOSA-N Glu-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O LGYZYFFDELZWRS-DCAQKATOSA-N 0.000 description 3
- CAVMESABQIKFKT-IUCAKERBSA-N Glu-Gly-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)N CAVMESABQIKFKT-IUCAKERBSA-N 0.000 description 3
- JLXVRFDTDUGQEE-YFKPBYRVSA-N Gly-Arg Chemical compound NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N JLXVRFDTDUGQEE-YFKPBYRVSA-N 0.000 description 3
- XBWMTPAIUQIWKA-BYULHYEWSA-N Gly-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN XBWMTPAIUQIWKA-BYULHYEWSA-N 0.000 description 3
- NTOWAXLMQFKJPT-YUMQZZPRSA-N Gly-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CN NTOWAXLMQFKJPT-YUMQZZPRSA-N 0.000 description 3
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 3
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 3
- FLUVGKKRRMLNPU-CQDKDKBSSA-N His-Ala-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O FLUVGKKRRMLNPU-CQDKDKBSSA-N 0.000 description 3
- SVVULKPWDBIPCO-BZSNNMDCSA-N His-Phe-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O SVVULKPWDBIPCO-BZSNNMDCSA-N 0.000 description 3
- VXZZUXWAOMWWJH-QTKMDUPCSA-N His-Thr-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O VXZZUXWAOMWWJH-QTKMDUPCSA-N 0.000 description 3
- UIRUVUUGUYCMBY-KCTSRDHCSA-N His-Trp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CN=CN3)N UIRUVUUGUYCMBY-KCTSRDHCSA-N 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- AQCUAZTZSPQJFF-ZKWXMUAHSA-N Ile-Ala-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O AQCUAZTZSPQJFF-ZKWXMUAHSA-N 0.000 description 3
- OUUCIIJSBIBCHB-ZPFDUUQYSA-N Ile-Leu-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O OUUCIIJSBIBCHB-ZPFDUUQYSA-N 0.000 description 3
- YJRSIJZUIUANHO-NAKRPEOUSA-N Ile-Val-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)O)N YJRSIJZUIUANHO-NAKRPEOUSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 3
- NEEOBPIXKWSBRF-IUCAKERBSA-N Leu-Glu-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O NEEOBPIXKWSBRF-IUCAKERBSA-N 0.000 description 3
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- 101710098556 Lipase A Proteins 0.000 description 3
- ULUQBUKAPDUKOC-GVXVVHGQSA-N Lys-Glu-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O ULUQBUKAPDUKOC-GVXVVHGQSA-N 0.000 description 3
- ZFNYWKHYUMEZDZ-WDSOQIARSA-N Lys-Trp-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCCCN)N ZFNYWKHYUMEZDZ-WDSOQIARSA-N 0.000 description 3
- NYTDJEZBAAFLLG-IHRRRGAJSA-N Lys-Val-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O NYTDJEZBAAFLLG-IHRRRGAJSA-N 0.000 description 3
- 101710099648 Lysosomal acid lipase/cholesteryl ester hydrolase Proteins 0.000 description 3
- 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- RIYZXJVARWJLKS-KKUMJFAQSA-N Phe-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 RIYZXJVARWJLKS-KKUMJFAQSA-N 0.000 description 3
- CSDMCMITJLKBAH-SOUVJXGZSA-N Phe-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O CSDMCMITJLKBAH-SOUVJXGZSA-N 0.000 description 3
- RFEXGCASCQGGHZ-STQMWFEESA-N Phe-Gly-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O RFEXGCASCQGGHZ-STQMWFEESA-N 0.000 description 3
- YTILBRIUASDGBL-BZSNNMDCSA-N Phe-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 YTILBRIUASDGBL-BZSNNMDCSA-N 0.000 description 3
- WECYCNFPGZLOOU-FXQIFTODSA-N Pro-Asn-Cys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O WECYCNFPGZLOOU-FXQIFTODSA-N 0.000 description 3
- ILMLVTGTUJPQFP-FXQIFTODSA-N Pro-Asp-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ILMLVTGTUJPQFP-FXQIFTODSA-N 0.000 description 3
- FISHYTLIMUYTQY-GUBZILKMSA-N Pro-Gln-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1 FISHYTLIMUYTQY-GUBZILKMSA-N 0.000 description 3
- CMOIIANLNNYUTP-SRVKXCTJSA-N Pro-Gln-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O CMOIIANLNNYUTP-SRVKXCTJSA-N 0.000 description 3
- XQSREVQDGCPFRJ-STQMWFEESA-N Pro-Gly-Phe Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XQSREVQDGCPFRJ-STQMWFEESA-N 0.000 description 3
- LEIKGVHQTKHOLM-IUCAKERBSA-N Pro-Pro-Gly Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 LEIKGVHQTKHOLM-IUCAKERBSA-N 0.000 description 3
- KBUAPZAZPWNYSW-SRVKXCTJSA-N Pro-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KBUAPZAZPWNYSW-SRVKXCTJSA-N 0.000 description 3
- AIOWVDNPESPXRB-YTWAJWBKSA-N Pro-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2)O AIOWVDNPESPXRB-YTWAJWBKSA-N 0.000 description 3
- GZNYIXWOIUFLGO-ZJDVBMNYSA-N Pro-Thr-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZNYIXWOIUFLGO-ZJDVBMNYSA-N 0.000 description 3
- 108010025216 RVF peptide Proteins 0.000 description 3
- DGPGKMKUNGKHPK-QEJZJMRPSA-N Ser-Gln-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)N DGPGKMKUNGKHPK-QEJZJMRPSA-N 0.000 description 3
- YRBGKVIWMNEVCZ-WDSKDSINSA-N Ser-Glu-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O YRBGKVIWMNEVCZ-WDSKDSINSA-N 0.000 description 3
- NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 3
- RXUOAOOZIWABBW-XGEHTFHBSA-N Ser-Thr-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N RXUOAOOZIWABBW-XGEHTFHBSA-N 0.000 description 3
- KKKVOZNCLALMPV-XKBZYTNZSA-N Ser-Thr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KKKVOZNCLALMPV-XKBZYTNZSA-N 0.000 description 3
- UBTNVMGPMYDYIU-HJPIBITLSA-N Ser-Tyr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UBTNVMGPMYDYIU-HJPIBITLSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012505 Superdex™ Substances 0.000 description 3
- MQBTXMPQNCGSSZ-OSUNSFLBSA-N Thr-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)CCCN=C(N)N MQBTXMPQNCGSSZ-OSUNSFLBSA-N 0.000 description 3
- GARULAKWZGFIKC-RWRJDSDZSA-N Thr-Gln-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GARULAKWZGFIKC-RWRJDSDZSA-N 0.000 description 3
- JLNMFGCJODTXDH-WEDXCCLWSA-N Thr-Lys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O JLNMFGCJODTXDH-WEDXCCLWSA-N 0.000 description 3
- RVMNUBQWPVOUKH-HEIBUPTGSA-N Thr-Ser-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMNUBQWPVOUKH-HEIBUPTGSA-N 0.000 description 3
- HYVLNORXQGKONN-NUTKFTJISA-N Trp-Ala-Lys Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O)=CNC2=C1 HYVLNORXQGKONN-NUTKFTJISA-N 0.000 description 3
- LHHDBONOFZDWMW-AAEUAGOBSA-N Trp-Asp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N LHHDBONOFZDWMW-AAEUAGOBSA-N 0.000 description 3
- WSGPBCAGEGHKQJ-BBRMVZONSA-N Trp-Gly-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC1=CNC2=CC=CC=C21)N WSGPBCAGEGHKQJ-BBRMVZONSA-N 0.000 description 3
- YXSSXUIBUJGHJY-SFJXLCSZSA-N Trp-Thr-Phe Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)[C@H](O)C)C(O)=O)C1=CC=CC=C1 YXSSXUIBUJGHJY-SFJXLCSZSA-N 0.000 description 3
- BABINGWMZBWXIX-BPUTZDHNSA-N Trp-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N BABINGWMZBWXIX-BPUTZDHNSA-N 0.000 description 3
- FBHBVXUBTYVCRU-BZSNNMDCSA-N Tyr-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CN=CN1 FBHBVXUBTYVCRU-BZSNNMDCSA-N 0.000 description 3
- LYPKCSYAKLTBHJ-ILWGZMRPSA-N Tyr-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)N)C(=O)O LYPKCSYAKLTBHJ-ILWGZMRPSA-N 0.000 description 3
- KOPBYUSPXBQIHD-NRPADANISA-N Val-Cys-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KOPBYUSPXBQIHD-NRPADANISA-N 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 108010070944 alanylhistidine Proteins 0.000 description 3
- 108010062796 arginyllysine Proteins 0.000 description 3
- 108010077245 asparaginyl-proline Proteins 0.000 description 3
- 108010092854 aspartyllysine Proteins 0.000 description 3
- 238000004061 bleaching Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000005336 cracking Methods 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 108010040030 histidinoalanine Proteins 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 108010068488 methionylphenylalanine Proteins 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- -1 pH 8) mixing Substances 0.000 description 3
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 229940085127 phytase Drugs 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 108010070643 prolylglutamic acid Proteins 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000007655 standard test method Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 108010038745 tryptophylglycine Proteins 0.000 description 3
- 108010020532 tyrosyl-proline Proteins 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- BLGHHPHXVJWCNK-GUBZILKMSA-N Ala-Gln-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BLGHHPHXVJWCNK-GUBZILKMSA-N 0.000 description 2
- WKOBSJOZRJJVRZ-FXQIFTODSA-N Ala-Glu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WKOBSJOZRJJVRZ-FXQIFTODSA-N 0.000 description 2
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 2
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 2
- KQESEZXHYOUIIM-CQDKDKBSSA-N Ala-Lys-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KQESEZXHYOUIIM-CQDKDKBSSA-N 0.000 description 2
- DHBKYZYFEXXUAK-ONGXEEELSA-N Ala-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 DHBKYZYFEXXUAK-ONGXEEELSA-N 0.000 description 2
- VNFSAYFQLXPHPY-CIQUZCHMSA-N Ala-Thr-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VNFSAYFQLXPHPY-CIQUZCHMSA-N 0.000 description 2
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 2
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 2
- OMSKGWFGWCQFBD-KZVJFYERSA-N Ala-Val-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OMSKGWFGWCQFBD-KZVJFYERSA-N 0.000 description 2
- KWKQGHSSNHPGOW-BQBZGAKWSA-N Arg-Ala-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(O)=O KWKQGHSSNHPGOW-BQBZGAKWSA-N 0.000 description 2
- BVBKBQRPOJFCQM-DCAQKATOSA-N Arg-Asn-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BVBKBQRPOJFCQM-DCAQKATOSA-N 0.000 description 2
- OCDJOVKIUJVUMO-SRVKXCTJSA-N Arg-His-Gln Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N OCDJOVKIUJVUMO-SRVKXCTJSA-N 0.000 description 2
- MMGCRPZQZWTZTA-IHRRRGAJSA-N Arg-His-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N MMGCRPZQZWTZTA-IHRRRGAJSA-N 0.000 description 2
- GXXWTNKNFFKTJB-NAKRPEOUSA-N Arg-Ile-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O GXXWTNKNFFKTJB-NAKRPEOUSA-N 0.000 description 2
- GMFAGHNRXPSSJS-SRVKXCTJSA-N Arg-Leu-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GMFAGHNRXPSSJS-SRVKXCTJSA-N 0.000 description 2
- YTMKMRSYXHBGER-IHRRRGAJSA-N Arg-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YTMKMRSYXHBGER-IHRRRGAJSA-N 0.000 description 2
- HUZGPXBILPMCHM-IHRRRGAJSA-N Asn-Arg-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HUZGPXBILPMCHM-IHRRRGAJSA-N 0.000 description 2
- XSGBIBGAMKTHMY-WHFBIAKZSA-N Asn-Asp-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O XSGBIBGAMKTHMY-WHFBIAKZSA-N 0.000 description 2
- TWVTVZUGEDBAJF-ACZMJKKPSA-N Asn-Cys-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N)N TWVTVZUGEDBAJF-ACZMJKKPSA-N 0.000 description 2
- DDPXDCKYWDGZAL-BQBZGAKWSA-N Asn-Gly-Arg Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N DDPXDCKYWDGZAL-BQBZGAKWSA-N 0.000 description 2
- HYQYLOSCICEYTR-YUMQZZPRSA-N Asn-Gly-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O HYQYLOSCICEYTR-YUMQZZPRSA-N 0.000 description 2
- NPZJLGMWMDNQDD-GHCJXIJMSA-N Asn-Ser-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NPZJLGMWMDNQDD-GHCJXIJMSA-N 0.000 description 2
- FHCRKXCTKSHNOE-QEJZJMRPSA-N Asn-Trp-Glu Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N FHCRKXCTKSHNOE-QEJZJMRPSA-N 0.000 description 2
- VPPXTHJNTYDNFJ-CIUDSAMLSA-N Asp-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N VPPXTHJNTYDNFJ-CIUDSAMLSA-N 0.000 description 2
- XPGVTUBABLRGHY-BIIVOSGPSA-N Asp-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N XPGVTUBABLRGHY-BIIVOSGPSA-N 0.000 description 2
- WSOKZUVWBXVJHX-CIUDSAMLSA-N Asp-Arg-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O WSOKZUVWBXVJHX-CIUDSAMLSA-N 0.000 description 2
- QXHVOUSPVAWEMX-ZLUOBGJFSA-N Asp-Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O QXHVOUSPVAWEMX-ZLUOBGJFSA-N 0.000 description 2
- ZSJFGGSPCCHMNE-LAEOZQHASA-N Asp-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N ZSJFGGSPCCHMNE-LAEOZQHASA-N 0.000 description 2
- RQYMKRMRZWJGHC-BQBZGAKWSA-N Asp-Gly-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)O)N RQYMKRMRZWJGHC-BQBZGAKWSA-N 0.000 description 2
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 2
- ODNWIBOCFGMRTP-SRVKXCTJSA-N Asp-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CN=CN1 ODNWIBOCFGMRTP-SRVKXCTJSA-N 0.000 description 2
- SPKCGKRUYKMDHP-GUDRVLHUSA-N Asp-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N SPKCGKRUYKMDHP-GUDRVLHUSA-N 0.000 description 2
- KLYPOCBLKMPBIQ-GHCJXIJMSA-N Asp-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N KLYPOCBLKMPBIQ-GHCJXIJMSA-N 0.000 description 2
- OEDJQRXNDRUGEU-SRVKXCTJSA-N Asp-Leu-His Chemical compound N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O OEDJQRXNDRUGEU-SRVKXCTJSA-N 0.000 description 2
- HJZLUGQGJWXJCJ-CIUDSAMLSA-N Asp-Pro-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O HJZLUGQGJWXJCJ-CIUDSAMLSA-N 0.000 description 2
- GWWSUMLEWKQHLR-NUMRIWBASA-N Asp-Thr-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O GWWSUMLEWKQHLR-NUMRIWBASA-N 0.000 description 2
- PDIYGFYAMZZFCW-JIOCBJNQSA-N Asp-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N)O PDIYGFYAMZZFCW-JIOCBJNQSA-N 0.000 description 2
- BOXNGMVEVOGXOJ-UBHSHLNASA-N Asp-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N BOXNGMVEVOGXOJ-UBHSHLNASA-N 0.000 description 2
- 241001465318 Aspergillus terreus Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241001147386 Bos sp. Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- BIVLWXQGXJLGKG-BIIVOSGPSA-N Cys-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N)C(=O)O BIVLWXQGXJLGKG-BIIVOSGPSA-N 0.000 description 2
- IWVNIQXKTIQXCT-SRVKXCTJSA-N Cys-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CS)N)O IWVNIQXKTIQXCT-SRVKXCTJSA-N 0.000 description 2
- 241000255601 Drosophila melanogaster Species 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- 241000287830 Gallus sp. Species 0.000 description 2
- ZPDVKYLJTOFQJV-WDSKDSINSA-N Gln-Asn-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O ZPDVKYLJTOFQJV-WDSKDSINSA-N 0.000 description 2
- BVELAHPZLYLZDJ-HGNGGELXSA-N Gln-His-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O BVELAHPZLYLZDJ-HGNGGELXSA-N 0.000 description 2
- OSCLNNWLKKIQJM-WDSKDSINSA-N Gln-Ser-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O OSCLNNWLKKIQJM-WDSKDSINSA-N 0.000 description 2
- FITIQFSXXBKFFM-NRPADANISA-N Gln-Val-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FITIQFSXXBKFFM-NRPADANISA-N 0.000 description 2
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 2
- GCYFUZJHAXJKKE-KKUMJFAQSA-N Glu-Arg-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GCYFUZJHAXJKKE-KKUMJFAQSA-N 0.000 description 2
- FYYSIASRLDJUNP-WHFBIAKZSA-N Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FYYSIASRLDJUNP-WHFBIAKZSA-N 0.000 description 2
- FKGNJUCQKXQNRA-NRPADANISA-N Glu-Cys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O FKGNJUCQKXQNRA-NRPADANISA-N 0.000 description 2
- GYCPQVFKCPPRQB-GUBZILKMSA-N Glu-Gln-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)N GYCPQVFKCPPRQB-GUBZILKMSA-N 0.000 description 2
- WLIPTFCZLHCNFD-LPEHRKFASA-N Glu-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O WLIPTFCZLHCNFD-LPEHRKFASA-N 0.000 description 2
- CGOHAEBMDSEKFB-FXQIFTODSA-N Glu-Glu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O CGOHAEBMDSEKFB-FXQIFTODSA-N 0.000 description 2
- APHGWLWMOXGZRL-DCAQKATOSA-N Glu-Glu-His Chemical compound N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O APHGWLWMOXGZRL-DCAQKATOSA-N 0.000 description 2
- VGBSZQSKQRMLHD-MNXVOIDGSA-N Glu-Leu-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VGBSZQSKQRMLHD-MNXVOIDGSA-N 0.000 description 2
- ZTVGZOIBLRPQNR-KKUMJFAQSA-N Glu-Met-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZTVGZOIBLRPQNR-KKUMJFAQSA-N 0.000 description 2
- NNQDRRUXFJYCCJ-NHCYSSNCSA-N Glu-Pro-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O NNQDRRUXFJYCCJ-NHCYSSNCSA-N 0.000 description 2
- GPSHCSTUYOQPAI-JHEQGTHGSA-N Glu-Thr-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O GPSHCSTUYOQPAI-JHEQGTHGSA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- CLODWIOAKCSBAN-BQBZGAKWSA-N Gly-Arg-Asp Chemical compound NC(N)=NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(O)=O)C(O)=O CLODWIOAKCSBAN-BQBZGAKWSA-N 0.000 description 2
- TZOVVRJYUDETQG-RCOVLWMOSA-N Gly-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN TZOVVRJYUDETQG-RCOVLWMOSA-N 0.000 description 2
- HFXJIZNEXNIZIJ-BQBZGAKWSA-N Gly-Glu-Gln Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HFXJIZNEXNIZIJ-BQBZGAKWSA-N 0.000 description 2
- QSVCIFZPGLOZGH-WDSKDSINSA-N Gly-Glu-Ser Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O QSVCIFZPGLOZGH-WDSKDSINSA-N 0.000 description 2
- HQRHFUYMGCHHJS-LURJTMIESA-N Gly-Gly-Arg Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N HQRHFUYMGCHHJS-LURJTMIESA-N 0.000 description 2
- XMPXVJIDADUOQB-RCOVLWMOSA-N Gly-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C([O-])=O)NC(=O)CNC(=O)C[NH3+] XMPXVJIDADUOQB-RCOVLWMOSA-N 0.000 description 2
- UQJNXZSSGQIPIQ-FBCQKBJTSA-N Gly-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)CN UQJNXZSSGQIPIQ-FBCQKBJTSA-N 0.000 description 2
- MHXKHKWHPNETGG-QWRGUYRKSA-N Gly-Lys-Leu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O MHXKHKWHPNETGG-QWRGUYRKSA-N 0.000 description 2
- QLQDIJBYJZKQPR-BQBZGAKWSA-N Gly-Met-Cys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)CN QLQDIJBYJZKQPR-BQBZGAKWSA-N 0.000 description 2
- YHYDTTUSJXGTQK-UWVGGRQHSA-N Gly-Met-Leu Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(O)=O YHYDTTUSJXGTQK-UWVGGRQHSA-N 0.000 description 2
- YOBGUCWZPXJHTN-BQBZGAKWSA-N Gly-Ser-Arg Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YOBGUCWZPXJHTN-BQBZGAKWSA-N 0.000 description 2
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 2
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 2
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 2
- BXDLTKLPPKBVEL-FJXKBIBVSA-N Gly-Thr-Met Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(O)=O BXDLTKLPPKBVEL-FJXKBIBVSA-N 0.000 description 2
- NWOSHVVPKDQKKT-RYUDHWBXSA-N Gly-Tyr-Gln Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O NWOSHVVPKDQKKT-RYUDHWBXSA-N 0.000 description 2
- DUAWRXXTOQOECJ-JSGCOSHPSA-N Gly-Tyr-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O DUAWRXXTOQOECJ-JSGCOSHPSA-N 0.000 description 2
- KYFGGRHWLFZXPU-KKUMJFAQSA-N His-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N KYFGGRHWLFZXPU-KKUMJFAQSA-N 0.000 description 2
- WECYRWOMWSCWNX-XUXIUFHCSA-N Ile-Arg-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O WECYRWOMWSCWNX-XUXIUFHCSA-N 0.000 description 2
- YKRIXHPEIZUDDY-GMOBBJLQSA-N Ile-Asn-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YKRIXHPEIZUDDY-GMOBBJLQSA-N 0.000 description 2
- NPROWIBAWYMPAZ-GUDRVLHUSA-N Ile-Asp-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N NPROWIBAWYMPAZ-GUDRVLHUSA-N 0.000 description 2
- AQTWDZDISVGCAC-CFMVVWHZSA-N Ile-Asp-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N AQTWDZDISVGCAC-CFMVVWHZSA-N 0.000 description 2
- RMNMUUCYTMLWNA-ZPFDUUQYSA-N Ile-Lys-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N RMNMUUCYTMLWNA-ZPFDUUQYSA-N 0.000 description 2
- PNTWNAXGBOZMBO-MNXVOIDGSA-N Ile-Lys-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PNTWNAXGBOZMBO-MNXVOIDGSA-N 0.000 description 2
- FFAUOCITXBMRBT-YTFOTSKYSA-N Ile-Lys-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FFAUOCITXBMRBT-YTFOTSKYSA-N 0.000 description 2
- IDMNOFVUXYYZPF-DKIMLUQUSA-N Ile-Lys-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N IDMNOFVUXYYZPF-DKIMLUQUSA-N 0.000 description 2
- VZSDQFZFTCVEGF-ZEWNOJEFSA-N Ile-Phe-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O VZSDQFZFTCVEGF-ZEWNOJEFSA-N 0.000 description 2
- OWSWUWDMSNXTNE-GMOBBJLQSA-N Ile-Pro-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N OWSWUWDMSNXTNE-GMOBBJLQSA-N 0.000 description 2
- FQYQMFCIJNWDQZ-CYDGBPFRSA-N Ile-Pro-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 FQYQMFCIJNWDQZ-CYDGBPFRSA-N 0.000 description 2
- IPFKIGNDTUOFAF-CYDGBPFRSA-N Ile-Val-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IPFKIGNDTUOFAF-CYDGBPFRSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 2
- KFKWRHQBZQICHA-STQMWFEESA-N L-leucyl-L-phenylalanine Natural products CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- KWTVLKBOQATPHJ-SRVKXCTJSA-N Leu-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N KWTVLKBOQATPHJ-SRVKXCTJSA-N 0.000 description 2
- JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 2
- GBDMISNMNXVTNV-XIRDDKMYSA-N Leu-Asp-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O GBDMISNMNXVTNV-XIRDDKMYSA-N 0.000 description 2
- XQXGNBFMAXWIGI-MXAVVETBSA-N Leu-His-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)CC1=CN=CN1 XQXGNBFMAXWIGI-MXAVVETBSA-N 0.000 description 2
- UBZGNBKMIJHOHL-BZSNNMDCSA-N Leu-Leu-Phe Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 UBZGNBKMIJHOHL-BZSNNMDCSA-N 0.000 description 2
- OVZLLFONXILPDZ-VOAKCMCISA-N Leu-Lys-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OVZLLFONXILPDZ-VOAKCMCISA-N 0.000 description 2
- INCJJHQRZGQLFC-KBPBESRZSA-N Leu-Phe-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O INCJJHQRZGQLFC-KBPBESRZSA-N 0.000 description 2
- PTRKPHUGYULXPU-KKUMJFAQSA-N Leu-Phe-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O PTRKPHUGYULXPU-KKUMJFAQSA-N 0.000 description 2
- VULJUQZPSOASBZ-SRVKXCTJSA-N Leu-Pro-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O VULJUQZPSOASBZ-SRVKXCTJSA-N 0.000 description 2
- AMSSKPUHBUQBOQ-SRVKXCTJSA-N Leu-Ser-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N AMSSKPUHBUQBOQ-SRVKXCTJSA-N 0.000 description 2
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 2
- CNWDWAMPKVYJJB-NUTKFTJISA-N Leu-Trp-Ala Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 CNWDWAMPKVYJJB-NUTKFTJISA-N 0.000 description 2
- LSLUTXRANSUGFY-XIRDDKMYSA-N Leu-Trp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(O)=O LSLUTXRANSUGFY-XIRDDKMYSA-N 0.000 description 2
- ARNIBBOXIAWUOP-MGHWNKPDSA-N Leu-Tyr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ARNIBBOXIAWUOP-MGHWNKPDSA-N 0.000 description 2
- SEOXPEFQEOYURL-PMVMPFDFSA-N Leu-Tyr-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O SEOXPEFQEOYURL-PMVMPFDFSA-N 0.000 description 2
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- CLBGMWIYPYAZPR-AVGNSLFASA-N Lys-Arg-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O CLBGMWIYPYAZPR-AVGNSLFASA-N 0.000 description 2
- AAORVPFVUIHEAB-YUMQZZPRSA-N Lys-Asp-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O AAORVPFVUIHEAB-YUMQZZPRSA-N 0.000 description 2
- NTBFKPBULZGXQL-KKUMJFAQSA-N Lys-Asp-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NTBFKPBULZGXQL-KKUMJFAQSA-N 0.000 description 2
- DFXQCCBKGUNYGG-GUBZILKMSA-N Lys-Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN DFXQCCBKGUNYGG-GUBZILKMSA-N 0.000 description 2
- CRNNMTHBMRFQNG-GUBZILKMSA-N Lys-Glu-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N CRNNMTHBMRFQNG-GUBZILKMSA-N 0.000 description 2
- LPAJOCKCPRZEAG-MNXVOIDGSA-N Lys-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCCN LPAJOCKCPRZEAG-MNXVOIDGSA-N 0.000 description 2
- NJNRBRKHOWSGMN-SRVKXCTJSA-N Lys-Leu-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O NJNRBRKHOWSGMN-SRVKXCTJSA-N 0.000 description 2
- RIJCHEVHFWMDKD-SRVKXCTJSA-N Lys-Lys-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RIJCHEVHFWMDKD-SRVKXCTJSA-N 0.000 description 2
- SQXZLVXQXWILKW-KKUMJFAQSA-N Lys-Ser-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SQXZLVXQXWILKW-KKUMJFAQSA-N 0.000 description 2
- CAVRAQIDHUPECU-UVOCVTCTSA-N Lys-Thr-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAVRAQIDHUPECU-UVOCVTCTSA-N 0.000 description 2
- LMMBAXJRYSXCOQ-ACRUOGEOSA-N Lys-Tyr-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O LMMBAXJRYSXCOQ-ACRUOGEOSA-N 0.000 description 2
- SQRLLZAQNOQCEG-KKUMJFAQSA-N Lys-Tyr-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 SQRLLZAQNOQCEG-KKUMJFAQSA-N 0.000 description 2
- QLFAPXUXEBAWEK-NHCYSSNCSA-N Lys-Val-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QLFAPXUXEBAWEK-NHCYSSNCSA-N 0.000 description 2
- 239000007987 MES buffer Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- RKIIYGUHIQJCBW-SRVKXCTJSA-N Met-His-Glu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O RKIIYGUHIQJCBW-SRVKXCTJSA-N 0.000 description 2
- OCRSGGIJBDUXHU-WDSOQIARSA-N Met-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(O)=O)=CNC2=C1 OCRSGGIJBDUXHU-WDSOQIARSA-N 0.000 description 2
- IILAGWCGKJSBGB-IHRRRGAJSA-N Met-Phe-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N IILAGWCGKJSBGB-IHRRRGAJSA-N 0.000 description 2
- MIXPUVSPPOWTCR-FXQIFTODSA-N Met-Ser-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MIXPUVSPPOWTCR-FXQIFTODSA-N 0.000 description 2
- KYXDADPHSNFWQX-VEVYYDQMSA-N Met-Thr-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O KYXDADPHSNFWQX-VEVYYDQMSA-N 0.000 description 2
- KYJHWKAMFISDJE-RCWTZXSCSA-N Met-Thr-Met Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCSC KYJHWKAMFISDJE-RCWTZXSCSA-N 0.000 description 2
- ZBLSZPYQQRIHQU-RCWTZXSCSA-N Met-Thr-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O ZBLSZPYQQRIHQU-RCWTZXSCSA-N 0.000 description 2
- GHQFLTYXGUETFD-UFYCRDLUSA-N Met-Tyr-Tyr Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N GHQFLTYXGUETFD-UFYCRDLUSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 2
- 108010047562 NGR peptide Proteins 0.000 description 2
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 2
- MQVFHOPCKNTHGT-MELADBBJSA-N Phe-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O MQVFHOPCKNTHGT-MELADBBJSA-N 0.000 description 2
- UEHNWRNADDPYNK-DLOVCJGASA-N Phe-Cys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CC=CC=C1)N UEHNWRNADDPYNK-DLOVCJGASA-N 0.000 description 2
- WYPVCIACUMJRIB-JYJNAYRXSA-N Phe-Gln-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N WYPVCIACUMJRIB-JYJNAYRXSA-N 0.000 description 2
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 2
- ZUQACJLOHYRVPJ-DKIMLUQUSA-N Phe-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 ZUQACJLOHYRVPJ-DKIMLUQUSA-N 0.000 description 2
- AAERWTUHZKLDLC-IHRRRGAJSA-N Phe-Pro-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O AAERWTUHZKLDLC-IHRRRGAJSA-N 0.000 description 2
- ZYNBEWGJFXTBDU-ACRUOGEOSA-N Phe-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)N ZYNBEWGJFXTBDU-ACRUOGEOSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- DZZCICYRSZASNF-FXQIFTODSA-N Pro-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 DZZCICYRSZASNF-FXQIFTODSA-N 0.000 description 2
- KIZQGKLMXKGDIV-BQBZGAKWSA-N Pro-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 KIZQGKLMXKGDIV-BQBZGAKWSA-N 0.000 description 2
- VPVHXWGPALPDGP-GUBZILKMSA-N Pro-Asn-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VPVHXWGPALPDGP-GUBZILKMSA-N 0.000 description 2
- LHALYDBUDCWMDY-CIUDSAMLSA-N Pro-Glu-Ala Chemical compound C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O LHALYDBUDCWMDY-CIUDSAMLSA-N 0.000 description 2
- PULPZRAHVFBVTO-DCAQKATOSA-N Pro-Glu-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PULPZRAHVFBVTO-DCAQKATOSA-N 0.000 description 2
- MGDFPGCFVJFITQ-CIUDSAMLSA-N Pro-Glu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MGDFPGCFVJFITQ-CIUDSAMLSA-N 0.000 description 2
- SRBFGSGDNNQABI-FHWLQOOXSA-N Pro-Leu-Trp Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C(=O)[C@@H]1CCCN1 SRBFGSGDNNQABI-FHWLQOOXSA-N 0.000 description 2
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 2
- ZUZINZIJHJFJRN-UBHSHLNASA-N Pro-Phe-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 ZUZINZIJHJFJRN-UBHSHLNASA-N 0.000 description 2
- OOZJHTXCLJUODH-QXEWZRGKSA-N Pro-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 OOZJHTXCLJUODH-QXEWZRGKSA-N 0.000 description 2
- ZMLRZBWCXPQADC-TUAOUCFPSA-N Pro-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 ZMLRZBWCXPQADC-TUAOUCFPSA-N 0.000 description 2
- MTMJNKFZDQEVSY-BZSNNMDCSA-N Pro-Val-Trp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O MTMJNKFZDQEVSY-BZSNNMDCSA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- QWZIOCFPXMAXET-CIUDSAMLSA-N Ser-Arg-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O QWZIOCFPXMAXET-CIUDSAMLSA-N 0.000 description 2
- VAUMZJHYZQXZBQ-WHFBIAKZSA-N Ser-Asn-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O VAUMZJHYZQXZBQ-WHFBIAKZSA-N 0.000 description 2
- DKKGAAJTDKHWOD-BIIVOSGPSA-N Ser-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)C(=O)O DKKGAAJTDKHWOD-BIIVOSGPSA-N 0.000 description 2
- SNNSYBWPPVAXQW-ZLUOBGJFSA-N Ser-Cys-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O)N)O SNNSYBWPPVAXQW-ZLUOBGJFSA-N 0.000 description 2
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 2
- JWOBLHJRDADHLN-KKUMJFAQSA-N Ser-Leu-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JWOBLHJRDADHLN-KKUMJFAQSA-N 0.000 description 2
- NIOYDASGXWLHEZ-CIUDSAMLSA-N Ser-Met-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O NIOYDASGXWLHEZ-CIUDSAMLSA-N 0.000 description 2
- ANOQEBQWIAYIMV-AEJSXWLSSA-N Ser-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N ANOQEBQWIAYIMV-AEJSXWLSSA-N 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- LVHHEVGYAZGXDE-KDXUFGMBSA-N Thr-Ala-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(=O)O)N)O LVHHEVGYAZGXDE-KDXUFGMBSA-N 0.000 description 2
- VUVCRYXYUUPGSB-GLLZPBPUSA-N Thr-Gln-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O VUVCRYXYUUPGSB-GLLZPBPUSA-N 0.000 description 2
- HJOSVGCWOTYJFG-WDCWCFNPSA-N Thr-Glu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O HJOSVGCWOTYJFG-WDCWCFNPSA-N 0.000 description 2
- QQWNRERCGGZOKG-WEDXCCLWSA-N Thr-Gly-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O QQWNRERCGGZOKG-WEDXCCLWSA-N 0.000 description 2
- MPUMPERGHHJGRP-WEDXCCLWSA-N Thr-Gly-Lys Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N)O MPUMPERGHHJGRP-WEDXCCLWSA-N 0.000 description 2
- CRZNCABIJLRFKZ-IUKAMOBKSA-N Thr-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N CRZNCABIJLRFKZ-IUKAMOBKSA-N 0.000 description 2
- PZSDPRBZINDEJV-HTUGSXCWSA-N Thr-Phe-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PZSDPRBZINDEJV-HTUGSXCWSA-N 0.000 description 2
- NDZYTIMDOZMECO-SHGPDSBTSA-N Thr-Thr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O NDZYTIMDOZMECO-SHGPDSBTSA-N 0.000 description 2
- PWONLXBUSVIZPH-RHYQMDGZSA-N Thr-Val-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O PWONLXBUSVIZPH-RHYQMDGZSA-N 0.000 description 2
- 108700009124 Transcription Initiation Site Proteins 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- PXQPYPMSLBQHJJ-WFBYXXMGSA-N Trp-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N PXQPYPMSLBQHJJ-WFBYXXMGSA-N 0.000 description 2
- UGFOSENEZHEQKX-PJODQICGSA-N Trp-Val-Ala Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(O)=O UGFOSENEZHEQKX-PJODQICGSA-N 0.000 description 2
- TVOGEPLDNYTAHD-CQDKDKBSSA-N Tyr-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 TVOGEPLDNYTAHD-CQDKDKBSSA-N 0.000 description 2
- KSVMDJJCYKIXTK-IGNZVWTISA-N Tyr-Ala-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 KSVMDJJCYKIXTK-IGNZVWTISA-N 0.000 description 2
- XHALUUQSNXSPLP-UFYCRDLUSA-N Tyr-Arg-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 XHALUUQSNXSPLP-UFYCRDLUSA-N 0.000 description 2
- RCLOWEZASFJFEX-KKUMJFAQSA-N Tyr-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 RCLOWEZASFJFEX-KKUMJFAQSA-N 0.000 description 2
- PMDWYLVWHRTJIW-STQMWFEESA-N Tyr-Gly-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PMDWYLVWHRTJIW-STQMWFEESA-N 0.000 description 2
- KIJLSRYAUGGZIN-CFMVVWHZSA-N Tyr-Ile-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O KIJLSRYAUGGZIN-CFMVVWHZSA-N 0.000 description 2
- AXWBYOVVDRBOGU-SIUGBPQLSA-N Tyr-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N AXWBYOVVDRBOGU-SIUGBPQLSA-N 0.000 description 2
- WTTRJMAZPDHPGS-KKXDTOCCSA-N Tyr-Phe-Ala Chemical compound C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O WTTRJMAZPDHPGS-KKXDTOCCSA-N 0.000 description 2
- NHOVZGFNTGMYMI-KKUMJFAQSA-N Tyr-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NHOVZGFNTGMYMI-KKUMJFAQSA-N 0.000 description 2
- MDXLPNRXCFOBTL-BZSNNMDCSA-N Tyr-Ser-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MDXLPNRXCFOBTL-BZSNNMDCSA-N 0.000 description 2
- TYFLVOUZHQUBGM-IHRRRGAJSA-N Tyr-Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 TYFLVOUZHQUBGM-IHRRRGAJSA-N 0.000 description 2
- XLDYBRXERHITNH-QSFUFRPTSA-N Val-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)C(C)C XLDYBRXERHITNH-QSFUFRPTSA-N 0.000 description 2
- FRUYSSRPJXNRRB-GUBZILKMSA-N Val-Cys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N FRUYSSRPJXNRRB-GUBZILKMSA-N 0.000 description 2
- URIRWLJVWHYLET-ONGXEEELSA-N Val-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C URIRWLJVWHYLET-ONGXEEELSA-N 0.000 description 2
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 2
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 2
- XPKCFQZDQGVJCX-RHYQMDGZSA-N Val-Lys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N)O XPKCFQZDQGVJCX-RHYQMDGZSA-N 0.000 description 2
- QZKVWWIUSQGWMY-IHRRRGAJSA-N Val-Ser-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QZKVWWIUSQGWMY-IHRRRGAJSA-N 0.000 description 2
- CEKSLIVSNNGOKH-KZVJFYERSA-N Val-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](C(C)C)N)O CEKSLIVSNNGOKH-KZVJFYERSA-N 0.000 description 2
- RLVTVHSDKHBFQP-ULQDDVLXSA-N Val-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 RLVTVHSDKHBFQP-ULQDDVLXSA-N 0.000 description 2
- SSKKGOWRPNIVDW-AVGNSLFASA-N Val-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N SSKKGOWRPNIVDW-AVGNSLFASA-N 0.000 description 2
- 241000269370 Xenopus <genus> Species 0.000 description 2
- 241000269368 Xenopus laevis Species 0.000 description 2
- 241000269360 Xenopus sp. Species 0.000 description 2
- 108010039538 alanyl-glycyl-aspartyl-valine Proteins 0.000 description 2
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 2
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- 238000005571 anion exchange chromatography Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- 108010004073 cysteinylcysteine Proteins 0.000 description 2
- 108010016616 cysteinylglycine Proteins 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 108010078144 glutaminyl-glycine Proteins 0.000 description 2
- 108010062266 glycyl-glycyl-argininal Proteins 0.000 description 2
- 108010010096 glycyl-glycyl-tyrosine Proteins 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000000710 homodimer Substances 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 2
- 108010053037 kyotorphin Proteins 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 2
- 108010030617 leucyl-phenylalanyl-valine Proteins 0.000 description 2
- 108010091871 leucylmethionine Proteins 0.000 description 2
- 108010012058 leucyltyrosine Proteins 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 108010003700 lysyl aspartic acid Proteins 0.000 description 2
- 108010057952 lysyl-phenylalanyl-lysine Proteins 0.000 description 2
- 108010038320 lysylphenylalanine Proteins 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 108010012581 phenylalanylglutamate Proteins 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 108010003137 tyrosyltyrosine Proteins 0.000 description 2
- QHOREGFPJWHMCU-VGMFFHCQSA-N (2r)-3,3-dimethyl-2,4-bis(oxidanyl)-n-(3-oxidanylpropyl)butanamide Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO.OCC(C)(C)[C@@H](O)C(=O)NCCCO QHOREGFPJWHMCU-VGMFFHCQSA-N 0.000 description 1
- SYTBZMRGLBWNTM-SNVBAGLBSA-N (R)-flurbiprofen Chemical compound FC1=CC([C@H](C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-SNVBAGLBSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- 101710161460 3-oxoacyl-[acyl-carrier-protein] synthase Proteins 0.000 description 1
- 101710134681 40 kDa protein Proteins 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 1
- AWAXZRDKUHOPBO-GUBZILKMSA-N Ala-Gln-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O AWAXZRDKUHOPBO-GUBZILKMSA-N 0.000 description 1
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 description 1
- MPLOSMWGDNJSEV-WHFBIAKZSA-N Ala-Gly-Asp Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MPLOSMWGDNJSEV-WHFBIAKZSA-N 0.000 description 1
- REWSWYIDQIELBE-FXQIFTODSA-N Ala-Val-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O REWSWYIDQIELBE-FXQIFTODSA-N 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 101100519158 Arabidopsis thaliana PCR2 gene Proteins 0.000 description 1
- FTMRPIVPSDVGCC-GUBZILKMSA-N Arg-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N FTMRPIVPSDVGCC-GUBZILKMSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- RRVBEKYEFMCDIF-WHFBIAKZSA-N Asn-Cys-Gly Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)O)N)C(=O)N RRVBEKYEFMCDIF-WHFBIAKZSA-N 0.000 description 1
- GNKVBRYFXYWXAB-WDSKDSINSA-N Asn-Glu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O GNKVBRYFXYWXAB-WDSKDSINSA-N 0.000 description 1
- GHWWTICYPDKPTE-NGZCFLSTSA-N Asn-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N GHWWTICYPDKPTE-NGZCFLSTSA-N 0.000 description 1
- RRKCPMGSRIDLNC-AVGNSLFASA-N Asp-Glu-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RRKCPMGSRIDLNC-AVGNSLFASA-N 0.000 description 1
- KESWRFKUZRUTAH-FXQIFTODSA-N Asp-Pro-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O KESWRFKUZRUTAH-FXQIFTODSA-N 0.000 description 1
- JGLWFWXGOINXEA-YDHLFZDLSA-N Asp-Val-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 JGLWFWXGOINXEA-YDHLFZDLSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000228232 Aspergillus tubingensis Species 0.000 description 1
- 241000208199 Buxus sempervirens Species 0.000 description 1
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- MXZYQNJCBVJHSR-KATARQTJSA-N Cys-Lys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N)O MXZYQNJCBVJHSR-KATARQTJSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LKVCNGLNTAPMSZ-JYJNAYRXSA-N Gln-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCC(=O)N)N LKVCNGLNTAPMSZ-JYJNAYRXSA-N 0.000 description 1
- VLOLPWWCNKWRNB-LOKLDPHHSA-N Gln-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O VLOLPWWCNKWRNB-LOKLDPHHSA-N 0.000 description 1
- WPLGNDORMXTMQS-FXQIFTODSA-N Glu-Gln-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O WPLGNDORMXTMQS-FXQIFTODSA-N 0.000 description 1
- UMHRCVCZUPBBQW-GARJFASQSA-N Glu-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N UMHRCVCZUPBBQW-GARJFASQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- KQDMENMTYNBWMR-WHFBIAKZSA-N Gly-Asp-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KQDMENMTYNBWMR-WHFBIAKZSA-N 0.000 description 1
- XPJBQTCXPJNIFE-ZETCQYMHSA-N Gly-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 1
- BHPQOIPBLYJNAW-NGZCFLSTSA-N Gly-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN BHPQOIPBLYJNAW-NGZCFLSTSA-N 0.000 description 1
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 1
- PYFIQROSWQERAS-LBPRGKRZSA-N Gly-Trp-Gly Chemical compound C1=CC=C2C(C[C@H](NC(=O)CN)C(=O)NCC(O)=O)=CNC2=C1 PYFIQROSWQERAS-LBPRGKRZSA-N 0.000 description 1
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 1
- MUGLKCQHTUFLGF-WPRPVWTQSA-N Gly-Val-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)CN MUGLKCQHTUFLGF-WPRPVWTQSA-N 0.000 description 1
- HVCRQRQPIIRNLY-IUCAKERBSA-N His-Gln-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)O)N HVCRQRQPIIRNLY-IUCAKERBSA-N 0.000 description 1
- IIVZNQCUUMBBKF-GVXVVHGQSA-N His-Gln-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC1=CN=CN1 IIVZNQCUUMBBKF-GVXVVHGQSA-N 0.000 description 1
- SAPLASXFNUYUFE-CQDKDKBSSA-N His-Phe-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CN=CN2)N SAPLASXFNUYUFE-CQDKDKBSSA-N 0.000 description 1
- 101000777550 Homo sapiens CCN family member 2 Proteins 0.000 description 1
- BSWLQVGEVFYGIM-ZPFDUUQYSA-N Ile-Gln-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N BSWLQVGEVFYGIM-ZPFDUUQYSA-N 0.000 description 1
- LPFBXFILACZHIB-LAEOZQHASA-N Ile-Gly-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)N LPFBXFILACZHIB-LAEOZQHASA-N 0.000 description 1
- QHUREMVLLMNUAX-OSUNSFLBSA-N Ile-Thr-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)O)N QHUREMVLLMNUAX-OSUNSFLBSA-N 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- USTCFDAQCLDPBD-XIRDDKMYSA-N Leu-Asn-Trp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N USTCFDAQCLDPBD-XIRDDKMYSA-N 0.000 description 1
- VQPPIMUZCZCOIL-GUBZILKMSA-N Leu-Gln-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O VQPPIMUZCZCOIL-GUBZILKMSA-N 0.000 description 1
- WQWSMEOYXJTFRU-GUBZILKMSA-N Leu-Glu-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O WQWSMEOYXJTFRU-GUBZILKMSA-N 0.000 description 1
- BABSVXFGKFLIGW-UWVGGRQHSA-N Leu-Gly-Arg Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N BABSVXFGKFLIGW-UWVGGRQHSA-N 0.000 description 1
- AIRUUHAOKGVJAD-JYJNAYRXSA-N Leu-Phe-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIRUUHAOKGVJAD-JYJNAYRXSA-N 0.000 description 1
- UHNQRAFSEBGZFZ-YESZJQIVSA-N Leu-Phe-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N UHNQRAFSEBGZFZ-YESZJQIVSA-N 0.000 description 1
- BMVFXOQHDQZAQU-DCAQKATOSA-N Leu-Pro-Asp Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N BMVFXOQHDQZAQU-DCAQKATOSA-N 0.000 description 1
- YRRCOJOXAJNSAX-IHRRRGAJSA-N Leu-Pro-Lys Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N YRRCOJOXAJNSAX-IHRRRGAJSA-N 0.000 description 1
- AIMGJYMCTAABEN-GVXVVHGQSA-N Leu-Val-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIMGJYMCTAABEN-GVXVVHGQSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- GHOIOYHDDKXIDX-SZMVWBNQSA-N Lys-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCCN)C(O)=O)=CNC2=C1 GHOIOYHDDKXIDX-SZMVWBNQSA-N 0.000 description 1
- HAUUXTXKJNVIFY-ONGXEEELSA-N Lys-Gly-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HAUUXTXKJNVIFY-ONGXEEELSA-N 0.000 description 1
- JHNOXVASMSXSNB-WEDXCCLWSA-N Lys-Thr-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JHNOXVASMSXSNB-WEDXCCLWSA-N 0.000 description 1
- UGCIQUYEJIEHKX-GVXVVHGQSA-N Lys-Val-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O UGCIQUYEJIEHKX-GVXVVHGQSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- RDLSEGZJMYGFNS-FXQIFTODSA-N Met-Ser-Asp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RDLSEGZJMYGFNS-FXQIFTODSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 1
- 101150102573 PCR1 gene Proteins 0.000 description 1
- 101710176384 Peptide 1 Proteins 0.000 description 1
- IDUCUXTUHHIQIP-SOUVJXGZSA-N Phe-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O IDUCUXTUHHIQIP-SOUVJXGZSA-N 0.000 description 1
- XMQSOOJRRVEHRO-ULQDDVLXSA-N Phe-Leu-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 XMQSOOJRRVEHRO-ULQDDVLXSA-N 0.000 description 1
- MSHZERMPZKCODG-ACRUOGEOSA-N Phe-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 MSHZERMPZKCODG-ACRUOGEOSA-N 0.000 description 1
- 241000719029 Polla Species 0.000 description 1
- UEHYFUCOGHWASA-HJGDQZAQSA-N Pro-Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 UEHYFUCOGHWASA-HJGDQZAQSA-N 0.000 description 1
- WFIVLLFYUZZWOD-RHYQMDGZSA-N Pro-Lys-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WFIVLLFYUZZWOD-RHYQMDGZSA-N 0.000 description 1
- MKGIILKDUGDRRO-FXQIFTODSA-N Pro-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 MKGIILKDUGDRRO-FXQIFTODSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102100030262 Regucalcin Human genes 0.000 description 1
- 108050007056 Regucalcin Proteins 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 102000042081 SMP-30/CGR1 family Human genes 0.000 description 1
- 108091080004 SMP-30/CGR1 family Proteins 0.000 description 1
- LVVBAKCGXXUHFO-ZLUOBGJFSA-N Ser-Ala-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O LVVBAKCGXXUHFO-ZLUOBGJFSA-N 0.000 description 1
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- YBXMGKCLOPDEKA-NUMRIWBASA-N Thr-Asp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YBXMGKCLOPDEKA-NUMRIWBASA-N 0.000 description 1
- XOWKUMFHEZLKLT-CIQUZCHMSA-N Thr-Ile-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O XOWKUMFHEZLKLT-CIQUZCHMSA-N 0.000 description 1
- LKJCABTUFGTPPY-HJGDQZAQSA-N Thr-Pro-Gln Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O LKJCABTUFGTPPY-HJGDQZAQSA-N 0.000 description 1
- XKWABWFMQXMUMT-HJGDQZAQSA-N Thr-Pro-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XKWABWFMQXMUMT-HJGDQZAQSA-N 0.000 description 1
- AAZOYLQUEQRUMZ-GSSVUCPTSA-N Thr-Thr-Asn Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(N)=O AAZOYLQUEQRUMZ-GSSVUCPTSA-N 0.000 description 1
- BKIOKSLLAAZYTC-KKHAAJSZSA-N Thr-Val-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O BKIOKSLLAAZYTC-KKHAAJSZSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- BEIGSKUPTIFYRZ-SRVKXCTJSA-N Tyr-Asp-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O BEIGSKUPTIFYRZ-SRVKXCTJSA-N 0.000 description 1
- JXGUUJMPCRXMSO-HJOGWXRNSA-N Tyr-Phe-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 JXGUUJMPCRXMSO-HJOGWXRNSA-N 0.000 description 1
- WQOHKVRQDLNDIL-YJRXYDGGSA-N Tyr-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O WQOHKVRQDLNDIL-YJRXYDGGSA-N 0.000 description 1
- 108010064997 VPY tripeptide Proteins 0.000 description 1
- IVXJODPZRWHCCR-JYJNAYRXSA-N Val-Arg-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N IVXJODPZRWHCCR-JYJNAYRXSA-N 0.000 description 1
- ZMDCGGKHRKNWKD-LAEOZQHASA-N Val-Asn-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZMDCGGKHRKNWKD-LAEOZQHASA-N 0.000 description 1
- PMXBARDFIAPBGK-DZKIICNBSA-N Val-Glu-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PMXBARDFIAPBGK-DZKIICNBSA-N 0.000 description 1
- AIWLHFZYOUUJGB-UFYCRDLUSA-N Val-Phe-Tyr Chemical compound C([C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 AIWLHFZYOUUJGB-UFYCRDLUSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- QWXOJIDBSHLIFI-UHFFFAOYSA-N [3-(1-chloro-3'-methoxyspiro[adamantane-4,4'-dioxetane]-3'-yl)phenyl] dihydrogen phosphate Chemical compound O1OC2(C3CC4CC2CC(Cl)(C4)C3)C1(OC)C1=CC=CC(OP(O)(O)=O)=C1 QWXOJIDBSHLIFI-UHFFFAOYSA-N 0.000 description 1
- 230000006154 adenylylation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000009025 developmental regulation Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 229910000286 fullers earth Inorganic materials 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010054666 glycyl-leucyl-glycyl-glycine Proteins 0.000 description 1
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 102000047612 human CCN2 Human genes 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229910021654 trace metal Inorganic materials 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- AVBGNFCMKJOFIN-UHFFFAOYSA-N triethylammonium acetate Chemical compound CC(O)=O.CCN(CC)CC AVBGNFCMKJOFIN-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention relates to the to encode nucleotide sequence of gene of pantolactone hydrolase, and the carrier and the host cell that contain above-mentioned nucleotide sequence, and by above-mentioned nucleotide sequence coded pantolactone hydrolase. The present invention also provides the method for making and use pantolactone hydrolase.
Description
The light that the present invention relates to can be used for pantolactone (pantolactone) enantiomter splits the enzyme of (optical resolution), the gene that relates to the described enzyme of encoding also relates to the purposes of described enzyme in the method for preparing R-pantothenic acid or its salt or R-panthenol (R-panthenol).
Enantiomter is in its physiological effect, i.e. toxicity and pharmacodynamics effect, from the reaction of enzyme with and Perception Features (sensorial characteristics) aspect be different. Known the R-pantolactone is only arranged is intermediate product in the R-pantothenic acid preparation, and R-pantothenic acid is vitamin, all is necessary its growth concerning the human and animal, breeding and the normal physiological function. Pantothenic acid is as the precursor of coacetylase and as the acyl carrier of fatty acid synthetase; relate to and surpass 100 kinds different metabolic approach; comprising the energetic supersession of carbohydrate, protein and lipid, and lipid, neurotransmitter, steroid hormone, porphyrin and hormone is synthetic. Until recently, the method that is widely used in the preparation of R-pantolactone is that the light that R-and the S-pantolactone to chemical synthesis carries out splits. This kind method is very expensive, because it need to use expensive light resolution reagent. In addition, to the recovery of the R-enantiomter of pantolactone also difficult. Therefore, the pantolactone hydrolase that provides the light of the R-that can be used for pantolactone and S-enantiomter to split is that people are needed. Using this kind of enzyme, especially be hydrolyzed S-or the R-form of pantolactone, is the more economic and more maneuverable method of separating two kinds of enantiomters of pantolactone. The example of the salt of R-pantothenic acid comprises the R-calcium pantothenate.
In one embodiment, the invention provides the nucleotide sequence of the gene of coding pantolactone hydrolase, described pantolactone hydrolase obtains from horse liver, A.niger ATCC 9142, A.niger awamori ATCC 38854 or A.niger MacRae ATCC 46951. The public can be from American Type Culture Collection (ATCC), 10801 University Boulvard, and Manassas, VA 20110-2209 USA obtains above-mentioned bacterial strains.
In another embodiment, the invention provides the nucleotide sequence of coding pantolactone hydrolase, described sequence comprises: when pantolactone hydrolase during from the horse liver, and the nucleotide sequence shown in SEQ ID NO:1; When pantolactone hydrolase during from A.niger MacRae ATCC 46951, the nucleotide sequence shown in SEQ ID NO:5; When pantolactone hydrolase during from A.niger ATCC 9142, the sequence shown in SEQ ID NO:7; And when pantolactone hydrolase during from A.niger awamori ATCC 38854, the sequence shown in SEQ ID NO:9.
Described nucleotide sequence can comprise coded sequence and the regulating and controlling sequence of above-mentioned every kind of pantolactone hydrolase.
" regulating and controlling sequence " is defined as at this: instruct the arrangement of the nucleic acid control sequence of the transcribed nucleic acid that is operably connected. The example of this type of expression control sequenc is promoter. " promoter " is included near the necessary nucleotide sequence the transcription initiation site. Promoter also comprises alternatively the far-end enhancer or checks element, and it can be positioned reaching on the thousands of base-pairs after the transcription initiation site. " composing type " promoter is activated promoter all under most of environment and developmental condition. " induction type " promoter is the activated promoter of tool in environment or developmental regulation. Term " is operably connected " and refers to functional connection between expression of nucleic acid control sequence (for example arrangement of promoter or transcription factor binding site point) and the second nucleotide sequence, and wherein said expression control sequenc instructs transcribing corresponding to the nucleic acid of the second sequence.
Can use the fragment of nucleotide sequence, for example, in cross experiment as probe.
Insert nucleotide sequence in host living beings, make it transcribe and translate, in the situation with the manufacturing function polypeptide, the technical staff will recognize, because code degeneracy, and a variety of polynucleotide sequences same polypeptide of all will encoding. These variants also comprise within the scope of the present invention clearly. In addition, the present invention also comprises following sequence clearly, described sequence is identical in fact (according to hereinafter described determining) each other, their codings be wild type peptide mutant polypeptide or remain with the polypeptide (for example being obtained by the conservative replacement to polypeptide amino acid) of polypeptide function. In addition, variant can be the following dominant negative mutant of coding.
If according to hereinafter described carrying out most homogeneous when comparison, two nucleotide sequences or polypeptide nucleotide sequence or amino acid residue separately are same, and these two nucleotide sequences or polypeptide can be considered to " identical ". In the context about two or more pieces nucleic acid or peptide sequence, term " identical " or percentage " homogeny " refer to: carry out most homogeneous in comparison window (comparison window) and relatively reach when comparison, in the situation of observing to measure with a kind of in the following sequence comparison algorithm or by manual comparison and eyes, two or more pieces sequence or subsequence are same, or wherein same amino acid residue or nucleotides has specific percentage. When the percentage of sequence homogeny uses for protein or peptide, will be appreciated that, not identical residue position is normally owing to conservative 49-Phe ,82-Ser,115-Arg,144-Met,145-Asn ,161-Arg,169-Met Human Connective tissue growth factor causes different, wherein amino acid residue is substituted by other and (for example has similar chemical property, electric charge or hydrophobicity) amino acid residue, therefore do not change the functional attributes of molecule. When sequence replaces not simultaneously because of conservative, can because of the conservative essence that replaces, percentage sequence homogeny be raised to proofread and correct. The method of carrying out this adjusting is well known to a person skilled in the art. Typically, this comprises and will conservative replace as part but not completely mispairing is marked, thereby improves percentage sequence homogeny. Therefore, for example, divide for identical amino acid/11, giving in 0 minute the situation of non-conservative replacement, giving the conservative mark that replaces between 0 and 1. According to, for example, Meyers ﹠ Miller, the algorithm of Computer Applic.Biol.Sci.4:11-17 (1988), for example, at program PC/GENE (Intelligenetics, Mountain View, Calif., realize in USA), calculate to conservative replace to minute.
In the context about two nucleic acid or polypeptide, phrase " identical in fact " refers to: when comparison window is carried out the most homogeneous comparison, in the situation of observing to measure with a kind of in the following sequence comparison algorithm or by manual comparison and eyes, have at least 60%, preferred 80%, most preferably sequence or the subsequence of the nucleotides of 90-95% or amino acid residue homogeny. This definition also refer to can with the complementary series of the sequence of sequence hybridization to be measured.
To sequence comparatively speaking, typically, a sequence compares sequence to be measured as canonical sequence with it. When using sequence comparison algorithm, to be measured and canonical sequence all are input in the computer, if necessary, specify the subsequence coordinate, and specified sequence algorithm routine parameter. Can use default program parameter, perhaps specify other parameter. Then sequence comparison algorithm can based on program parameter, be treated the percentage sequence homogeny that is listed as with respect to canonical sequence that checks order and calculate.
" comparison window " used herein comprising: refer to a kind of segment, the quantity of its continuous position is selected from by 20 to 600, common about 50 to about 200, be more typically about 100 to about 150 groups that consist of, wherein, sequence can compare with the canonical sequence of the continuous position with same quantity, and this carries out after two sequences is by optimal alignment. The method that sequence is arranged to compare is well known in the art.
" through the conservative variant of modifying " is used for amino acid and nucleotide sequence. With regard to concrete nucleotide sequence, through the conservative variant of modifying refer to the to encode nucleic acid of identical or essentially identical amino acid sequence, perhaps, when nucleic acid not during encoding amino acid sequence, refer to essentially identical sequence. Because the degeneracy of genetic code, nucleic acid codon identical on the several functions any given protein of encoding is arranged. For example, codon GCA, GCC, GCG and GCU this seed amino acid of alanine of all encoding. Therefore, on each position that alanine is determined by codon, codon can be changed into any one in the above-mentioned corresponding codon, and can not change the polypeptide of encoding out. The variation of this type of nucleic acid is " silent variant ", and it is a kind of in conservative variation of modifying. The nucleotide sequence of every coded polypeptide is yet described every kind of possible silent variant of this nucleic acid herein. The technical staff will recognize that each codon in the nucleic acid (except the AUG, unique codon of its methionine of normally encoding) all can be modified, to produce identical molecule on the function. Therefore, every kind of silent variant of the nucleic acid of coded polypeptide all lies in every sequence that was described.
For amino acid sequence, the technical staff will recognize, indivedual replacements, disappearance or increase to nucleic acid, or in the sequence that is encoded, change single amino acids or little percentage (namely to what peptide, polypeptide or protein sequence carried out, less than 20%, for example 15%, 10%, 5%, 4%, 3%, 2% or 1%) amino acid whose replacement is " through the conservative variant of modifying ", and change wherein is that amino acid is replaced by chemically similar amino acid. Provide amino acid whose conservative replacement table similar on the function to be known in the art.
Each group in following six groups all contains can guard mutually the amino acid that replaces:
Alanine (A), serine (S), threonine (T);
Aspartic acid (D), glutamic acid (E);
Asparagine (N), glutamine (Q);
Arginine (R), lysine (K);
Isoleucine (I), leucine (L), methionine (M), valine (V); And
Phenylalanine (F), tyrosine (Y), tryptophan (W). (see, for example, Creighton, Proteins (1984)).
Article two, the sign that nucleotide sequence or polypeptide are identical in fact is: the antibody that the polypeptide of article one nucleic acid coding can produce with the polypeptide because of antagonism second nucleic acid coding carries out immunological cross-reaction. Therefore, for example, when two peptides only owing to conservative the replacement, have not simultaneously, then typically, wherein a polypeptide is identical in fact with the second polypeptide. Article two, the another kind sign that nucleotide sequence is identical in fact is: these two molecules or its complement can the phase mutual crosses under rigorous condition as mentioned below.
Phrase " with ... specific hybrid " refer to: under rigorous hybridization conditions, when sequence (for example is present in complex mixture, the total DNA of cell or RNA, or library DNA or RNA) in the time, molecule only be combined, is formed two strands with specific nucleotide sequence or hybridizes.
Phrase " rigorous hybridization conditions " refer to probe will be with its target sequence not with the condition of other sequence hybridization, typically, its target sequence is in the complex mixture of nucleotide sequence. Rigorous condition depends on sequence, and is also different in different situations. Long sequence can be under higher temperature specific hybrid. Usually, high rigor condition is selected as: melt temperature (T than the heat of specific sequence under given ionic strength and pHm) low about 5-10 ℃. Low rigor condition is selected as comparing T usuallymLow about 15-30 ℃. TmBe: (under given ionic strength, pH and nucleic acid concentration) during balance, (target sequence is excessive when existing, T to be complementary to the temperature of 50% in the probe of target and target sequence hybridizationmThe place, 50% probe is combined during balance). Rigorous condition will be following condition: salinity is lower than the sodium ion of about 1.0M, typically, about Na ion concentration of 0.01 to 1.0M (or other salt), pH 7.0 to 8.3, short probe (for example, 10 to 50 nucleotides) temperature is about at least 30 ℃, to long probe (for example, more than 50 nucleotides), temperature is about at least 60 ℃. Rigorous condition can also be removed stable reagent by adding, and for example formamide obtains. For selective or specific hybrid, positive signal is at least twice of background, preferred 10 times to background hybridization.
If the coded polypeptide of nucleic acid that can not the phase mutual cross under rigorous condition is that identical in fact, so such nucleic acid also remains identical in fact. This can betide, and for example, uses the maximum codon degeneracy degree that is allowed by genetic code to produce in the situation of nucleic acid copy. In this type of situation, typically, nucleic acid is hybridized under the rigorous hybridization conditions of moderate.
In the present invention, use nucleotide sequence disclosed herein, under rigorous condition, carry out the Southern Blot experiment of standard, can identify the genomic DNA (gDNA) or the cDNA that contain nucleic acid of the present invention. Plant disclosed purpose at this point, the rigorous condition that is suitable for this type of hybridization comprises: hybridizing in 40% formamide, 1M NaCl, 1% lauryl sodium sulfate (SDS) buffer solution under 37 ℃, at least in 0.2X SSC, be washed till under about 50 ℃ temperature less once, 20 minutes, temperature was normally at about 55 ℃ to about 60 ℃; Or suitable condition. Positive hybridization is the twice of background at least. Those of ordinary skill is easy to recognize that other hybridization and wash conditions can be used for providing the condition with similar rigor.
About two identical another kind signs of polynucleotides be: the canonical sequence that increases out by a pair of Oligonucleolide primers, under rigorous hybridization conditions, can be used as probe, from cDNA or genomic library, isolating sequence to be measured, or in northern or Southern Blot experiment, identify sequence to be measured.
The present invention also comprises expression vector defined herein. Expression vector comprises in the polynucleotide sequence listed above any one or more copies. Expression vector of the present invention can contain any polynucleotide sequence of this paper definition.
Therefore, in another embodiment, the invention provides a kind of expression vector, described carrier comprises the nucleotide sequence of the gene of the pantolactone hydrolase of encoding, and described pantolactone hydrolase is from horse liver, Bacillus subtilis, A.niger ATCC 9142, A.niger awamori ATCC 38854 or A.niger MacRae ATCC 46951; Perhaps described carrier comprises the nucleotide sequence of the gene of the pantolactone hydrolase of encoding, described pantolactone hydrolase is from the horse liver, shown in SEQ ID NO:2, from Bacillus subtilis, shown in SEQ ID NO:4, from A. niger ATCC 9142, shown in SEQ ID NO:8, from A.niger awamori ATCC 38854, shown in SEQ ID NO:10, and from A.niger MacRae ATCC 46951, part is shown in SEQ ID NO:6.
Alternatively, the polynucleotide sequence in the expression vector can be operably connected with expression control sequenc defined above.
The phrase " expression vector " that uses in this article is reproducible (replicatable) carrier, the dna sequence dna of the polynucleotide sequence that it is listed with coding this paper, and can regulate and control the expression of these dna sequence dnas. In this context, term " reproducible " refers to that in the host cell of the given type of introducing carrier, carrier can be replicated. In the place of interested polynucleotide sequence upstream near these polynucleotides, may provide the sequence of code signal peptide, its existence has been guaranteed to be secreted with the expressed polypeptide that is encoded of the host cell of carrier. Burst can be to be connected with the polynucleotide sequence that is selected is natural, perhaps can originate from another kind.
Carrier can be any carrier that tradition is used for recombinant DNA technique, will depend on usually that to the selection of carrier it is with the host cell that is introduced into. Therefore, carrier can be autonomously replicationg vector, that is, as the carrier that the outer material of chromosome exists, it copies and is independent of chromosome replication; The example of this kind carrier is plasmid, bacteriophage, clay or mini chromosome. In addition, carrier can be following carrier, when it is introduced in the host cell, can be incorporated in the host cell gene group, and copy with the host cell gene group that it is integrated into. Expression vector of the present invention can with any dna sequence dna of the present invention, can be used to express any polypeptide of the present invention.
The present invention also comprises cell or the host cell through cultivating, and wherein contains one or more polynucleotide sequence disclosed herein and/or one or more expression vector disclosed herein. " cell through cultivating " that use in this article comprises, any can under specified criteria, growth, and can express the cell of one or more polypeptide of polynucleotide encoding of the present invention. Preferably, the cell through cultivating is yeast, fungi, bacterium or algae. More preferably, the cell through cultivating is Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Aspergillus niger or Bacillus subtilis.
In another embodiment, the invention provides the pantolactone hydrolase that from horse liver, A.niger ATCC 9142, A.niger awamori ATCC 38854 or A.niger MacRae ATCC 46951, obtains.
In another embodiment, the invention provides a kind of pantolactone hydrolase, its amino acid sequence comprises: when from the horse liver, the amino acid sequence shown in the SEQ ID NO:2; When from A.niger MacRae ATCC 46951, the amino acid sequence shown in the SEQ ID NO:6; When from A.niger ATCC 9142, the amino acid sequence shown in the SEQ ID NO:8; When from A. niger awamori ATCC 38854, the amino acid sequence shown in the SEQ ID NO:10.
Shown in the SEQ ID NO:2 from the horse liver with show that from the pantolactone hydrolase of Bacillus subtilis the S-pantolactone hydrolase is active shown in the SEQ ID NO:4. Shown in the SEQ ID NO:8 from A.niger ATCC 9142, show that with the pantolactone hydrolase from A.niger MacRae ATCC 46951 of part shown in SEQ ID NO:6 the R-pantolactone hydrolase is active from A. niger awamori ATCC 38854 shown in the SEQ ID NO:10.
In another embodiment, the present invention comprises the fragment of above-mentioned amino acid sequence, and described fragment has the enzymatic activity of whole protein.
" fragment of amino acid sequence " according to the present invention can be defined as lacking one section amino acid whose sequence, and this section amino acid may be necessary concerning protein correctly folds. Yet in case protein is folded, this section amino acid just can be deleted, and can not destroy the function of single protein. These sections may reside in the folded protein, and for example ring perhaps can be N-or the C-end sequence not directly related with the activity of folded protein.
In addition, the present invention includes the derivative of the protein that comprises described R-and S-pantolactone hydrolase activity. Described derivative comprises the enzyme that is fixed, and for example is fixed by including (inclusion), and wherein said enzyme is retained on the film device, for example doughnut, polymer network structure or microcapsule. Also may be by crosslinked or come enzyme is fixed by producing enzyme crystal. The another kind of possible method that enzyme is fixed is that it is attached on the polymer of growing, for example silicon dioxide gel gel or silica graphite sol gel, perhaps by enzyme being attached on the prefabricated carrier, for example EupergitC, Eupergit 250L, PEG, Celite and Amberlite XAD-7. To the technology of the applicable another kind of immobilized enzyme of R-of the present invention and S-pantolactone hydrolase be with its be dispersed in can't be miscible with water organic solvent in. Usually, by nearly all technique for fixing known in the art, can be to having the protein of enzymatic activity, for example enzyme of the present invention is fixed.
In another embodiment, the present invention relates to the purposes with separated pantolactone hydrolase selective hydrolysis R-or S-pantolactone hydrolase, this can be used for the industrial production to the R-enantiomter of pantolactone, and the R-enantiomter of pantolactone is to produce the precursor of R-pantothenic acid and R-panthenol.
Therefore, an object of the present invention is to provide method or the approach that comes R-or S-pantolactone are carried out selective hydrolysis with separated pantolactone hydrolase as herein described.
In another embodiment, the invention provides the method for producing R-pantothenic acid or its salt or R-panthenol, comprising the step of in the presence of pantolactone hydrolase of the present invention, R-or S-pantolactone being carried out selective hydrolysis.
In another embodiment, the invention provides the method for the nucleotide sequence of clone and known array direct neighbor, for example the pantolactone hydrolase of coding novelty or the nucleotide sequence of its part.
Particularly, the present invention includes the new PCR strategy of energy amplify unknown sequence. Described new PCR strategy is included in the synthetic middle same primer that uses of article one and second DNA chain. This primer can with the known area hybridization of the gDNA that will be amplified. This primer shows the homology with known array 100%. Under the help of this primer, carry out the PCR first time, article one strand copy of genomic DNA is provided, arrive unknown nucleotide sequence. Carry out the PCR second time with the part PCR product first time as template, use therein (nested) primer can with the 3 ' direction that is positioned primer used among the PCR for the first time on dna fragmentation hybridization, but still be in logic the known portions of sequence. After this nested primers is hybridized at random with the single stranded DNA that the first time, polymeric enzyme reaction produced, produce the antisense strand of this single stranded DNA, himself is as being used for for the second time template of the same primer of PCR, generation second chain. In the end, originate in known array inside, extend contiguous genomic DNA or extend the dna fragmentation of any other DNA of disappearance partial sequence out manufactured by a kind of primer that can both hybridize with the new segment two ends.
Therefore, in another embodiment, the invention provides the method for the nucleotide sequence of clone and known array direct neighbor, described method comprises pcr amplification, and described amplification comprises:
A) carry out PCR second time with the single stranded DNA of PCR for the first time as template, in described second time PCR with the primer that can hybridize at random with the single stranded DNA of the PCR generation first time; And
B) thus, still use the at random hybridized primer of step in a), produce self as the antisense strand of second chain template.
Following embodiment is described in detail evaluation, sign and the expression of coding pantolactone hydrolase gene. These embodiment only are exemplary, but not want by any way scope of the present invention to be limited.
Embodiment 1 comes purifying (S)-pantolactone hydrolysing activity from commercially available horse liver esterase acetone powder
1g horse liver esterase acetone powder (Fluka Holding AG, Industriestrasse 25, P.O. Box 260, CH-9471 Buchs, Switzerland) is dissolved among the Tris/HCl of 40ml 50mM, and pH 7.5, wherein contain 2M ammonium sulfate, 1mM CaCl2、1mM MgCl
2With 10 μ M EDTA (buffer A). Go out undissolved material by centrifugation, afterwards, carry out filtration sterilization with 0.45 μ M filter. Protein solution is loaded among the butyl-agarose post HR26/10 (Amersham Pharmacia Biotech Europe GmbH, D ü bendorf, Switzerland) that crosses with the buffer A balance. Wash this post with the 100ml buffer A. Use afterwards the buffer B (buffer A that does not have ammonium sulfate) of 400ml from 0 to 100% linear gradient. Lactonase is middle by wash-out out in gradient. Collect the segment that shows the pantolactone hydrolysing activity, buffer solution is changed to 20mM Tris/HCl, the 1mM CaCl of pH 8.02、1mM MgCl
2And 10 μ M EDTA. The segment of collecting is loaded to MonoQ-and fills out in advance among (pre-packed) post HR 26/10 (Amersham Pharmacia Biotech Europe GmbH, D ü bendorf, Switzerland), uses the linear gradient of 0 to 350mM NaCl. Protein begins namely by wash-out out this gradient. Again collect active part, be concentrated to 1 ml, loading is to Superdex 200 posts (Amersham Pharmacia Biotech Europe GmbH, D ü bendorf, Switzerland). 50mM Tris/HCl, 1mM CaCl with pH 8.02、1mM
MgCl
2And 10 μ M EDTA as elution buffer, lactonase as last peak by wash-out out, it shows the molecular size of about 31kDa, conforms to the size shown in the SDS-PAGE.
By 37 ℃ with enzyme in the 200mM of pH 9.0 Tris/ acetate buffer, 5mM MgCl2Middle cultivation was measured in 60 minutes, and the discovery maximum specific activity is 13.3U/ (mg protein). Measure the concentration of (S)-and (R)-pantolactone by HPLC.
2 pairs of (S)-pantolactone hydrolases from the horse liver of embodiment carry out preliminary sign
(a) molecular size, structure and isoelectric point:
According to SDA-PAGE, albuminate has the molecular weight of about 35kDa. With the elution time of calibrated solvent resistant column, the molecular weight of native protein is calculated as about 31kDa. This means that lactonase from the horse liver is 30 to 35kDa monomer. Use the 2D gel, isoelectric point is measured as in the scope of pH 5.5.
(b) the terminal and internal amino acid order-checking of N-:
Digest with the protein of trypsase to enrichment after the 2D gel electrophoresis. By mass spectrum the peptide that produces is analyzed. The N-end sequence of peptide No.66 has been shown among the SEQ NO:11.
This sequence shows that with the MS-spectrum this protein belongs to the protein families that is known as Senescence Marker Protein-30 or calmodulin (regucalcins), and it mainly is found in the vertebrate. From the calmodulin sequence of rat, mouse, people, chicken, rabbit, ox, Xenopus laevis, and determined from the sequence of two less homologys of Drosophila melanogaster. Yet, from the also not separated and order-checking of this gene of horse.
(c) metal dependence:
For measuring different divalent metals to the impact of the pantolactone enzymatic activity of horse liver enzyme, with 1.3,2.6,5.2 or the Ca of 10.4mM2+、Mg
2+Or Mn2+Join in the reactant mixture that 200mM Tris/ acetate and 50mM (R, S)-pantolactone by pH 9.0 form. At 37 ℃ reactant mixture is carried out 60 minutes cultivation, come cessation reaction with the methyl alcohol of the isopyknic 2mM of containing EDTA. Measure the minimizing of (S)-pantolactone by HPLC. Calcium makes enzymatic activity reduce, and magnesium and manganese then make enzymatic activity increase.
(d) heat endurance:
Under 30 to 80 ℃ temperature, with purified enzyme at 5.2mM MgCl2With cultivated 15 minutes in the 200mM Tris/ acetate of pH 9.0. After 30 minutes, measure activity (60 minutes, 37 ℃) with standard test method on ice. Until 60 ℃ of enzymes still are stable. It is at 65 ℃ of beginning inactivations, 70 ℃ of activity of losing above 50%.
Embodiment 3 clones are from (S)-pantolactone enzyme of horse liver
Use the sequence information from all known mammalian genes (seeing below) to design primer, be used for the PCR that carries out for the cDNA that makes from the horse liver from age " Hafflinger " of Bavaria, described cDNA is by Roche Molecular Biochemicals, Penzberg, German friendship provides. Prepare total RNA from liver organization with QIAGEN RNeasy Maxi Kit (Qiagen, Hilden, Germany).
Homology between horse liver lactonase and other member of calmodulin family is shown in the table 1. Mensuration is that the Application standard parameter is measured by the GAP program in the GCG program package. The numeral of similitude is shown in cornerwise the right in the table, and the numeral of homogeny is shown in the diagonal left side.
Table 1: the amino acid sequence similarity in the calmodulin family and homogeny
Horse | Ox | Rabbit | The people | Rat | Mouse | Chicken | X.laev | D.mela | |
Horse | - | 92.6 | 92.0 | 90.6 | 88.3 | 88.3 | 84.3 | 77.9 | 48.8 |
Ox | 91.0 | - | 90.3 | 93.0 | 90.3 | 90.0 | 83.6 | 76.6 | 48.9 |
Rabbit | 90.6 | 89.3 | - | 91.0 | 87.6 | 87.6 | 82.6 | 77.6 | 47.7 |
The people | 89.6 | 91.3 | 89.3 | - | 90.0 | 90.6 | 82.3 | 76.9 | 48.4 |
Rat | 86.0 | 87.3 | 85.0 | 88.3 | - | 95.7 | 80.9 | 77.9 | 49.3 |
Mouse | 86.3 | 87.3 | 85.3 | 88.6 | 94.0 | - | 81.6 | 77.3 | 50.0 |
Chicken | 77.9 | 77.9 | 76.6 | 77.9 | 75.9 | 75.9 | - | 81.9 | 48.9 |
X.laev | 70.9 | 69.9 | 71.2 | 70.2 | 71.6 | 70.2 | 73.9 | - | 47.5 |
D.mela | 36.8 | 37.0 | 37.2 | 37.5 | 37.0 | 38.4 | 36.3 | 37.0 | - |
Chicken: chicken; X.laev:Xenopus laevis; D.mela:Drosophila melanogaster
With Titan One Tube RT-PCT Kit (Roche Molecular Biochemicals, Penzberg, Germany) and covered the homologous primer of initiation codon and terminator codon upstream 50bp sequence, utilize RT-PCT to amplify the fragment (the 1-885 position nucleotides of SEQ ID NO:1) of 885bp. The method that reaction is recommended according to manufacturer is carried out.
The structure that is used for the N-end 5 ' primer (SEQ ID NO:12) of PCR for the first time and C-end 3 '-primer (3 '-CAGTTTCCTTAAGGGGGGATA-5 ') (SEQ ID NO:13) is based on from the N-end sequence of ox (SEQ ID NO:14), rabbit (SEQ ID NO:15), people (SEQ ID NO:16), rat (SEQ ID NO:17), mouse (SEQ ID NO:18), chicken (SEQ ID NO:19) and Xenopus (SEQ ID NO:20) and from the C-end sequence of ox (SEQ ID NO:21), rabbit (SEQ ID NO:22), people (SEQ ID NO:23), rat (SEQ ID NO:24), mouse (SEQ ID NO:25), chicken (SEQ ID NO:26) and Xenopus (SEQ ID NO:27).
This fragment is cloned in the TA cloning vector (Invitrogen, Carlsberg, CA, USA). Order-checking proves that it is from horse liver calmodulin. By being called as the method for 5 '/3 ' RACE, with Roche Molecular Biochemicals, Penzberg, the independent kit that Germany provides is isolated 5 ' of disappearance-end: use the primer (SEQ ID NO:28) of perfect matching from separated horse liver cDNA manufacture order chain DNA. This single stranded DNA of purifying adds the polyC tail, and nested primers, the polyG primer held with article one primer 5 ' carry out another time PCR. The 5 '-terminal dna fragmentation that is representing the disappearance of gene is amplified out. With cloning 3 '-end according to the forward primer of known sequences Design (SEQ ID NO:29) and last the amino acid whose primer of gene (SEQ ID NO:30) that originates in that mainly designs according to ox and rabbit gene. The last time among the PCR, design 5 ' of covering gene initial sum terminator codon-and 3 '-primer with the sequence information that obtains, according to the full-length cDNA of from total RNA, isolating lactonase mentioned above. This cDNA and amino acid sequence are showed among SEQ ID NO:1 and the SEQ ID NO:2. This gene is by 900bp/299 Amino acid profile.
With the obtainable expression vector of a kind of commercial sources, for example from the pQE60 of Qiagen, the gene of the expressed in E. coli, its C-is terminal to be merged with the His label. According to standardization program the protein that adds the His label is expressed and purifying, produce the protein of 33 kDa of demonstration (S)-pantolactone enzymatic activity.
Embodiment 4 comes purifying (R)-pantolactone hydrolysis to live by commercially available A.niger lipase A crude preparation by using
The property
In the enzyme product that is obtained by the A.niger fermentation not of the same race that can obtain from commercial channels, identified the activity of specificity hydrolysis (R)-pantolactone. Be the concrete enzyme of purifying, used the Co.Ltd. from Amano Pharmaceuticals, Nagoya, the commercial formulation that is called as Lipase A " Amano " of Japan. According to the sequence data that obtains from two enzymes with the common purifying of lactonase, said preparation freeze-drying and the broken overexpression A. awamori cell from the lipase of A.tubigensis of hanging oneself. This material is dissolved in the 20mM Tris/HCl of pH 7.5, the MgCl of 2.5mM2In (standard buffer solution). The ethanol of adding 5% is to increase the solubility of material. By centrifugal (30 minutes, 15000rpm, 4 ℃) and the filtration (with the filter of 0.45 μ m) followed, isolate the material that can't enter into solution. First by ultrafiltration the part of having dissolved is carried out the purifying first time in Amicon cell ultrafilter (50kDa burble point), to remove any salt and micromolecular compound, they can upset follow-up anion-exchange chromatography step. Then the protein loading is filled out Q-Ago-Gel post (Amersham Pharmacia Biotech Europe GmbH, D ü bendorf, Switzerland) in advance to HR26/10. Wash post with the 200ml standard buffer solution, then the linear gradient (400m1) by 0 to 350mM NaCl elutes protein. Containing activated segment is collected. Add ammonium sulfate, to final concentration be 1.5M, treated protein solution loading to HR 26/10 butyl-agarose Gel Pre is filled out in the post (Amersham Pharmacia Biotech Europe GmbH, D ü bendorf, Switzerland). The standard buffer solution that contains 1.5M ammonium sulfate with 200ml washs, and isolates protein by 1.5 to the 0M ammonium sulphate gradients that successively decrease (400ml). This moment, activity was eluted at two peaks, and was collected respectively. The volume of twice gleanings is reduced to less than 2ml. Use standard buffer solution, isolate two kinds of concentrates by carrying out gel filtration at Superdex 200 posts. The active fragment of every kind of separator is collected and concentrates. The activity of gleanings II trends towards a little earlier in gleanings I by wash-out out, and this shows that the molecular weight of respective egg white matter may be slightly high.
80U/ml (40 ℃) is the high activity of having measured respectively for gleanings I and gleanings II. Shown in the 2D gel, protein formulation not exclusively is homology, this real specific activity of expression even can be higher. Yet because the lactonase activity corresponding to the protein band of 38kDa in the gel filtration elution curve, also is dominant protein in the final preparation, this band most possibly is lactonase. According to the result of gel filtration, natural lactonase has the molecular weight of 75kDa. This is hinting the homodimer structure of this enzyme.
Embodiment 5 carries out preliminary sign to (R)-pantolactone hydrolase
(a) structure of native form and molecular weight:
With condition as described in Example 4, at the 72ml place, elute enzyme with Superdex 200 (Amersham Pharmacia Biotech Europe GmbH, D ü bendorf, Switzerland). Infer that from calibration curve this has reflected the molecular weight of 75kDa. SDS-PAGE shows that molecular weight is 38kDa. The homodimer that the combination of above-mentioned data hint is comprised of two 38 identical kDa subunits from (R)-pantolactone enzyme of A.niger.
(b) heat endurance:
In the 20mM of pH 7.5 Tris/HCl, in 0,30,40,50,55,60,70 ℃ the diluted enzymes of 50 μ l (0.1U) are carried out one hour cultivation. After 15 minutes, measure residual activity with standard test method on ice. Until 50 ℃ of enzymes all are stable. Under higher temperature, it begins inactivation.
(c) optimum temperature:
Adopt following condition, in 20,30,40,50,55 and 60 ℃, (the R)-pantolactone enzyme from the intense enrichment of commercial source (seeing embodiment 5) carried out 30 minutes cultivation:
100mM (R, S)-pantolactone
100mM MgCl
2
200mM Tris/HCl,pH 8.0
0.05U (R)-and the pantolactone enzyme, final volume is 10 μ l.
Under used condition, it is about 50 ℃ from the optimum temperature of (R)-pantolactone enzyme of commercialization A.niger preparation.
(d) confactor dependence and inhibition:
Activity from (R)-pantolactone enzyme of A.niger needs Mg2+Or Mn2+ Add 1mM EDTA and can suppress its activity fully.
(e) best pH:
When pH changed between 7.0 to 11.0, this enzyme did not demonstrate " normally " pH-activity curve. At 40 ℃, 10 mg Amano Lipase A in the 200mM TEA-acetate buffer (pH 7.0 to 11.0) are carried out 20 minutes cultivation, described buffer solution contains 0.1%Span 80, the 20mM magnesium acetate. Add isopyknic 500mM MES buffer solution and stop the reaction of sample, described pH of buffer is 5.5, contains 50mM EDTA; Sample is carried out centrifugal (10,000g, 10 minutes), then analyze by HPLC, wherein, with 0.46 * 15cm CHIRADEX post, come wash-out with 70: 30 water-methanols, 1ml/ minute, 20 ℃. High activity is to reach in about 10 o'clock at pH. 11.0, activity there is no considerable change from this position to pH. High selectivity reached at pH in about 9.0 o'clock.
Embodiment 6 cultivates A.niger ATCC 9142,9029,26875,62863 and 10864, and right
Its (R)-pantolactone enzymatic activity is evaluated and tested
For know that whether the lactonase activity extensively exists, and cultivates five A.niger bacterial strains under the following conditions in Aspergillus belongs to:
Culture medium (with respect to every liter amount): 1.2g NaNO3、0.5g KH
2PO
4、0.2g
MgSO
4×7H
2The trace metal solution of O, 0.5g yeast extract, 5% glucose and 0.04ml, described solution such as Vishniac and Santer, Bacteriol.Rev.21:195-213 (1957) is described.
With every ml 5 * 106Individual spore is in 30 ℃ of 300ml preculture things that go to inoculate in 11 bottles. After 8 hours, the preculture thing is joined in 1.71 culture mediums in 21 fermentation tanks, fermentation tank is with pH and dissolved oxygen control. By automatic adding 5M NaOH pH is remained on 5.5. Under low ventilation condition (air saturation of 5-10%), cell is carried out 14 hours cultivation. Afterwards dissolved oxygen levels is increased to the 30-50% air saturation. After 5 hours, the results mycelium filters it, spends mineral matter washing twice, is frozen in the liquid nitrogen. With French Press a part is wherein directly carried out cracking. With standard test method culture medium and cell pyrolysis liquid are carried out research for the pantolactone enzymatic activity.
(R)-the pantolactone enzymatic activity mainly is found in the lysate of all tested A.niger bacterial strains. In culture medium, only found very little activity.
7 pairs of (R)-pantolactone enzymes through enrichment from the lipase preparation of embodiment carry out Trypsin Induced
The amino acid sequence of the little peptide that produces is measured
The preparation through enrichment to embodiment 5 on the 2D gel is analyzed. With trypsase two main points are digested, it is respectively 33 and 40kDa, 4.7 and 5.6 pI. Peptide (the equipment: Hewlett Packard 1090 that separates generation by HPLC, post: Vydac C18 (0.21 * 25cm), the 210nm place absorbs, flow velocity: 0.20ml/ minute, buffer A: 0.075%TFA, buffer B: the 0.065%TFA in 80% acetonitrile, gradient: 2%B (0-10 minute), 2-75%B (10-120 minute)). Come the peptide of selecting is checked order by the Edman edman degradation Edman, point C[pI 5.6,39kDa (Poll C)]: Fxn 42 (peptide 1) (SEQ ID NO:81), Fxn 57 (peptide 3) (SEQ ID NO:82), Fx 73 (peptide 2) (SEQ ID NO:83), Fx 74 (SEQ ID NO:84) and Fx 81 (SEQ ID NO:85), point C[pI 4.7,33kDa (Poll A/B)]: N terminal (SEQ ID NO:86), Fx 58 (SEQ ID NO:87), Fx 64 (SEQ ID NO:88), Fx 65 (SEQ ID NO:89), Fx 73 (SEQ ID NO:90) and Fx 68 (SEQ ID NO:91). X represents undetermined amino acid, and the amino acid in the round parentheses can't clearly be determined.
Carry out database search with all short peptide sequences as target, do not obtain reliable information and can help to determine that in two main points which representing lactonase. Therefore, we utilize a cover anion-exchange chromatography that the lactonase preparation of embodiment 5 is carried out further enrichment. Filling out in advance on the MonoQ post HR 16/10 (Amersham Pharmacia Biotech Europe GmbH, D ü bendorf, Switzerland), under 0 to the 350mM NaCl gradient, to protein solution (at the 20mM of pH 7.5 Tris/HCl, 2.5mM MgCl2In) separate. Activity to all segments is measured. According to described isoelectric focusing and the SDS-PAGE of carrying out of manufacturer (Invitrogen, Carlsbad, CA, USA), active part is analyzed. Compare the segment activity data that SDS-PAGE gel and IEF draw, the hint lactonase is 38 to 40kDa protein, and pI is at pH about 5.6. These data are coincide very well with some PollC. Therefore, the amino acid sequence of this point just is used to design the PCR primer and is used for the oligonucleotides that the Southern trace is tested. Collect the activated segment of tool, analyze at the 2D gel again, analyze and show that than 2D gel before, PollC is with respect to more clearly enrichment of PollA/B.
Embodiment 8 is designed for the degenerate oligonucleotide of Southern trace test and is used for from A.niger
The PCR primer of clone's (R)-pantolactone enzyme
Use is from 12 of different Aspergillus kinds different phytase sequences, CODONFREQUENCY program by GCG package version 10.2, obtain the codon operating position of Aspergillus, use it for and reduce because the number of the possible different dna sequence dna combinations that genetic code degeneration causes. As deciding factor, primer 3 '-end has all been considered every kind of possible combination with Aspergillus codon operating position, but primer 5 '-end has just been ignored some rare codons. Carrying out with oligonucleotides in the situation of hybrid experiment, in the same way to 3 '-and 5 '-end process. Contain the oligonucleotides of " S (sense) " or " AS (anti-sense) " in the title for PCR. Do not contain the oligonucleotides of S or AS in the title for hybrid experiment.
Being used for from the oligonucleotides of A.niger clone (R)-pantolactone enzyme is Fxn42 (SEQ ID NO:31), Fxn42S (SEQ ID NO:32), Fxn42AS (SEQ ID NO:33), Fx 57 (SEQ ID NO:34), Fxn57S (SEQ ID NO:35), Fxn57AS (SEQ ID NO:36), Fx 73 (SEQ ID NO:37), Fx 73S (SEQ ID NO:38), Fx 73AS (SEQ ID NO:39), Fx 74 (SEQ ID NO:40), Fx 74S (SEQ ID NO:41) and Fx 74AS (SEQ ID NO:42).
Embodiment 9 is from A.niger ATCC 9142, A.niger NRRI3135, A.niger ssp.
Isolated genes among awamori (ATCC 38854) or the A.niger MacRae (ATCC 46951)
Group DNA
With 1 * 106Spore/ml removes to inoculate YPD culture medium [the Sherman et al. of 300ml, Laboratory course manual for methods in yeast genetics, Cold Spring Harbor Laoratory, Cold Spring Harbor, New York (1986)]. Under fierce vibration (200 rpm), in 30 ℃ culture is carried out incubated overnight. Collect mycelium with Whatman filter paper by filtering, wash with PBS (waiting the phosphatizing acid buffer), freezing in liquid nitrogen. In ice-cold mortar, mycelium is worn into fine powder. This powder Eddy diffusion in 50 mM Tris/HCl, the 1.0%SDS of the pH 8.0 of 1/3 volume, 50mM EDTA, is frequently put upside down under the condition in 65 ℃ and to be cultivated 15 minutes. Solution is cooled to 50 ℃. Add Proteinase K (final concentration is 100 μ g/ml). Solution was cultivated 1 hour at 50 ℃. The Proteinase K that adds in addition 100mg/ml continues to cultivate 3 hours. Phenol/chloroform/the isoamyl alcohol (50/49/1) that adds 1/3 volume. After the thorough and soft mixing, emulsion is carried out centrifugal (12000g, 20 minutes, 4 ℃). Shift out water, again extraction. Another centrifugation step (12000g, 10 minutes, 4 ℃) afterwards, extracts water with chloroform. To the isopropyl alcohol of 0.7 times of volume of aqueous phase adding, soft mixed solution 15 minutes. By centrifugal (10000g, 30 minutes, 4 ℃) collecting precipitation DNA. The 3M KCl that adds the pH 5.2 of 1/10 volume in the residual supernatant cultivated 15 minutes under soft vibration. After the centrifugation step, the ethanol with 70% washes twice to two parts of precipitations again, and air drying is dissolved in the 0.5ml water. At last, process DNA to remove residual RNA with RNase.
Embodiment 10 clones are from (R)-pantolactone enzyme of A.niger ATCC 9142
According to the embodiment 6 described genomic DNAs (gDNA) that prepare A.niger ATCC 9142. Use (the Stratagene from Stratagene, La Jolla, CA, USA) Robocycler Infinity as the PCR instrument, use from the TAQ polymerase kit of Roche Molecular Biochemicals (Penzberg, Germany) and carry out PCR:
-95 ℃ of 1 μ l gDNA (1/10 dilution) step 1:5 minute
1 μ l mixture of ribonucleotides step 2:30 second-95 ℃
5 μ l are with Mg2+PCR standard buffer solution step 3:30 second-50 ℃
-72 ℃ of 1 μ l primer S (100pM/ μ l) step 4:1 minute
1 μ l primer AS (100pM/ μ l)
1 μ l is from the TAQ polymerase of Roche Molecular Biochemicals
40μl H
2O
Step 2 is to 4 repetitions 35 times.
Combination of primers:
Numbering | Upstream primer | Downstream primer | PCR product [bp] |
1 | Fxn42S | Fxn57AS | 300,310 |
2 | Fxn42S | Fx73AS | - |
3 | Fxn42S | Fx74AS | - |
4 | Fxn57S | Fxn42AS | 80 |
5 | Fxn57S | Fx73AS | 580 |
6 | Fxn57S | Fx74AS | 510 |
7 | Fx73S | Fxn42AS | - |
8 | Fx73S | Fxn57AS | 300,315,320 |
9 | Fx73S | Fx74AS | - |
10 | Fx74S | Fxn42AS | 180 |
11 | Fx74S | Fxn57AS | 340 |
12 | Fx74S | Fx73AS | 840 |
13 | Fxn42S | Fx57AS,Fx73AS,Fx74AS | - |
14 | Fxn57S | Fxn42AS,Fx73AS,Fx74AS- | 580 |
15 | Fx73S | Fxn42AS,Fxn57AS,Fx74AS | - |
16 | Fx74S | Fxn42AS,Fxn57AS,Fx73AS | 350 |
All can carry out inspection about self grappling (self-priming) to all primers. Fxn57AS be unique can produce a great deal of self in conjunction with the primer of product, self grappling product is about 300 to 320bp. With 55 ℃ hybridization temperature, PCR 5,6,8,10 and 11 still can produce one or more product. 60 ℃ lower adopts amplification in 30 seconds and 30 circulations, PCR 5,6,8,10 and 11 still can produce the one or more PCR product corresponding with hanging down the band that produces under the hybridization temperature.
Use the product of from Ago-Gel, isolating the 840bp of PCR reaction 12 from the QIAEX II gel extraction agent box of Qiagen (Qiagen, Hilden, Germany), it is dissolved among the 40 μ l H2O.
-95 ℃ of the fragments of 1 μ l 840bp (110 dilution) step 1:5 minute
1 μ l mixture of ribonucleotides step 2:30 second-95 ℃
5 μ l are with Mg2+PCR standard buffer solution step 3:30 second-55 ℃
1 μ l primer S (10pMol/ μ l) step 4:30 second-72 ℃
1 μ l primer AS (10pMol/ μ l)
1 μ l is from the TAQ polymerase of Roche Molecular Biochemicals
40μl H
2O
Step 2 is to 4 repetitions 30 times.
Used and reacted 2,5,10,11 and 12 combination of primers. Except reaction 2, other PCR product that responded produces. The sequence that this means primer 42S/AS, 57S/AS, 73S/AS and 74S/AS is the part of 840bp fragment. The height proximity of these four pairs of primers indicates that strongly the fragment of 840bp is the part of interested lactonase gene. This hypothesis has obtained the support of order-checking. The amino acid sequence of peptide Fx 57 (SEQ ID NO:90) has obtained confirmation in the fragment of 840bp, and the sequence of peptide Fxn 42 (SEQ ID NO:45) has only obtained partly confirming.
Can also isolate the corresponding DNA fragments of A.niger MacRae. About the situation of A.awamori, only can isolate the product of primers F xn57S and Fx73AS by the method. The sequence of above-mentioned Aspergillus has about 90% homogeny with the sequence of A.niger ATCC 9142 on dna level.
For separating 5 ' of lactonase gene-and 3 '-end, use following method:
(a) separate 3 '-end:
-95 ℃ of the gDNA steps of 1 μ l A.niger ATCC 9142 1:5 minute
1 μ l mixture of ribonucleotides step 2:30 second-95 ℃
5 μ l are with Mg2+PCR standard buffer solution step 3:30 second-55 ℃
1 μ l primer Oal2AS or Oal3S (10pMol/ μ l) step 4:30 second-72 ℃
1 μ l is from the TAQ polymerase of Roche Molecular Biochemicals
41μl H
2O
Step 2 is to 4 repetitions 30 times.
With isopyknic phenol/chloroform PCR is mixed and to carry out twice extraction, carry out once separately with chloroform again. Then the 3M potassium acetate of the pH 5.2 by adding 1/10 volume and the ethanol of 2 times of volumes are settled out DNA. (in the board-like centrifuge tube of Eppendorf, 14000rpm) afterwards, wash precipitation with 70% ethanol, air is dry, finally is dissolved in the 20 μ l aqua sterilisas for 15 minutes centrifugal.
PCR for the second time:
4 μ l are from-95 ℃ of DNA steps 1:5 minute of the PCR first time
1 μ l mixture of ribonucleotides step 2:30 second-95 ℃
5 μ l are with Mg2+PCR standard buffer solution step 3:30 second-58 ℃
-72 ℃ of 1 μ l primer Oal4S or Oal1AS (10pMol/ μ l) step 4:1 minute
1 μ l is from the High Fidelity Mix 38 μ l H of Roche Molecular Biochemicals2O
Step 2 is to 4 repetitions 35 times.
Use the Oal4S primer, produced the dna molecular of one section 900bp. Order-checking shows 3 '-end of its encoding gene.
(b) separate 5 '-end:
Oligonucleotides Fxn42, the Fxn57, Fx73 and the Fx74 that cross with the DIG mark are as probe, the DIG system (Roche Molecular Biochemicals) that use is surveyed with the x-ray film chemiluminescence carries out hybrid experiment to the genomic DNA of A.niger ATCC 9142. Hybridization and detection are carried out according to the recommendation of manufacturer.
Come the genomic DNA of 10 μ g is digested with BamHI, EcoRI, HindIII, PstI, SacI and XhoI. With Roche Molecular Biochemicals hybridization solution 42 ℃ of hybridization of spending the night. Room temperature carries out with 2 * SSC, 0.1% SDS then carrying out twice washing step at 50 ℃ with 0.5 * SSC, 0.1% SDS after twice washing step again. With CSPD (Disodium 2-chloro-5-(4-methoxyspiro{1,2-dioxetane-3,2 '-(5 '-chloro) tricyclo[3.3.1.1 3,7] decan}-4-yl)-1-phenyl phospate) as substrate, alkaline phosphatase is surveyed, afterwards x-ray film is exposed to filter (filter) 1 hour. The signal that does not share on the film.
Therefore, use PCR product (seeing embodiment 11) that the DIG mark of the at random grappling of reaction 5 and 11 crosses as probe. Hybridize after the same method, just wash conditions is changed under the room temperature 2 * 5 minutes a little, 55 ℃ lower 2 * 15 minutes. Shown following band on the film:
Restriction Enzyme | The probe of 340bp [kb] | The probe of 580bp [kb] |
BamHI | 10 | 10/2.8 |
EcoRI | 4.5 | 4.5/5.2 |
HindIII | 4.2/6.5 | 3.0/4.2/6.5 |
PstI | 4.4 | 2.8/4.4 |
SacI | 23 | 23/3.9 |
XhoI | 6 | 6/20 |
For cloning whole gene or being 5 ' of its disappearance-end at least, according to hybrid experiment, with HindIII the chromosomal DNA of A.niger ATCC 9142 is digested, produce the fragment that contains the lactonase gene of about 4kb, experimental technique is as follows:
20 μ l chromosomal DNAs
20 μ l 10x buffer solutions
5μl HindIII(10U/μl)
175μl H
2O
Cultivated 16 hours at 37 ℃.
Use the PCR purification kit from Qiagen (Qiagen, Hilden, Germany) that the DNA through digestion is carried out purifying, and wash-out is 100 μ l. Following coupled reaction is spent the night at 16 ℃ and is carried out. Purified DNA is diluted with water to 2ml. Recommend to add ligase and ligase buffer solution according to manufacturer (Roche Molecular Biochemicals). Connect the solution of finishing and be used as template, carry out different PCR, wherein use the inside primer of the lactonase gene that separates through part:
-95 ℃ of 5 μ l coupled reaction solution steps 1:5 minute
1 μ l mixture of ribonucleotides step 2:30 second-95 ℃
5 μ l are with Mg2+PCR standard buffer solution step 3:30 second-55 ℃
-72 ℃ of 1 μ l sense primers (10pMol/ μ l) step 4:3 minute
1 μ i anti-sense primer (10pMol/ μ l)
1 μ l is from the High Fidelity polymerase mixed liquor 40 μ l H of Roche Molecular Biochemicals2O
Step 2 is to 4 repetitions 32 times.
Four kinds of combination of primers, Oal3S/Fxn57AS, Oal4S/Fxn57AS, Oal3S/Oal8AS and Oal4S/Oal8AS can both produce the dna fragmentation of wall scroll 4kb. All primers are to all being oriented to the outside of gene. Therefore, the lactonase gene should be positioned at as certainly connecting on the ring-shaped DNA molecule of HindIII fragment.
Use from the QIAEX II gel extraction agent box of Qiagen and from gel, isolate fragment, according to manufacturer (Applied Biosystems, Foster City, CA, the two deoxidation methods of USA) recommending check order with ABI 310Genetic Analyzer. The sequence that obtains confirms that isolated fragment contains two ends from (R)-pantolactone enzyme gene of A.niger ATCC 9142.
With primer Oal10S and Oal12AS, also may isolate the homologous gene of A.niger ssp.awamori, wherein contain and the duplicate amino acid sequence of all measured peptides. Unique difference only is the sequence of peptide Fxn42. This moment, Fxn42 was from the order-checking to two peptides. Most probable situation is, when carrying out HPLC when separating enzyme fragment through digestion, eluted simultaneously two different peptides. Order-checking has at first only disclosed the sequence of main peptide, but it is with very strong background. After the order-checking of first peptide finished, remaining was exactly the sequence of second peptide, and it has other four amino acid:
A) K-P-F-A-H-Q-V-K (SEQ ID NO:43) and
B) R-H-H-N-A-P-A-P-T-P-E-D-P-E-R-R (SEQ ID NO:44) provides
K-P-F-A-H-Q-V-K-T-x-E-D (SEQ ID NO:45), it is Fxn 42.
Why this explained also that oligonucleotides Fxn42S and Fxn42AS based on peptide Fxn 42 can't provide the result who share. According to amino acid sequence, the molecular weight that has 36573Da from the protein of strains A TCC 9142, the absorptance that the 280nm place estimates is 1.83 (1mg/ml protein solutions), and be calculated as 36547 Da from the molecular weight of the amino acid sequence of A.niger ssp.awamori, for the 1mg/ml protein solution, the E of estimation280nmBe 1.831 (Pace et al., 1995).
11 pairs of (R)-pantolactone enzyme genes from A.niger ATCC 9142 of embodiment clone and
Express
The sequence that obtains according to the whole three kinds of methods described in the embodiment 10 is compared, it is assembled, produce the sequence of the 2443bp of a whole lactonase gene of continuous covering. Be initiation codon, terminator codon and the possible introne of measuring this gene, the obtainable amino acid sequence of the peptide that will obtain from the purified genes from commercial formulation, the result who obtains with two program TESTCODE and the CODONPREFERENCE of GCG package version 10.2 unites use. Although two programs have all determined terminator codon and an introne in the same way, and initiation codon is also not obvious, particularly, because the peptide that does not have other obtainable N-end of peptide Fx 74 (SEQ ID NO:84) to be sequenced. There is not help to what all possible translation to homologous amino acid sequence of finding during the data library searching was carried out, because the N-end portion of protein is complete allos more yet. Therefore, in the position upstream of peptide Fx 74 but still two methionine residues in same reading frame, finding be selected, use it for and make up different expression cassettes. The zone of between the 666-742 base-pair of SEQ ID NO:7, having found to be rich in CT. Yet this position of being rich in the zone of CT is not veritably preference Met rather than other amino acid as initiation codon because should the zone in fungi and initiation codon between distance sizable variation is arranged usually. In addition, identified possible poly-putative adenylylation site in the downstream of gene.
For from the long introne of the 72bp of the gene of A.niger ATCC 9142, the DNA section most probable of the from the 976th to 981 nucleotides represents 5 '-shearing site, the section most probable of the from the 1029th to 1035 or from 1016 to 1022 nucleotides represents the inside conserved sequence (consensus sequence) of inferring, and the DNA section most probable of the from the 1045th to 1047 nucleotides represents 3 '-shearing site (SEQ ID NO:7). The corresponding sequence of A.niger MacRae gene is positioned bp 32 to 37,66 to 72 and 80 to 82 in the long introne (SEQ ID NO:79) of 51 bp. The introne long for the 50bp of the oal gene of A.niger ssp.awamori, 5 '-shearing site starts from the 203rd nucleotides (GTGCCC), inner conservative region is at the 236th nucleotides place (AACTAAC), and 3 '-shearing site is (SEQ ID NO:9) at the 250th nucleotides place (CAG).
The introne of oal | Length | 5 '-site | Inner site | 3 '-site |
A.niger ATCC 9142 | 72 | GTACCC | ACCTAAC | TAG |
A.niger MacRae | 51 | GTAATC | AACTAAC | CAG |
A.niger ssp awamori | 50 | GTGCCC | AACTAAC | CAG |
The conserved sequence of 5 '-shearing site is GTPuNGPy. Neither one has G at the 5th in the site of listing. The conserved sequence that is used for the yeast in the site, inside that lasso trick (lariat) forms is TACTAAC. 3 '-shearing site has the conserved sequence [Unkles of PyAG, Gene organization in industrial filamentous fungi.In Applied molecular genetics of filamentous fungi (Kinghoun, ed.), pp.28-53.Blackie Academic ﹠ Professional, Wester Cleddens Road, Bishopbriggs, Glasgow G642NZ, UK, Glasgow (1992)].
Produced following cDNA:
-for the oal (SEQ ID NO:98) that expresses at E.coli
-for the oalEco (SEQ ID NO:94) that expresses at Saccharomyces cerevisiae
-for the oalEShort that expresses at S.cerevisiae (31 amino acid whose short versions of second possible Met at the 32nd place of usefulness SEQ ID NO:95)
-the oalS (it is because the misleading sequence of Fxn 42 peptides that oalS is made into, and it finally is accredited as artefact) that is used for expressing at E.coli
-for the oalSEco that expresses at S.cerevisiae
-for the oalhis that contains the terminal his-label of C-that expresses at E.coli
-for the oalEhis that expresses at S.cerevisiae
-for the oalNhis (SEQ ID NO:92) that contains the terminal his-label of N-that expresses at E.coli
-the oalENhis (SEQ ID NO:96) (construct oalsec, it contains the signal peptide of the phytase of A.terreus cbs, this signal peptide is used for the expression and secretion at S.cerevisiae) that is used for expressing at S.cerevisiae
Common operation:
At first, in twice PCR, isolate the hypothesis coded sequence (cDNA) of oal gene. By PCR for the third time two kinds of PCR products are assembled up. Use following primer:
OallAS (SEQ ID NO:46), Oal2AS (SEQ ID NO:47), Oal3S (SEQ ID NO:48), Oal4S (SEQ ID NO:49), Oal5S (SEQ ID NO:50), Oal6AS (SEQ ID NO:51), Oal7AS (SEQ ID NO:52), Oal8AS (SEQ ID NO:53), Oal9AS (SEQ ID NO:54), Oa110S (SEQ ID NO:55), Oal10SEco (SEQ ID NO:56), OalENhis (SEQ ID NO:57), Oal10SShis (SEQ ID NO:58), Oal11S (SEQ ID NO:59), Oal12AS (SEQ ID NO:60), Oal12ASEco (SEQ ID NO:61), Oal12AShis (SEQ ID NO:62), Oal12ASHisEco (SEQ ID NO:63), Oal13S (SEQ ID NO:64), Oa113AS (SEQ ID NO:65), Oal14S (SEQ ID NO:66), Oal14AS (SEQ ID NO:67), Oal15S (SEQ ID NO:68), Oal15AS (SEQ ID NO:69), Oa116S (SEQ ID NO:70) (second Met), OalsecS (SEQ ID NO:71), OalsecAS (SEQ ID NO:72), pQE80EcoS (SEQ ID NO:73), pQE80EcoNhisS (SEQ ID NO:74), pQE80BamAS (SEQ ID NO:75), pQE80BamhisAS (SEQ ID NO:76), pQE80EcoSshort (SEQ ID NO:77) and CP-a (SEQ ID NO:78).
Oal11S directly starts from the front, site of the more upstream of initiation codon, and Oal9AS starts from some nucleotides place, terminator codon downstream of hypothesis. For two kinds of PCR products that can will obtain without introne in PCR for the third time assemble up, Oal14S and Oal14AS are complementary, and it contains terminal point from extron I to the sequence the starting point of extron II.
-95 ℃ of 1 μ l gDNA (1/10 dilution) step 1:5 minute
1 μ l mixture of ribonucleotides step 2:30 second-95 ℃
5 μ l are with Mg2+PCR standard buffer solution step 3:30 second-55 ℃
-72 ℃ of 1 μ l Oal11S (10pMol/ μ l) step 4:1 minute
1μl Oal14AS(10pMol/μl)
1 μ l is from the High Fidelity polymerase mixed liquor of Roche Molecular Biochemicals
40μl H
2O
Step 2 is to 4 repetitions 35 times.
-95 ℃ of 1 μ l gDNA (1/10 dilution) step 1:5 minute
1 μ l mixture of ribonucleotides step 2:30 second-95 ℃
5 μ l are with Mg2+PCR standard buffer solution step 3:30 second-55 ℃
-72 ℃ of 1 μ l Oal14S (10pMol/ μ l) step 4:1 minute
1μl Oal9AS(10pMol/μl)
1 μ l is from the High Fidelity polymerase mixed liquor of Roche Molecular Biochemicals
40μl H
2O
Step 2 is to 4 repetitions 35 times.
The PCR that the gDNA of A.niger ATCC 9142 is carried out has provided the PCR product with expectation size. By agarose gel electrophoresis the PCR product is carried out purifying. Use the QIAEX II kit from Qiagen (Qiagen, Hilden, Germany) from gel, to extract the PCR product, use it for for the third time PCR:
-95 ℃ of PCR product 1 and 2 each 0.5 μ l steps 1:5 minute
1 μ l mixture of ribonucleotides step 2:30 second-95 ℃
5 μ l are with Mg2+PCR standard buffer solution step 3:30 second-55 ℃
-72 ℃ of 1 μ l Oal12S (10pMol/ μ l) step 4:1 minute
1μl Oal10AS(10pMol/μl)
1 μ l is from the High Fidelity polymerase mixed liquor of Roche Molecular Biochemicals
40μl H
2O
Step 2 is to 4 repetitions 30 times.
By agarose gel electrophoresis end-product is carried out purifying, from gel, extract, and according to the method that Invitrogen (carlsbad, CA, USA) provides it is cloned the carrier into TA-, be used for the PCR product is carried out Direct Cloning. All other essential clone's steps are all according to described the carrying out of Sambrook et al. (1989). The plasmid that contains correct insertion (oal1) that detects by order-checking is used as template in all follow-up construction steps.
(a) be used for the construct oal and the oalEco that express at E.coli and Saccharomyces cerevisiae: according to following proposal, with primer pQE80EcoS and pQE80BamAS oal1 is carried out PCR, with generation construct Eco-oal-Bam:
1 μ l contains the plasmid (10ng) as the oal1 that inserts
1 μ l mixture of ribonucleotides
5 μ l are with Mg2+The PCR standard buffer solution
1μl pQE80EcoS(10pMol/μl)
1μl pQE80BamAS(10pMol/μl)
1 μ l is from the High Fidelity polymerase mixed liquor of Roche Molecular Biochemicals
40μl H
2O
Step 1:5 minute-95 ℃
Step 1:30 second-95 ℃
Step 1:30 second-55 ℃
Step 4:1 minute-72 ℃
Step 2 is to 4 repetitions 30 times.
By agarose gel electrophoresis the PCR product is carried out purifying, from gel, extract the interested fragment of people (QIAEX II, Qiagen), digest with EcoRI and BamHI, again carry out purifying with agarose gel electrophoresis, be connected on the carrier pQE80 from Qiagen, transform E.coli Top10. Isolate four clones' plasmid, insertion is checked order. The plasmid that contains correct construct is converted into E.coli M15 or suitable E.coli bacterial strain. All molecular engineerings all are standard techniques known to the skilled.
For the Yeast expression construct, used primer is changed to Oal10EcoS and Oal12ASEco, with EcoRI the PCR product is digested separately, by the EcoRI restriction site on the carrier, clone end-product into pYES2 or be used for the suitable expression vector of S.cerevisiae. According to Hinnen et al., Proc.Natl.Acad.Sci.USA 75:1929-1933 (1978) or according to the specification that provides simultaneously with bacterial strain carries out the bacterial strain to S.cerevisiae, INVScl (Invitrogen for example, Carlsbad, CA, USA) conversion.
(b) for the construct pQE80oalS (with 31 amino acid whose versions that shorten of second possible Met) that expresses at E.coli:
State the same PCR scheme of content with catching up with, with same template, primer pQE80EcoSshort and pQE80BamAS. Process according to the reactant liquor that described in (a) PCR is reacted after finishing.
(c) for the construct oalS that expresses at S.cerevisiae:
Use primer Oal16S and Oal12ASEco. Other all carries out described in (a).
(d) for the construct pQE80oalhis that contains the terminal his-label of C-that expresses at E.coli:
Carry out PCR with primer pQE80EcoS and pQE80BamhisAS, see (a).
(e) for the construct oalhis that expresses at S.cerevisiae:
Carry out PCR with primer Oal10Seco and Oal12ASHisEco, see (a).
(f) for the construct pQE80oalNhis that contains the terminal His-label of N-that expresses at E.coli:
Carrying out PCR with primer pQE80EcoNhisS and pQE80BamAS (sees a).
(g) for the construct oalENhis that expresses at S.cerevisiae:
Carrying out PCR with primer OalENhis and Oal12ASEco (sees a).
(h) construct oalsec, it contains the signal peptide of the phytase of A.terreus cbs, and this signal peptide is used for the expression and secretion at S.cerevisiae:
With three times independently PCR prepare this construct. At first, by being carried out PCR, conservative phytase gene isolates burst [Lehmann et al., Protein Eng.13:49-57 (2000)].
1.0 μ l contains the plasmid (10ng) as the conservative phytase gene that inserts
1.0 μ l mixture of ribonucleotides
5.0 μ l is with Mg2+The PCR standard buffer solution
1.0μl CP-a(10pMol/μl)
1.0μl OalsecAS(10pMol/μl)
1.0 μ l is from the High Fidelity polymerase mixed liquor of Roche Molecular Biochemicals
40μl H
2O
Step 1:5 minute-95 ℃
Step 1:30 second-95 ℃
Step 1:30 second-55 ℃
Step 4:30 second-72 ℃
Step 2 is to 4 repetitions 30 times.
1.0 μ l contains the plasmid (10ng) of oal1 gene
1.0 μ l mixture of ribonucleotides
5.0 μ l is with Mg2+The PCR standard buffer solution
1.0μl OalsecS(10pMol/μl)
1.0μl Oal12ASEco(10pMol/μl)
1.0 μ l is from the High Fidelity polymerase mixed liquor of Roche Molecular Biochemicals
40μl H
2O
Step 1:5 minute-95 ℃
Step 1:30 second-95 ℃
Step 1:30 second-55 ℃
Step 4:45 second-72 ℃
Step 2 is to 4 repetitions 30 times.
By coming purified pcr product at the enterprising row agarose gel electrophoresis of 1.5% Ago-Gel, from gel, extract PCR product (QIAEX II, Qiagen), use it for for the third time PCR:
0.5 the product of μ l PCR1
0.5 the product of μ l PCR2
1.0 μ l mixture of ribonucleotides
5.0 μ l is with Mg2+The PCR standard buffer solution
1.0μl CP-a(10pMol/μl)
1.0μl Oal12ASEco(10pMol/μl)
1.0 μ l is from the High Fidelity polymerase mixed liquor of Roche Molecular Biochemicals
40μl H
2O
Step 1:5 minute-95 ℃
Step 1:30 second-95 ℃
Step 1:30 second-55 ℃
Step 4:1 minute-72 ℃
Step 2 is to 4 repetitions 30 times.
By agarose gel electrophoresis the PCR product is carried out purifying, from gel, extract the PCR product, digest with EcoRI, again carry out purifying with agarose gel electrophoresis, be connected in the S.cerevisiae expression vector according to above-mentioned.
The expression of embodiment 12oal
(a) in E.coli:
Express pQE80oal, pQE80oalS, pQE80oalhis and pQE80oalNhis in E.coli M15, described E.coli M15 contains pREP4, and it contains the repressor (seeing Germany, the expression specification of the Qiagen of Hilden) of lac promoter. The OD that overnight culture is diluted to 600 nm is 0.1, and being cultured to OD600nm at 30 ℃ is 1.5. Then induce culture with 0.5mM IPTG, cultivated 6 hours at 30 ℃ again. By centrifugal (5000g, 20 minutes) harvesting, be frozen in-80 ℃. According to the scheme that manufacturer provides, with B-PER (Pierce, Rockford, IL, USA) they are carried out cracking. Again after the centrifugation step, supernatant is used for hydrolysis to (R)-pantolactone.
In the transformant that contains construct pQE80oalS and pQE80oalhis, all do not find active in supernatant and the cell pyrolysis liquid, and in the situation with construct pQE80oal and pQE80oalNhis, about 5% in the soluble protein is activated (the R)-pantolactone of tool enzyme.
With the method same with the gene that does not have the His-label, express the construct that contains the terminal His-label of N-. Use " QIAexpressionist " the described scheme from Qiagen (Hilden, Germany), the protein that adds the His-label to native form from cell pyrolysis liquid carries out purifying.
(b) in S.cerevisiae:
Construct oalEco, oalES, oalEhis, oalENhis and oalsec express in S.cerevisiae INVScl or similar suitable bacterial strain. Transform and at SDura-culture medium [Sherman et al., Laboratory course manual for methods in yeast genetics, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1986)] go up after the coating, at 30 ℃ flat board is carried out 3 to 4 days cultivation, pick the bacterium colony of turning out, transfer them in the 2ml SDura-fluid nutrient medium, under fierce vibration, cultivated 3 days in 30 ℃. Above-mentioned culture is used as the preculture thing of 25ml SDura-culture medium. Under the fierce vibration in 30 ℃ cultivate again 3 days after, with the culture of preparation [Sherman et al., as mentioned above] the 500ml YPD culture medium in 21 bottles of the inoculations. After cultivating under the same conditions 3 days again, by the centrifugal cell of from culture medium, isolating, carry out cracking with Y-PER (Pierce, Rockford, IL).
As situation about expressing among the E.coli, only there are oalEco and oalENhis construct to cause the expression of active (R)-pantolactone enzyme, it only is found in cell pyrolysis liquid. With 75ml YPD culture, also can produce (R)-pantolactone enzyme of 300U. Corresponding lysate shows the specific activity of about 5 U/mg total proteins.
With the sequence data of above-mentioned introne position, also available similar mode is to making up and express from the oal gene of A.awamori with from the oal gene of A.niger ATCC 46951.
The Oal of 13 pairs of heterogenous expressions in E.coli or S.cerevisiae of embodiment is fixed, and
Use it for the Hydrolysis Resolution to (RS)-pantolactone
For in bioreactor, bringing into play multiple use, (the R)-pantolactone enzyme from A.niger is fixed. After in E.coli or S.cerevisiae, expressing, by chemical means, for example B-PER (E.coli) or Y-PER (S.cerevisiae) (Pierce, Rockford, IL, USA), or by mechanical means for example ultrasonic wave or high pressure carry out fragmentation to cell. Come cleared lysate by centrifugal. Preparation is directly used in fixing. Perhaps, before fixing, use another purification step, for example ammonium sulfate precipitation increases the Oal specific activity further.
Fix by the following method this biocatalyst:
(1) fixing at silicon dioxide gel gel (Silica Sol-Gel):
According to described poly-(the silicic acid glycerine)-1.0 (PGS-1.0) for preparing of document [Gill and Ballesteros, J.Am.Chem.Soc.120:8587-8598 (1998)], it is dissolved in half the icy water of its quality. Get wherein 100 or the part of 200mg, with 50 or the ice-cold living things catalysis developing agent storage liquid formulation (from the soluble enzyme of some preparations) of 100mg mix up hill and dale, be mixed in the 50mM phosphate in 2ml or the 5ml bottle and carry out, pH 7.0, with the soft rotation of bottle 2 minutes, to form the thin layer of hydrogel at the bottle wall. Bottle was placed 20 minutes on ice, then (unlatching) be transferred to refrigerator. Hydrogel is at 5 ℃ of ripe 48-72 hours, to form xerogel (xerogel). By 5 ℃ with 100rpm vibration, with 2 * 1 or 2 * 4ml pH be the bottle that 7 50mM phosphate buffer washs xerogel, then be 2 * 1 or 2 * 4ml pH be 7 50mM TEA-acetate, wherein contain the 10mM magnesium acetate.
(2) Oal is fixed on the silica polyvinyl alcohol collosol and gel (Sol-Gel Silica-Polyvinyl Alcohol):
Similar in method and (1), difference is to store before liquid be combined with lactonase, DGS solution will with the polyvinyl alcohol of appropriate quantity (PVA, from Aldrich, the 85K in the water of 13%w/w) mixing. Follow-up method is shown in (1).
(3) Oal is fixed on the polymine that activates and support with glutaraldehyde:
With polymine (1g, anhydrous, HMW, branched polymer is from Aldrich), CA (0.2g, 36%Ac) and cellulose acetate-butyrate (0.2g, 48% acetic acid and butyric acid content are from Aldrich) be dissolved in the carrene of 5mL, with solution to 7g bleaching earth (Fullers Earth, the 30-60 order is from Aldrich) carry out dressing. Through the material of wet dressing in air under room temperature dry 0.5 hour, until provide about 9g by the bleaching earth of dressing. Then with its Eddy diffusion in the ice-cold mixture of glutaraldehyde (8mL, 50%w/w is from Aldrich) and phosphate buffer (pH 8 for 50mL, 50mM), stirred 2 hours with 200rpm. Wash that (then 4 * 10mL) holders through overactivation wash (pH 8 for 4 * 10 mL, 20mM) with phosphate buffer, then discharge liquid with water. Wet holder and ice-cold lactonase are stored liquid (in the 50mM phosphoric acid, pH 8) mixing, suspension is carried out 20-30 hour stirring with 200rpm. Liquid is softly removed from the enzyme that is fixed, washed with phosphate that (3 * 5mL) wet fixtures are processed with monoethanolamine (pH 8 for 20mL, 20mM), wash (pH 7 for 2 * 5mL, 20mM) with phosphate again, then discharge liquid.
(4) for the reaction condition that (RS)-pantolactone is hydrolyzed and splits
Reaction 2 or the bottle of 4mL in carry out, wherein use 50 or the biocatalyst of 100mg and 1 or the 0.5M racemic lactone (in 0.75M triethylamine-acetate, pH 8.5, contain the magnesium acetate of 20mM) of 2mL. Bottle is cultivated the essential time period under 40 ℃, 200rpm, solution is discharged, and analyze with chirality HPLC, before beginning circulates, wash (2 * 1 or 2mL) catalyst with fresh substrate solution next time. Stop reaction for the sample of analyzing with isopyknic 500mM MES buffer solution, described pH of buffer is 5.5, wherein contain 50 mM EDTA, centrifugal (10000g, 10 minutes) then analyze by HPLC, wherein use the CHIRADEX post of 0.46 * 15cm, carry out wash-out with the water-methanol of 70:30,1mL/ minute, carry out at 20 ℃. In 15 minutes, initial velocity is measured, measured the E value at the end of each circulation.
Summarized the effect in (RS)-pantolactone being carried out split process in batches of the enzyme preparation that is fixed selected in the table 2. Collosol and gel and covalency fixed solution all are proved to be as effectively, even 24 every batch be 1 hour circulation after, catalyst has kept the 62-72% of its initial activity, and demonstrates: excessive (excess) value of enantiomter and the enantio-selectivity of (R)-pantolactone is respectively 89-98% and 71-88%. In addition, when prolonging batch time of carrying out when testing, the catalyst function mode also is very similar, namely carries out in the situation of a day rather than 1 hour when every batch reaction, and it has shown good long-time operation stability.
Table 2: (RS)-pantolactone is split in batches by the lactonase preparation that is fixed
Catalyst | Load (U/g) | Efficient (%) | Active (U/g) | The number of times of residual activity (% is after the 1h circulation) batch reactions circulation | |||||||||||
2 | 4 | 6 | 8 | 10 | 12 | 14 | 16 | 18 | 20 | 22 | 24 | ||||
Silicon dioxide gel gel (pure silicon dioxide xerogel) fixture | |||||||||||||||
Yeast 26U/mL | 78 | 71 | 55 | 96 | 91 | 88 | 87 | 83 | 86 | 85 | 80 | 78 | 74 | 71 | 68 |
E.coli 8.2U/mg | 820 | 58 | 476 | 92 | 87 | 87 | 84 | 80 | 77 | 73 | 72 | 70 | 72 | 69 | 66 |
E.coli 2.6U/mg | 260 | 48 | 124 | 90 | 87 | 81 | 85 | 82 | 80 | 73 | 76 | 70 | 69 | 65 | 62 |
Silica-PVA collosol and gel (5: the 1w/w xerogel) fixture |
Yeast 26U/mL | 78 | 84 | 64 | 93 | 90 | 91 | 85 | 83 | 81 | 76 | 72 | 70 | - | 66 | 63 |
E.coli 8.2U/mg | 820 | 82 | 671 | 91 | 87 | 83 | 82 | 80 | 77 | 78 | 72 | 70 | 67 | 67 | 66 |
E.coli 2.6U/mg | 260 | 80 | 207 | 92 | 87 | 84 | 80 | 79 | 73 | 75 | 70 | 69 | 65 | 63 | |
Bleaching earth-acetic acid/cellulose butyrate-poly-(aziridine)-glutaraldehyde fixture | |||||||||||||||
Yeast 26U/mL | 52 | 34 | 18 | 91 | 88 | 85 | 82 | 82 | 81 | ||||||
E.coli 8.2U/mg | 164 | 50 | 82 | 95 | 92 | 88 | 85 | 84 | 86 | 81 | 79 | 79 | 76 | 74 | 71 |
E.coli 8.2U/mg | 410 | 23 | 95 | 93 | 90 | 86 | 85 | 83 | 80 | 79 | 75 | 72 | |||
E.coli 2.6U/mg | 130 | 25 | 33 | 97 | 88 | 87 | 87 | 87 | 86 | 83 | 80 | 77 | 78 | 75 | 72 |
Enantio-selectivity: value (E) scope of the value of excessive (%ee) of enantiomter and enantio-selectivity is respectively above 89-98% and 71-88%. |
Catalyst*:Biocatalyst/Prod.Organism(Recomb.Activity)
The Oal that is expressed by restructuring E.coli that embodiment 14 is fixed carries out (RS)-pantolactone continuously
The application that splits
According to prepare described in the embodiment 14 (2) through the fixing restructuring lactonase biocatalyst (expressing among the E.coli) of collosol and gel-PVA, be used in packed bed (packed-bed) reactor, the racemic lactone be split continuously: with biocatalyst (1.1g, the 0.21kU g that is fixed-1, 0.231kU altogether) and the dried Omnifit that inserts with 0.46 * 15cm of Teflon terminal (endpiece) adds in the cover glass column. It adds the cover glass column with the Omnifit of 1 * 10cm and links to each other, and is filled with the cellulose bead of 1-2mm in the glass column of 1 * 10 cm, and it is to insert by two syringe pumps that 50mL glass/Teflon syringe is housed. These posts all link to each other with circulator bath, are maintained at 40 ℃ during fractionation is carried out. By the following method reactor is regulated: under the room temperature with 5mL min-1Speed add Tris-acetate buffer (100mM, pH 7, contain the 100mM magnesium acetate), carried out 30 minutes; Then be at room temperature with 1: 1 volume ratio, 2mL min-1Overall flow rate, add the combination of ester solution (1.5M in the water) and Tris-acetate buffer (2.5M, pH 8.25, contain the 50mM magnesium acetate) in the racemic, carried out 30 minutes. Then flow velocity is reduced to 1.2mL min-1, pillar is heated to 40 ℃, system was allowed to balance 15 minutes. Therefore reactor has been carried out about 45 minutes operation, collected eluent at ice bath, with this understanding, with the constant conversion ratio of 46-48% the charging thing of 52.7mL (being equivalent to 5.14g RSPL) has altogether been processed. With sulfuric acid (the 10%v/v aqueous solution) pH of eluent is adjusted to 6.5, with carrene solution is extracted (10 * 75mL), organic layer is dry on anhydrous magnesium sulfate, rotary evaporation, (S)-pantolactone that generation is comprised of the SPL of 10% RPL and 90% (analyzed draw by chirality HPLC) is rich in thing (2.67g, in theory 98%). (40% w/w) carries out acidifying to water with sulfuric acid, to pH 1.5, be heated to 70 ℃, 1 hour, again in cooled on ice, saturated with sodium chloride, (10 * 75mL), organic layer is dry on anhydrous magnesium sulfate then to use dichloromethane extraction, rotary evaporation, produce (R)-pantolactone and be rich in thing (2.23g, theoretical yield 92%), its enantiomeric purity is 93%. To (R)-/(S)-the combination rate of recovery be 95%.
The result of embodiment (13) and (14) clearly illustrates that, the restructuring lactonase is effective biocatalyst for Hydrolysis Resolution racemic pantolactone, this catalyst also can effectively be fixed, fixture can be used for producing highly enriched (R)-pantolactone of the excessive 90-98% of reaching of enantiomerism, no matter be all like this in batch operation or the situation of continued operation.
Embodiment 15 gram falls and expresses (S)-pantolactone specificity lactonase from B.subtilis
Use the amino acid sequence from the lactonase of ox and horse liver, we have found that several other shows the sequence that has limited homology with above-mentioned sequence. By PCR with in the middle of their from yvre gene of B. subtilis (YVRE BACSUBe noted as the member's of SMP30/CGR1 family/suppose 33.2kDa albumen) from genomic DNA the clone out, 5 ' and 3 ' of use therein primer-end also contains the follow-up needed restriction site of step (EcoRI and PstI) of cloning in the expression vector. It is identical that PCR condition and genomic DNA from A.niger separate the used condition of oal gene (seeing embodiment 8). Digest PCR product and carrier (from Stratagene (La Jolla with EcoRI and PstI, CA, USA) PET41a), come purifying by agarose gel electrophoresis, connect, and it is transformed into E.coli Top10 cell (Stratagene, La Jolla, CA, USA). Use this kind strategy, this gene is integrated in the reading frame from the GST GFP of E.coli.
Express and purifying according to the scheme that manufacturer provides. With wherein additionally containing 5mM CaCl2Code test measure the activity of the protein that is purified at 40C. This enzyme has shown very high selective to (S)-pantolactone. Said preparation has the specific activity with respect to every mg enrichment fusion 1-2U. This enzyme is only at Mg2+Or Ca2+Has activity in the situation that ion exists.
Sequence table
<110〉DSM IP Assets BV
<120〉novel enzyme
<130>21717
<160>99
<170>PatentIn version 3.1
<210>1
<211>900
<212>DNA
<213>Equus caballus
<220>
<221>CDS
<222>(1)..(900)
<223>
<400>1
atg tct tcc att aag att gag tgt gtt ctg ccc gag aac tgc cag tgc 48
Met Ser Ser Ile Lys Ile Glu Cys Val Leu Pro Glu Asn Cys Gln Cys
1 5 10 15
ggt gag tcg cca gtg tgg gag gaa gcg tcc agc tct ctg ctc ttc gta 96
Gly Glu Ser Pro Val Trp Glu Glu Ala Ser Ser Ser Leu Leu Phe Val
20 25 30
gat att cct gcc aaa aag gtt tgc cgg tgg gat gcg ctc agc aag caa 144
Asp Ile Pro Ala Lys Lys Val Cys Arg Trp Asp Ala Leu Ser Lys Gln
35 40 45
gtg cag cga atg acc gtg gat gcc ccg gtt ggc tca gtg gcc ctc cgc 192
Val Gln Arg Met Thr Val Asp Ala Pro Val Gly Ser Val Ala Leu Arg
50 55 60
cag tcg gga ggc tat gtc gcc aca att gga acg aag ttc tgt gct ttg 240
Gln Ser Gly Gly Tyr Val Ala Thr Ile Gly Thr Lys Phe Cys Ala Leu
65 70 75 80
aac tgg gaa gat cag tca gta gtt gtc ctg gcc gcg gta gag aaa gac 288
Asn Trp Glu Asp Gln Ser Val Val Val Leu Ala Ala Val Glu Lys Asp
85 90 95
aag aaa aac aat cga ttc aat gac ggg aag gtg gat ccc gcg ggg aga 336
Lys Lys Asn Asn Arg Phe Asn Asp Gly Lys Val Asp Pro Ala Gly Arg
100 105 110
tac ttt gct ggc acc atg gct gag gaa aca gcc ccg gca gtt acg gag 384
Tyr Phe Ala Gly Thr Met Ala Glu Glu Thr Ala Pro Ala Val Thr Glu
115 120 125
cgg cac caa ggg tcc ctg tac gcc ctc ttt cct gac cac cac gtg gaa 432
Arg His Gln Gly Ser Leu Tyr Ala Leu Phe Pro Asp His His Val Glu
130 135 140
aag tac ttt gac cag gtg gac atc tcc aac ggt ttg gat tgg tcc ctg 480
Lys Tyr Phe Asp Gln Val Asp Ile Ser Asn Gly Leu Asp Trp Ser Leu
145 150 155 160
gac cac aaa atc ttc tat tac atc gac agc ctg tcc tac tct gtg gat 528
Asp His Lys Ile Phe Tyr Tyr Ile Asp Ser Leu Ser Tyr Ser Val Asp
165 170 175
gcc ttt gac tat gac ctg ctg aca gga agg atc tct aac cgc aga agt 576
Ala Phe Asp Tyr Asp Leu Leu Thr Gly Arg Ile Ser Asn Arg Arg Ser
180 185 190
gtt tac aag ctg gag aag gaa gaa cat atc cca gat gga atg tgt att 624
Val Tyr Lys Leu Glu Lys Glu Glu His Ile Pro Asp Gly Met Cys Ile
195 200 205
gat act gag ggg aag ctc tgg gtg gcc tgt tac aac gga gga aga gtg 672
Asp Thr Glu Gly Lys Leu Trp Val Ala Cys Tyr Asn Gly Gly Arg Val
210 215 220
att cgt tta gat cct gag aca ggg aaa aga ctc caa act gtg aag ttg 720
Ile Arg Leu Asp Pro Glu Thr Gly Lys Arg Leu Gln Thr Val Lys Leu
225 230 235 240
cct gtt gat aaa acc act tcg tgc tgc ttc gga ggg aag gat tac tct 768
Pro Val Asp Lys Thr Thr Ser Cys Cys Phe Gly Gly Lys Asp Tyr Ser
245 250 255
gaa atg tac gtg acc tgc gcc cgg gct gga ctc gac ccc gag gct ctc 816
Glu Met Tyr Val Thr Cys Ala Arg Ala Gly Leu Asp Pro Glu Ala Leu
260 265 270
tcg cgg cag cct gaa gct ggt ggc att ttc aag ata act ggc ctg ggg 864
Ser Arg Gln Pro Glu Ala Gly Gly Ile Phe Lys Ile Thr Gly Leu Gly
275 280 285
gtc aaa gga att cct ccc tat gcc tac gca gga tga 900
Val Lys Gly Ile Pro Pro Tyr Ala Tyr Ala Gly
290 295
<210>2
<211>299
<212>PRT
<213>Equus caballus
<400>2
Met Ser Ser Ile Lys Ile Glu Cys Val Leu Pro Glu Asn Cys Gln Cys
1 5 10 15
Gly Glu Ser Pro Val Trp Glu Glu Ala Ser Ser Ser Leu Leu Phe Val
20 25 30
Asp Ile Pro Ala Lys Lys Val Cys Arg Trp Asp Ala Leu Ser Lys Gln
35 40 45
Val Gln Arg Met Thr Val Asp Ala Pro Val Gly Ser Val Ala Leu Arg
50 55 60
Gln Ser Gly Gly Tyr Val Ala Thr Ile Gly Thr Lys Phe Cys Ala Leu
65 70 75 80
Asn Trp Glu Asp Gln Ser Val Val Val Leu Ala Ala Val Glu Lys Asp
85 90 95
Lys Lys Asn Asn Arg Phe Asn Asp Gly Lys Val Asp Pro Ala Gly Arg
100 105 110
Tyr Phe Ala Gly Thr Met Ala Glu Glu Thr Ala Pro Ala Val Thr Glu
115 120 125
Arg His Gln Gly Ser Leu Tyr Ala Leu Phe Pro Asp His His Val Glu
130 135 140
Lys Tyr Phe Asp Gln Val Asp Ile Ser Asn Gly Leu Asp Trp Ser Leu
145 150 155 160
Asp His Lys Ile Phe Tyr Tyr Ile Asp Ser Leu Ser Tyr Ser Val Asp
165 170 175
Ala Phe Asp Tyr Asp Leu Leu Thr Gly Arg Ile Ser Asn Arg Arg Ser
180 185 190
Val Tyr Lys Leu Glu Lys Glu Glu His Ile Pro Asp Gly Met Cys Ile
195 200 205
Asp Thr Glu Gly Lys Leu Trp Val Ala Cys Tyr Asn Gly Gly Arg Val
210 215 220
Ile Arg Leu Asp Pro Glu Thr Gly Lys Arg Leu Gln Thr Val Lys Leu
225 230 235 240
Pro Val Asp Lys Thr Thr Ser Cys Cys Phe Gly Gly Lys Asp Tyr Ser
245 250 255
Glu Met Tyr Val Thr Cys Ala Arg Ala Gly Leu Asp Pro Glu Ala Leu
260 265 270
Ser Arg Gln Pro Glu Ala Gly Gly Ile Phe Lys Ile Thr Gly Leu Gly
275 280 285
Val Lys Gly Ile Pro Pro Tyr Ala Tyr Ala Gly
290 295
<210>3
<211>879
<212>DNA
<213>Bacillus subtilis
<220>
<221>CDS
<222>(1)..(879)
<223>
<400>3
atg gat gca gta ttg gaa gca gac act cgg gca gtg att ggt gaa ggc 48
Met Asp Ala Val Leu Glu Ala Asp Thr Arg Ala Val Ile Gly Glu Gly
1 5 10 15
ccg tta tgg gat gaa gag aac ggc cgc tta tat tgg gtt gat atc ctg 96
Pro Leu Trp Asp Glu Glu Asn Gly Arg Leu Tyr Trp Val Asp Ile Leu
20 25 30
ggg agc gag ctc cac atc ttt gac cct gaa gaa aaa atc aac cga tca 144
Gly Ser Glu Leu His Ile Phe Asp Pro Glu Glu Lys Ile Asn Arg Ser
35 40 45
atc aaa ttc aaa tcc ttt gtg acg gcg ctt gcg aaa tat tca aag gat 192
Ile Lys Phe Lys Ser Phe Val Thr Ala Leu Ala Lys Tyr Ser Lys Asp
50 55 60
gaa ctg att atg acg atg aag gac ggg ttt tac ctg tat cat ctt cgg 240
Glu Leu Ile Met Thr Met Lys Asp Gly Phe Tyr Leu Tyr His Leu Arg
65 70 75 80
gat gac agc ttg gaa aaa att aaa cag ccg aag gac atg cat gag agc 288
Asp Asp Ser Leu Glu Lys Ile Lys Gln Pro Lys Asp Met His Glu Ser
85 90 95
ctg aga ttt aat gat gct aaa tgt gac ccg tac gga agg ctt tgg gcg 336
Leu Arg Phe Asn Asp Ala Lys Cys Asp Pro Tyr Gly Arg Leu Trp Ala
100 105 110
ggg acg acg agc atg gaa ggc gag caa aaa cag gcg tcg ctg tac cgt 384
Gly Thr Thr Ser Met Glu Gly Glu Gln Lys Gln Ala Ser Leu Tyr Arg
115 120 125
ttg aat cta gac ggc agt ctt gtc aaa atc aag gat caa gtc tcc acc 432
Leu Asn Leu Asp Gly Ser Leu Val Lys Ile Lys Asp Gln Val Ser Thr
130 135 140
tca aac ggt ttg gat tgg gac cgc gag cgg aat ttg atg tat tac atc 480
Ser Asn Gly Leu Asp Trp Asp Arg Glu Arg Asn Leu Met Tyr Tyr Ile
145 150 155 160
gac acg ccg acc cag gag att gta cgt tac agc tat gat cct caa agc 528
Asp Thr Pro Thr Gln Glu Ile Val Arg Tyr Ser Tyr Asp Pro Gln Ser
165 170 175
gga gat gtt tcg aat cca gaa cct gtc tat cgt ttt gat cag tca gac 576
Gly Asp Val Ser Asn Pro Glu Pro Val Tyr Arg Phe Asp Gln Ser Asp
180 185 190
gga ttg ccg gac ggc atg aca att gac caa aat ggc atg ctg tgg gtg 624
Gly Leu Pro Asp Gly Met Thr Ile Asp Gln Asn Gly Met Leu Trp Val
195 200 205
gcg ctg ttt ggc ggc agc cgc gtt gtt cac att gac ccg ttt cag aaa 672
Ala Leu Phe Gly Gly Ser Arg Val Val His Ile Asp Pro Phe Gln Lys
210 215 220
aaa gaa atc aat tca atc agc gtg ccg gct aaa tat gtc acg tgc tgc 720
Lys Glu Ile Asn Ser Ile Ser Val Pro Ala Lys Tyr Val Thr Cys Cys
225 230 235 240
gcg ttc ggc ggc aga gac tta aaa acc ctt tac att aca acg gca aca 768
Ala Phe Gly Gly Arg Asp Leu Lys Thr Leu Tyr Ile Thr Thr Ala Thr
245 250 255
gaa caa atg aca gaa aaa gag aga tac gag cag cct cac gct gga ggg 816
Glu Gln Met Thr Glu Lys Glu Arg Tyr Glu Gln Pro His Ala Gly Gly
260 265 270
ttg ttt tca gca caa ctg gaa aca ggc gga tat cag ccg gta cca ttt 864
Leu Phe Ser Ala Gln Leu Glu Thr Gly Gly Tyr Gln Pro Val Pro Phe
275 280 285
gct gga gac gta taa 879
Ala Gly Asp Val
290
<210>4
<211>292
<212>PRT
<213>Bacillus subtilis
<400>4
Met Asp Ala Val Leu Glu Ala Asp Thr Arg Ala Val Ile Gly Glu Gly
1 5 10 15
Pro Leu Trp Asp Glu Glu Asn Gly Arg Leu Tyr Trp Val Asp Ile Leu
20 25 30
Gly Ser Glu Leu His Ile Phe Asp Pro Glu Glu Lys Ile Asn Arg Ser
35 40 45
Ile Lys Phe Lys Ser Phe Val Thr Ala Leu Ala Lys Tyr Ser Lys Asp
50 55 60
Glu Leu Ile Met Thr Met Lys Asp Gly Phe Tyr Leu Tyr His Leu Arg
65 70 75 80
Asp Asp Ser Leu Glu Lys Ile Lys Gln Pro Lys Asp Met His Glu Ser
85 90 95
Leu Arg Phe Asn Asp Ala Lys Cys Asp Pro Tyr Gly Arg Leu Trp Ala
100 105 110
Gly Thr Thr Ser Met Glu Gly Glu Gln Lys Gln Ala Ser Leu Tyr Arg
115 120 125
Leu Asn Leu Asp Gly Ser Leu Val Lys Ile Lys Asp Gln Val Ser Thr
130 135 140
Ser Asn Gly Leu Asp Trp Asp Arg Glu Arg Asn Leu Met Tyr Tyr Ile
145 150 155 160
Asp Thr Pro Thr Gln Glu Ile Val Arg Tyr Ser Tyr Asp Pro Gln Ser
165 170 175
Gly Asp Val Ser Asn Pro Glu Pro Val Tyr Arg Phe Asp Gln Ser Asp
180 185 190
Gly Leu Pro Asp Gly Met Thr Ile Asp Gln Asn Gly Met Leu Trp Val
195 200 205
Ala Leu Phe Gly Gly Ser Arg Val Val His Ile Asp Pro Phe Gln Lys
210 215 220
Lys Glu Ile Asn Ser Ile Ser Val Pro Ala Lys Tyr Val Thr Cys Cys
225 230 235 240
Ala Phe Gly Gly Arg Asp Leu Lys Thr Leu Tyr Ile Thr Thr Ala Thr
245 250 255
Glu Gln Met Thr Glu Lys Glu Arg Tyr Glu Gln Pro His Ala Gly Gly
260 265 270
Leu Phe Ser Ala Gln Leu Glu Thr Gly Gly Tyr Gln Pro Val Pro Phe
275 280 285
Ala Gly Asp Val
290
<210>5
<211>726
<212>DNA
<213>Aspergillus niger
<220>
<221>CDS
<222>(1)..(726)
<223>
<400>5
aac tgg gac ctg gaa aaa ctc aat cct cca ggc ttc ggc cgc aaa ccc 48
Asn Trp Asp Leu Glu Lys Leu Asn Pro Pro Gly Phe Gly Arg Lys Pro
1 5 10 15
ttc gcc cac cag gtt aaa tgg gtc agc gaa ggc cac gcc ttc gac gac 96
Phe Ala His Gln Val Lys Trp Val Ser Glu Gly His Ala Phe Asp Asp
20 25 30
gag tac cac ttc aac cca cag caa tcc tcc caa tgg gac ggc cta cga 144
Glu Tyr His Phe Asn Pro Gln Gln Ser Ser Gln Trp Asp Gly Leu Arg
35 40 45
cac cac aat gcc cca gcc cca aca ccc gac gac cct gac cgc cgc gtc 192
His His Asn Ala Pro Ala Pro Thr Pro Asp Asp Pro Asp Arg Arg Val
50 55 60
ttc tac ggc ggc acc acc tcc acc gag atc ctc gac ccg tcc tca gct 240
Phe Tyr Gly Gly Thr Thr Ser Thr Glu Ile Leu Asp Pro Ser Ser Ala
65 70 75 80
cgc atc ggc atc gct cac tgg gcc aag aag ggc atc gcc ggc cgt ggc 288
Arg Ile Gly Ile Ala His Trp Ala Lys Lys Gly Ile Ala Gly Arg Gly
85 90 95
gtc ctc atc gac tac gcg tcc tac atc cag cga acc aag ggc ata cca 336
Val Leu Ile Asp Tyr Ala Ser Tyr Ile Gln Arg Thr Lys Gly Ile Pro
100 105 110
gta aac gcc cta acc cgg cac acc gtc tcc ctg gac gac gtc ctc acc 384
Val Asn Ala Leu Thr Arg His Thr Val Ser Leu Asp Asp Val Leu Thr
115 120 125
atc gcg aaa gaa tgc aac atc acc ttc cag cca ggc gac att ctc ttc 432
Ile Ala Lys Glu Cys Asn Ile Thr Phe Gln Pro Gly Asp Ile Leu Phe
130 135 140
ttg cgt gtc ggc ctg ccc acc aca tgg gat aac atg tcc gat gac gag 480
Leu Arg Val Gly Leu Pro Thr Thr Trp Asp Asn Met Ser Asp Asp Glu
145 150 155 160
aag gtc aaa tac agt caa cag gaa atg cct cag cat gca ggg tta gag 528
Lys Val Lys Tyr Ser Gln Gln Glu Met Pro Gln His Ala Gly Leu Glu
165 170 175
cag agt gag cgc gtg gtg cgg ttc ctc tgg gac cag cat ttc gcg gct 576
Gln Ser Glu Arg Val Val Arg Phe Leu Trp Asp Gln His Phe Ala Ala
180 185 190
gtg gcg ggt gat gcg gtc agc ttc gag gtg tat ccg cct gta gag aag 624
Val Ala Gly Asp Ala Val Ser Phe Glu Val Tyr Pro Pro Val Glu Lys
195 200 205
gag tgg gat ttg cat cat ttt ctg ttg gcc ggg tgg gga gtg ccg att 672
Glu Trp Asp Leu His His Phe Leu Leu Ala Gly Trp Gly Val Pro Ile
210 215 220
ggg gag atg ttt gat ctg gag ggg ttg aag gag gtt tgt gag agg ttg 720
Gly Glu Met Phe Asp Leu Glu Gly Leu Lys Glu Val Cys Glu Arg Leu
225 230 235 240
ggc agg 726
Gly Arg
<210>6
<211>242
<212>PRT
<213>Aspergillus niger
<400>6
Asn Trp Asp Leu Glu Lys Leu Asn Pro Pro Gly Phe Gly Arg Lys Pro
1 5 10 15
Phe Ala His Gln Val Lys Trp Val Ser Glu Gly His Ala Phe Asp Asp
20 25 30
Glu Tyr His Phe Asn Pro Gln Gln Ser Ser Gln Trp Asp Gly Leu Arg
35 40 45
His His Asn Ala Pro Ala Pro Thr Pro Asp Asp Pro Asp Arg Arg Val
50 55 60
Phe Tyr Gly Gly Thr Thr Ser Thr Glu Ile Leu Asp Pro Ser Ser Ala
65 70 75 80
Arg Ile Gly Ile Ala His Trp Ala Lys Lys Gly Ile Ala Gly Arg Gly
85 90 95
Val Leu Ile Asp Tyr Ala Ser Tyr Ile Gln Arg Thr Lys Gly Ile Pro
100 105 110
Val Asn Ala Leu Thr Arg His Thr Val Ser Leu Asp Asp Val Leu Thr
115 120 125
Ile Ala Lys Glu Cys Asn Ile Thr Phe Gln Pro Gly Asp Ile Leu Phe
130 135 140
Leu Arg Val Gly Leu Pro Thr Thr Trp Asp Asn Met Ser Asp Asp Glu
145 150 155 160
Lys Val Lys Tyr Ser Gln Gln Glu Met Pro Gln His Ala Gly Leu Glu
165 170 175
Gln Ser Glu Arg Val Val Arg Phe Leu Trp Asp Gln His Phe Ala Ala
180 185 190
Val Ala Gly Asp Ala Val Ser Phe Glu Val Tyr Pro Pro Val Glu Lys
195 200 205
Glu Trp Asp Leu His His Phe Leu Leu Ala Gly Trp Gly Val Pro Ile
210 215 220
Gly Glu Met Phe Asp Leu Glu Gly Leu Lys Glu Val Cys Glu Arg Leu
225 230 235 240
Gly Arg
<210>7
<211>2443
<212>DNA
<213>Aspergillus niger
<220>
<221>CDS
<222>(774)..(977)
<223>
<220>
<221>CDS
<222>(1050)..(1820)
<223>
<400>7
ccgctatcac tcagcggcag tcgggcgcag acaatgctac cgaggattca gggcacaagg 60
gggatcagtt acgtggggcg tgacgatgta tgggtttcat gaggatgcgt ttacgagtgc 120
gtttggggtg gtggaagagt tgggggcgaa gatcccgttt ccggtggctg atagtcggtt 180
gagagggggt gcagtgaagg aggtgagatg gttggaatat gtgttcagat tggtgttgca 240
gggggtgcag ggcttgattt tgtggctggt gggagaggga aaagggaagc agaaggcgag 300
ctagaacctt ttacacactg cctctcgaat gaacattcag aaattttgga tagacaaggt 360
ttctgtcggt gctattctgg gcgttgcaat acctgtcaca ttgaataacc tccgaggtga 420
ttatccacgc aatcccatat catctgatgt accccttgca taatctgtct ttaccaaatc 480
aggtagaaag taagaccatc cggataggct gtatactacc tcgtgtccac atcggggata 540
ctgaacacga ttgtatatca attcgatgat ggagatacaa ccctaatgaa ccaagcacag 600
ccgtggatct ccccggactt tctccgatgg cttccccacc cgccaatcca gcatcaacta 660
aacaacccct cacgctcttc atcatctctc atttcactcc cacctatcat ctacagcttc 720
acaaacaaca ctactccctc ccaagcacac acctctactg acaagatacc acg atg 776
Met
1
gcc gac tcc ctc ccg aaa acc tac gac gac ctc ccc gac aag cgg cgc 824
Ala Asp Ser Leu Pro Lys Thr Tyr Asp Asp Leu Pro Asp Lys Arg Arg
5 10 15
tac tgg ccc gca acc ccc aac tcc gcc gac gag gga ctg ggg atg ctc 872
Tyr Trp Pro Ala Thr Pro Asn Ser Ala Asp Glu Gly Leu Gly Met Leu
20 25 30
cgt ctc ctc act cca gaa att gtc gcc aac gca gca cgc acc cag atc 920
Arg Leu Leu Thr Pro Glu Ile Val Ala Asn Ala Ala Arg Thr Gln Ile
35 40 45
cag acc ggc gag cgc gta tgc ctg aac tgg gac ctg gag aag ctg aac 968
Gln Thr Gly Glu Arg Val Cys Leu Asn Trp Asp Leu Glu Lys Leu Asn
50 55 60 65
cca cca ggt accctccctt ctacctcagt gacataggtt cacccccaac 1017
Pro Pro Gly
ctcacccatc aacctaactt aaaaacatag gc ttc ggc cgc aaa ccc ttc gcc 1070
Phe Gly Arg Lys Pro Phe Ala
70 75
cac cac gta aaa tgg gtc tcc gaa ggc cac gcc ttc gac gac gaa tac 1118
His His Val Lys Trp Val Ser Glu Gly His Ala Phe Asp Asp Glu Tyr
80 85 90
cac ttc aac ccg caa caa tcc tcc caa tgg gac ggt ctg cga cac cac 1166
His Phe Asn Pro Gln Gln Ser Ser Gln Trp Asp Gly Leu Arg His His
95 100 105
aac gcc ccg gct cca acc ccc gac gac cct aac cgc cgg gtc ttc tac 1214
Asn Ala Pro Ala Pro Thr Pro Asp Asp Pro Asn Arg Arg Val Phe Tyr
110 115 120
ggc ggc acc acc tcc acc gag atc ctc gac ccc tcg tcc acc cga atc 1262
Gly Gly Thr Thr Ser Thr Glu Ile Leu Asp Pro Ser Ser Thr Arg Ile
125 130 135
ggc ata gcc cac tgg gcc aag aaa ggc atc gcc ggc cgc ggc gtc ctc 1310
Gly Ile Ala His Trp Ala Lys Lys Gly Ile Ala Gly Arg Gly Val Leu
140 145 150 155
atc gac tac gcc tcc tac gtg caa cga acc aag ggc gtc aca gta aac 1358
Ile Asp Tyr Ala Ser Tyr Val Gln Arg Thr Lys Gly Val Thr Val Asn
160 165 170
gcc cta acc cgc cac acc gtc tcc ctg gac gac gtc ctc acc atc gcg 1406
Ala Leu Thr Arg His Thr Val Ser Leu Asp Asp Val Leu Thr Ile Ala
175 180 185
aag gaa tgc aac atc acc ttc gaa cca ggc gac att ctc ttc ctg cgc 1454
Lys Glu Cys Asn Ile Thr Phe Glu Pro Gly Asp Ile Leu Phe Leu Arg
190 195 200
gtc ggt cta ccg act aca tgg gat aac atg acc gat gag gag agg gtc 1502
Val Gly Leu Pro Thr Thr Trp Asp Asn Met Thr Asp Glu Glu Arg Val
205 210 215
aag tat agt cag cag gaa acg ccc aac cat gca gga tta gag cag agt 1550
Lys Tyr Ser Gln Gln Glu Thr Pro Asn His Ala Gly Leu Glu Gln Ser
220 225 230 235
gag cgt gtg gtg cgg ttc ctt tgg gat cag cat ttc gcc gct gta gcg 1598
Glu Arg Val Val Arg Phe Leu Trp Asp Gln His Phe Ala Ala Val Ala
240 245 250
ggt gat gcg gtc agc ttt gag gtg tat ccg ccg gta gag aag gag tgg 1646
Gly Asp Ala Val Ser Phe Glu Val Tyr Pro Pro Val Glu Lys Glu Trp
255 260 265
gat tta cat cat ttt ttg ctg gct ggg tgg gga cta ccg att ggg gag 1694
Asp Leu His His Phe Leu Leu Ala Gly Trp Gly Leu Pro Ile Gly Glu
270 275 280
atg ttt gat ctt gag ggg ttg aag gag gtg tgt gag agg ttg gga agg 1742
Met Phe Asp Leu Glu Gly Leu Lys Glu Val Cys Glu Arg Leu Gly Arg
285 290 295
tgg acg ttt ttc gtt agt tct agt ccg ttg aac tgt ggg aga ggt gtg 1790
Trp Thr Phe Phe Val Ser Ser Ser Pro Leu Asn Cys Gly Arg Gly Val
300 305 310 315
tcg agt ccg ccg aat tgt atg gca att ttt taaaatgcag aggtggtgtg 1840
Ser Ser Pro Pro Asn Cys Met Ala Ile Phe
320 325
ggaacggagt tggatggacg atggagtgga tagaacagcg ggagttgatg tattgagctg 1900
gggccctagt catgatttgt ctgaatctgg agactataca tagcaccttc agggcatcaa 1960
gaggcataat atgcagttat acttgtgata ttacattctt tggccacagt tatgactgtc 2020
tcttatattg actttgaagt gtcttctttg agccgagtat acttggatta taggattcca 2080
atgacggtac atcccgaagg tctgtcccag cacttcccta atcgcagtgg taatacctac 2140
tactagccag tatatctaaa gtacaccact cggaactcat tcacatatac gaatggtgac 2200
tatgaagggg taatacattc acaacaagat cagtaaatag cagttgcgag gaatgcaaga 2260
ctagcccttc gtacattcaa tatcagaagt tgggactata aaggccactg cctccctcac 2320
tagcccgtaa agcaatacct cgctgctacc attgccaact gcagggtgtt tccagtaaac 2380
ggagtggctg ttcccaccgt gcagcactct gtacccactc cccttcctgc tgtcattctg 2440
att 2443
<210>8
<211>325
<212>PRT
<213>Aspergillus niger
<400>8
Met Ala Asp Ser Leu Pro Lys Thr Tyr Asp Asp Leu Pro Asp Lys Arg
1 5 10 15
Arg Tyr Trp Pro Ala Thr Pro Asn Ser Ala Asp Glu Gly Leu Gly Met
20 25 30
Leu Arg Leu Leu Thr Pro Glu Ile Val Ala Asn Ala Ala Arg Thr Gln
35 40 45
Ile Gln Thr Gly Glu Arg Val Cys Leu Asn Trp Asp Leu Glu Lys Leu
50 55 60
Asn Pro Pro Gly Phe Gly Arg Lys Pro Phe Ala His His Val Lys Trp
65 70 75 80
Val Ser Glu Gly His Ala Phe Asp Asp Glu Tyr His Phe Asn Pro Gln
85 90 95
Gln Ser Ser Gln Trp Asp Gly Leu Arg His His Asn Ala Pro Ala Pro
100 105 110
Thr Pro Asp Asp Pro Asn Arg Arg Val Phe Tyr Gly Gly Thr Thr Ser
115 120 125
Thr Glu Ile Leu Asp Pro Ser Ser Thr Arg Ile Gly Ile Ala His Trp
130 135 140
Ala Lys Lys Gly Ile Ala Gly Arg Gly Val Leu Ile Asp Tyr Ala Ser
145 150 155 160
Tyr Val Gln Arg Thr Lys Gly Val Thr Val Asn Ala Leu Thr Arg His
165 170 175
Thr Val Ser Leu Asp Asp Va1 Leu Thr Ile Ala Lys Glu Cys Asn Ile
180 185 190
Thr Phe Glu Pro Gly Asp Ile Leu Phe Leu Arg Val Gly Leu Pro Thr
195 200 205
Thr Trp Asp Asn Met Thr Asp Glu Glu Arg Val Lys Tyr Ser Gln Gln
210 215 220
Glu Thr Pro Asn His Ala Gly Leu Glu Gln Ser Glu Arg Val Val Arg
225 230 235 240
Phe Leu Trp Asp Gln His Phe Ala Ala Val Ala Gly Asp Ala Val Ser
245 250 255
Phe Glu Val Tyr Pro Pro Val Glu Lys Glu Trp Asp Leu His His Phe
260 265 270
Leu Leu Ala Gly Trp Gly Leu Pro Ile Gly Glu Met Phe Asp Leu Glu
275 280 285
Gly Leu Lys Glu Val Cys Glu Arg Leu Gly Arg Trp Thr Phe Phe Val
290 295 300
Ser Ser Ser Pro Leu Asn Cys Gly Arg Gly Val Ser Ser Pro Pro Asn
305 310 315 320
Cys Met Ala Ile Phe
325
<210>9
<211>1025
<212>DNA
<213>Aspergillus awamorii
<220>
<221>CDS
<222>(1)..(204)
<223>
<220>
<221>CDS
<222>(255)..(1025)
<223>
<400>9
atg gcc gac tcc ctc ccg aaa acc tac gac gac ctc ccc gac aag cgg 48
Met Ala Asp Ser Leu Pro Lys Thr Tyr Asp Asp Leu Pro Asp Lys Arg
1 5 10 15
cgc tac tgg ccc gca gcc ccc aac tcc gcc gac gag ggg ctg ggg atg 96
Arg Tyr Trp Pro Ala Ala Pro Asn Ser Ala Asp Glu Gly Leu Gly Met
20 25 30
ctc cgt ctc ctc acc cca gaa gtg gtc gcc aac gca gca cgc acc cag 144
Leu Arg Leu Leu Thr Pro Glu Val Val Ala Asn Ala Ala Arg Thr Gln
35 40 45
atc cag acc ggc gag cgt gta tgc ctc aac tgg gac ctg gag aag cta 192
Ile Gln Thr Gly Glu Arg Val Cys Leu Asn Trp Asp Leu Glu Lys Leu
50 55 60
aac cca cca ggt gcccctcctt ccacccccat cgtctctcac caactaacca 244
Asn Pro Pro Gly
65
aaacacaggt ttc ggc cgc aaa ccc ttc gcc cac cag gtt aaa tgg gtc 293
Phe Gly Arg Lys Pro Phe Ala His Gln Val Lys Trp Val
70 75 80
aac gaa ggc cac gcc ttc gac gac gaa tac cac ttc aat ccc cag caa 341
Asn Glu Gly His Ala Phe Asp Asp Glu Tyr His Phe Asn Pro Gln Gln
85 90 95
tcc tcc caa tgg gac ggc ctc cga cac cac aac gcc ccg gcc cca aca 389
Ser Ser Gln Trp Asp Gly Leu Arg His His Asn Ala Pro Ala Pro Thr
100 105 110
ccc gaa gac cct gag cgc cgc gtc ttc tac ggc ggc acc acc tcc acc 437
Pro Glu Asp Pro Glu Arg Arg Val Phe Tyr Gly Gly Thr Thr Ser Thr
115 120 125
gag atc ctc gac ccc tcg tcc gca cgg atc ggc ata gcc cac tgg gcc 485
Glu Ile Leu Asp Pro Ser Ser Ala Arg Ile Gly Ile Ala His Trp Ala
130 135 140 145
aag aag ggc atc gcc ggc cgc ggc gtc ctc ata gac tac gcc tcc tac 533
Lys Lys Gly Ile Ala Gly Arg Gly Val Leu Ile Asp Tyr Ala Ser Tyr
150 155 160
atc cag cga acc aag ggc atc aca gta aac gcc cta acc cgc cac acc 581
Ile Gln Arg Thr Lys Gly Ile Thr Val Asn Ala Leu Thr Arg His Thr
165 170 175
gtc tcc ctc gac gac gtc ctc acc atc gcg aag gaa tgc aac att acc 629
Val Ser Leu Asp Asp Val Leu Thr Ile Ala Lys Glu Cys Asn Ile Thr
180 185 190
ttc cag cca ggc gac att ctc ttc ctg cgc gtt ggt cta ccg aca acg 677
Phe Gln Pro Gly Asp Ile Leu Phe Leu Arg Val Gly Leu Pro Thr Thr
195 200 205
tgg gat aac atg tcc gat gaa gag aag gtc gag tat agt caa cag caa 725
Trp Asp Asn Met Ser Asp Glu Glu Lys Val Glu Tyr Ser Gln Gln Gln
210 215 220 225
aca ccc cag cat gca ggt tta gag cag agc gag cgt gtg gtg cgg ttc 773
Thr Pro Gln His Ala Gly Leu Glu Gln Ser Glu Arg Val Val Arg Phe
230 235 240
ctc tgg gac cag cat ttc gcg gct gtg gcg ggc gat gcg gtc agc ttt 821
Leu Trp Asp Gln His Phe Ala Ala Val Ala Gly Asp Ala Val Ser Phe
245 250 255
gag gtg tat ccg ccg gta gag aag gag tgg gat tta cac cat ttc ttg 869
Glu Val Tyr Pro Pro Val Glu Lys Glu Trp Asp Leu His His Phe Leu
260 265 270
ctt gct ggg tgg gga gtg ccg att gga gag atg ttt gat ctg gag ggg 917
Leu Ala Gly Trp Gly Val Pro Ile Gly Glu Met Phe Asp Leu Glu Gly
275 280 285
ttg aag gag gtg tgt gag agg ttg ggc agg tgg acg ttt ttt gtt agt 965
Leu Lys Glu Val Cys Glu Arg Leu Gly Arg Trp Thr Phe Phe Val Ser
290 295 300 305
tcg agt ccg ttg aat tgt aag acg ggg gtg tcg agt ccg ccg aat tgt 1013
Ser Ser Pro Leu Asn Cys Lys Thr Gly Val Ser Ser Pro Pro Asn Cys
310 315 320
atg gca att ttt 1025
Met Ala Ile Phe
325
<210>10
<211>325
<212>PRT
<213>Aspergillus awamorii
<400>10
Met Ala Asp Ser Leu Pro Lys Thr Tyr Asp Asp Leu Pro Asp Lys Arg
1 5 10 15
Arg Tyr Trp Pro Ala Ala Pro Asn Ser Ala Asp Glu Gly Leu Gly Met
20 25 30
Leu Arg Leu Leu Thr Pro Glu Val Val Ala Asn Ala Ala Arg Thr Gln
35 40 45
Ile Gln Thr Gly Glu Arg Val Cys Leu Asn Trp Asp Leu Glu Lys Leu
50 55 60
Asn Pro Pro Gly Phe Gly Arg Lys Pro Phe Ala His Gln Val Lys Trp
65 70 75 80
Val Asn Glu Gly His Ala Phe Asp Asp Glu Tyr His Phe Asn Pro Gln
85 90 95
Gln Ser Ser Gln Trp Asp Gly Leu Arg His His Asn Ala Pro Ala Pro
100 105 110
Thr Pro Glu Asp Pro Glu Arg Arg Val Phe Tyr Gly Gly Thr Thr Ser
115 120 125
Thr Glu Ile Leu Asp Pro Ser Ser Ala Arg Ile Gly Ile Ala His Trp
130 135 140
Ala Lys Lys Gly Ile Ala Gly Arg Gly Val Leu Ile Asp Tyr Ala Ser
145 150 155 160
Tyr Ile Gln Arg Thr Lys Gly Ile Thr Val Asn Ala Leu Thr Arg His
165 170 175
Thr Val Ser Leu Asp Asp Val Leu Thr Ile Ala Lys Glu Cys Asn Ile
180 185 190
Thr Phe Gln Pro Gly Asp Ile Leu Phe Leu Arg Val Gly Leu Pro Thr
195 200 205
Thr Trp Asp Asn Met Ser Asp Glu Glu Lys Val Glu Tyr Ser Gln Gln
210 215 220
Gln Thr Pro Gln His Ala Gly Leu Glu Gln Ser Glu Arg Val Val Arg
225 230 235 240
Phe Leu Trp Asp Gln His Phe Ala Ala Val Ala Gly Asp Ala Val Ser
245 250 255
Phe Glu Val Tyr Pro Pro Val Glu Lys Glu Trp Asp Leu His His Phe
260 265 270
Leu Leu Ala Gly Trp Gly Val Pro Ile Gly Glu Met Phe Asp Leu Glu
275 280 285
Gly Leu Lys Glu Val Cys Glu Arg Leu Gly Arg Trp Thr Phe Phe Val
290 295 300
Ser Ser Ser Pro Leu Asn Cys Lys Thr Gly Val Ser Ser Pro Pro Asn
305 310 315 320
Cys Met Ala Ile Phe
325
<210>11
<211>11
<212>PRT
<213>Equus caballus
<400>11
His Gln Gly Ser Leu Val Ala Leu Phe Pro Asp
1 5 10
<210>12
<211>23
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(23)
<223〉5 '-primer
<400>12
atgtcttcca tcaagattga atg 23
<210>13
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉3 '-primer
<400>13
gtcaaaggaa ttccccccta t 21
<210>14
<211>30
<212>DNA
<213>Bos sp.
<400>14
atgtcttcca ttaagattga gtgtgttttg 30
<210>15
<211>30
<212>DNA
<213>Oryctolagus cuniculus
<400>15
atgtcttcca ttaagatcga gtgtgttttg 30
<210>16
<211>30
<212>DNA
<213>Homo sapiens
<400>16
atgtcttcca ttaagattga gtgtgttttg 30
<210>17
<211>30
<212>DNA
<213>Rattus norvegicus
<400>17
atgtcttcca tcaagattga atgtgtttta 30
<210>18
<211>30
<212>DNA
<213>Mus sp.
<400>18
atgtcttcca tcaaagttga atgtgtttta 30
<210>19
<211>30
<212>DNA
<213>Gallus sp.
<400>19
atgtcgtccg ttaagatcga gtgcgtcggg 30
<210>20
<211>30
<212>DNA
<213>Xenopus sp.
<400>20
atgtcttcca tcaagataga atgtgtagtc 30
<210>21
<211>39
<212>DNA
<213>Bos sp.
<400>21
ataactggcc taggagtcaa aggaattcct ccctatcct 39
<210>22
<211>39
<212>DNA
<213>Oryctolagus cuniculus
<400>22
ataactggcc tgggggtcaa aggaattccc ccctactcc 39
<210>23
<211>39
<212>DNA
<213>Homo sapiens
<400>23
ataactggtc tgggggtcaa aggaattgct ccctactcc 39
<210>24
<211>39
<212>DNA
<213>Rattus norvegicus
<400>24
ataacaggtc ttggggtcaa aggaattgct ccatattcc 39
<210>25
<211>39
<212>DNA
<213>Mus sp.
<400>25
ataacaggtc tcggagtcaa aggaattgcc ccatattcc 39
<210>26
<211>39
<212>DNA
<213>Gallus sp.
<400>26
atcactgggc ttggtgtgaa aggaatcccg ccatatcca 39
<210>27
<211>39
<212>DNA
<213>Xenopus sp.
<400>27
attactggac ttggagtaaa aggaatcgca ccaactgca 39
<210>28
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer of perfect matching
<400>28
aatacacatt ccatctggga t 21
<210>29
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉forward primer
<400>29
gaactgtgaa gttgcctgtt g 21
<210>30
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer
<400>30
ggaagaggat gtcac tcatc c 21
<210>31
<211>26
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(6)..(6)
<223〉n represents C, G or T
<220>
<221>misc_feature
<222>(9)..(9)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(12)..(12)
<223〉n represents C, G or T
<220>
<221>misc_feature
<222>(15).,(15)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(18)..(18)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(21)..(21)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(1)..(26)
<223〉oligonucleotides Fxn42
<400>31
aagccnttng cncancangt naagac 26
<210>32
<211>26
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(15)..(15)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(1)..(26)
<223〉oligonucleotides Fxn42S
<220>
<221>misc_feature
<222>(18)..(18)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(21)..(21)
<223〉n represents C, G or T
<220>
<221>misc_feature
<222>(24)..(24)
<223〉n represents A or G
<400>32
aagccgttcg cccancangt naanac 26
<210>33
<211>26
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(6)..(6)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(15)..(15)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(18)..(18)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(21)..(21)
<223〉n represents A, C, T or G
<220>
<221>misc_feature
<222>(24)..(24)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(1)..(26)
<223〉oligonucleotides Fxn42AS
<400>33
gtcttnacct ggtgngcnaa nggntt 26
<210>34
<211>24
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(3)..(3)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(6)..(6)
<223〉n represents A, C or G
<220>
<221>misc_feature
<222>(9)..(9)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(12)..(12)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(15)..(15)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(21)..(21)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(1)..(24)
<223〉oligonucleotides Fxn57
<400>34
atnggnatng cncantgggc naag 24
<210>35
<211>24
<212>DNA
<213〉people T
<220>
<221>misc_feature
<222>(9)..(9)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(12)..(12)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(15)..(15)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(21)..(21)
<223〉n represents C, G or T
<220>
<221>misc_feature
<222>(24)..(24)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(1)..(24)
<223〉oligonucleotides Fxn57S
<400>35
atcggcatng cncantgggc naan 24
<210>36
<211>24
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(13)..(13)
<223〉n represents A, C or G
<220>
<221>misc_feature
<222>(16)..(16)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(19)..(19)
<223〉n represents A, C, T or G
<220>
<221>misc_feature
<222>(22)..(22)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(1)..(24)
<223〉oligonucleotides Fxn57AS
<400>36
cttggcccag tgngcnatnc cnat 24
<210>37
<211>39
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(6)..(6)
<223〉n represents C, G or T
<220>
<221>misc_feature
<222>(9)..(9)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(12)..(12)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(15)..(15)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(18)..(18)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(21)..(21)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(24)..(24)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(27)..(27)
<223〉n represents C, G or T
<220>
<221>misc_feature
<222>(30)..(30)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(33)..(33)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(1)..(39)
<223〉oligonucleotides Fx73
<220>
<221>misc_feature
<222>(36)..(36)
<223〉n represents C or T
<400>37
tggacnttnt tngtntcntc ntcnccnctn aantgnaag 39
<210>38
<211>39
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(24)..(24)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(27)..(27)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(30)..(30)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(33)..(33)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(36)..(36)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(39)..(39)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(1)..(39)
<223〉oligonucleotides Fx73S
<400>38
tggaccttgt tggtgtcctc ctcnccnctn aantgnaan 39
<210>39
<211>39
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(22)..(22)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(25)..(25)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(28)..(28)
<223〉n represents A or C
<220>
<221>misc_feature
<222>(31)..(31)
<223〉n represents A or C
<220>
<221>misc_feature
<222>(34)..(34)
<223〉n represents A, C or G
<220>
<221>misc_feature
<222>(1)..(39)
<223〉oligonucleotides Fx73AS
<400>39
cttgcagttc agcggggagg anganacnaa naangtcca 39
<210>40
<211>38
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(3)..(3)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(6)..(6)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(9)..(9)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(12)..(12)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(18)..(18)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(21)..(21)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(24)..(24)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(27)..(27)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(30)..(30)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(33)..(33)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(36)..(36)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(1)..(38)
<223〉oligonucleotides FX74
<400>40
gtntgnctna antggganct nganaanctn aanccncc 38
<210>41
<211>29
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(15)..(15)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(18)..(18)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(21)..(21)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(24)..(24)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(27)..(27)
<223〉n represents C, G or T
<220>
<221>misc_feature
<222>(1)..(29)
<223〉oligonucleotides Fx74S
<400>41
aactgggacc tgganaanct naanccncc 29
<210>42
<211>27
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(12)..(12)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(15)..(15)
<223〉n represents C or T
<220>
<221>misc_feature
<222>(18)..(18)
<223〉n represents C or G
<220>
<221>misc_feature
<222>(21)..(21)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(27)..(27)
<223〉n represents A or G
<220>
<221>misc_feature
<222>(1)..(27)
<223〉oligonucleotides Fx74AS
<400>42
ggcgggt tca gnttntcnag ntcccan 27
<210>43
<211>8
<212>PRT
<213>Aspergillus sp.
<400>43
Iys Pro Phe Ala His Gln Val Lys
1 5
<210>44
<211>16
<212>PRT
<213>Aspergillus sp.
<400>44
Arg His His Asn Ala Pro Ala Pro Thr Pro Glu Asp Pro Glu Arg Arg
1 5 10 15
<210>45
<211>12
<212>PRT
<213>Aspergillus sp.
<220>
<221>MISC_FEATURE
<222>(10)..(10)
Does<223〉x represent?
<400>45
Lys Pro Phe Ala His Gln Val Lys Thr Xaa Glu Asp
1 5 10
<210>46
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer Oal1AS
<400>46
cgaagggttt gcggccgaag c 21
<210>47
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer Oal2AS
<400>47
aaggcgtggc cttcggagac c 21
<210>48
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer Oal3S
<400>48
gtagcgggtg atgcggtcag c 21
<210>49
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer Oal4S
<400>49
tgtatccgcc ggtagagaag g 21
<210>50
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer Oal5S
<400>50
ccctcgtcca cccgaatcgg c 21
<210>51
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer Oal6AS
<400>51
gcgtagtcga tgaggacgcc g 21
<210>52
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer Oal7AS
<400>52
tgactatact tgaccctctc c 21
<210>53
<211>22
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(22)
<223〉primer Oal8AS
<400>53
ggagacccat tttacgtggt gg 22
<210>54
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer Oal9AS
<400>54
ccgttcccac accacctctg c 21
<210>55
<211>24
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(24)
<223〉primer Oal10s
<400>55
atggccgact ccctcccgaa aacc 24
<210>56
<211>27
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(27)
<223〉primer Oal10SEco
<400>56
atataagaat tcaaatggcc gactccc 27
<210>57
<211>53
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(53)
<223〉primer OalENhis
<400>57
gaattcaaat gagaggatcc catcaccatc accatcacgc cgactccctc ccg 53
<210>58
<211>19
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(19)
<223〉primer Oal10SShis
<400>58
atgagaggat cgcatcacc 19
<210>59
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer Oal11S
<400>59
ctctactgac aagataccac g 21
<210>60
<211>26
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(26)
<223〉primer Oal12AS
<400>60
ttaaaaaatt gccatacaat tcggcg 26
<210>61
<211>38
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(38)
<223〉primer Oal12ASEco
<400>61
tatatagaat tcttaaaaaa ttgccataca attcggcg 38
<210>62
<211>44
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(44)
<223〉primer Oal12AShis
<400>62
tcaatggtga tggtgatgat gaaaaattgc catacaattc ggcg 44
<210>63
<211>56
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(56)
<223〉primer Oal12ASHisEco
<400>63
tatatagaat tcttaatggt gatggtgatg atgaaaaatt gccatacaat tcggcg 56
<210>64
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer Oal13S
<400>64
ggagatacaa ccctaatgaa c 21
<210>65
<211>21
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(21)
<223〉primer Oal13AS
<400>65
gttcattagg gttgtatctc c 21
<210>66
<211>37
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(37)
<223〉primer Oal14S
<400>66
gagaagctga acccaccagg cttcggccgc aaaccct 37
<210>67
<211>37
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(37)
<223〉primer Oal14AS
<400>67
agggtttgcg gccgaagcct ggtgggttca gcttctc 37
<210>68
<211>37
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(37)
<223〉primer Oal15S
<400>68
cttcgcccac cacgtaaaaa cccccgacga ccctaac 37
<210>69
<211>37
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(37)
<223〉primer Oal15AS
<400>69
gttagggtcg tcgggggttt ttacgtggtg ggcgaag 37
<210>70
<211>32
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(32)
<223〉primer Oal16S
<400>70
gaattcaaat gctccgtctc ctcactccac tc 32
<210>71
<211>30
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(30)
<223〉primer OalsecS
<400>71
ggtcctcgtg gtaatgccga ctccctcccg 30
<210>72
<211>27
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(27)
<223〉primer OalsecAS
<400>72
cgggagggag tcggcattac cacgagg 27
<210>73
<211>48
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(48)
<223〉primer pQE80EcoS
<400>73
tatatagaat tcattaaaga ggagaaatta actatggccg actccctc 48
<210>74
<211>52
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(52)
<223〉primer pQE80EcoNhisS
<400>74
tatatagaat tcattaaaga ggagaaatta actatgagag gatcgcatca cc 52
<210>75
<211>34
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(34)
<223〉primer pQE80BamAS
<400>75
tatatagtcg acttaaaaaa ttgccataca attc 34
<210>76
<211>56
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(56)
<223〉primer pQE80BamhisAS
<400>76
tatatagtcg actcaatggt gatggtgatg atgaaaaatt gccatacaat tcggcg 56
<210>77
<211>57
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(57)
<223〉primer pQE80EcoSshort
<400>77
tatatagaat tcattaaaga ggagaaatta actatgctcc gtctcctcac tccactc 57
<210>78
<211>26
<212>DNA
<213〉artificial
<220>
<221>misc_feature
<222>(1)..(26)
<223〉primer CP-a
<400>78
tatatgaatt catgggcgtg ttcgtc 26
<210>79
<211>777
<212>DNA
<213>Aspergillus niger
<220>
<221>Intron
<222>(32)..(82)
<223>
<220>
<221>CDS
<222>(83)..(777)
<223>
<220>
<221>CDS
<222>(1)..(31)
<223>
<400>79
aac tgg gac ctg gaa aaa ctc aat cct cca g gtaatcccct ccttccaacc 51
Asn Trp Asp Leu Glu Lys Leu Asn Pro Pro
1 5 10
catcctctat cgccaactaa cctaaacaca g gc ttc ggc cgc aaa ccc ttc 102
Gly Phe Gly Arg Lys Pro Phe
15
gcc cac cag gtt aaa tgg gtc agc gaa ggc cac gcc ttc gac gac gag 150
Ala His Gln Val Lys Trp Val Ser Glu Gly His Ala Phe Asp Asp Glu
20 25 30
tac cac ttc aac cca cag caa tcc tcc caa tgg gac ggc cta cga cac 198
Tyr His Phe Asn Pro Gln Gln Ser Ser Gln Trp Asp Gly Leu Arg His
35 40 45
cac aat gcc cca gcc cca aca ccc gac gac cct gac cgc cgc gtc ttc 246
His Asn Ala Pro Ala Pro Thr Pro Asp Asp Pro Asp Arg Arg Val Phe
50 55 60 65
tac ggc ggc acc acc tcc acc gag atc ctc gac ccg tcc tca gct cgc 294
Tyr Gly Gly Thr Thr Ser Thr Glu Ile Leu Asp Pro Ser Ser Ala Arg
70 75 80
atc ggc atc gct cac tgg gcc aag aag ggc atc gcc ggc cgt ggc gtc 342
Ile Gly Ile Ala His Trp Ala Lys Lys Gly Ile Ala Gly Arg Gly Val
85 90 95
ctc atc gac tac gcg tcc tac atc cag cga acc aag ggc ata cca gta 390
Leu Ile Asp Tyr Ala Set Tyr Ile Gln Arg Thr Lys Gly Ile Pro Val
100 105 110
aac gcc cta acc cgg cac acc gtc tcc ctg gac gac gtc ctc acc atc 438
Asn Ala Leu Thr Arg His Thr Val Ser Leu Asp Asp Val Leu Thr Ile
115 120 125
gcg aaa gaa tgc aac atc acc ttc cag cca ggc gac att ctc ttc ttg 486
Ala Lys Glu Cys Asn Ile Thr Phe Gln Pro Gly Asp Ile Leu Phe Leu
130 135 140 145
cgt gtc ggc ctg ccc acc aca tgg gat aac atg tcc gat gac gag aag 534
Arg Val Gly Leu Pro Thr Thr Trp Asp Asn Met Ser Asp Asp Glu Lys
150 155 160
gtc aaa tac agt caa cag gaa atg cct cag cat gca ggg tta gag cag 582
Val Lys Tyr Ser Gln Gln Glu Met Pro Gln His Ala Gly Leu Glu Gln
165 170 175
agt gag cgc gtg gtg cgg ttc ctc tgg gac cag cat ttc gcg gct gtg 630
Ser Glu Arg Val Val Arg Phe Leu Trp Asp Gln His Phe Ala Ala Val
180 185 190
gcg ggt gat gcg gtc agc ttc gag gtg tat ccg cct gta gag aag gag 678
Ala Gly Asp Ala Val Ser Phe Glu Val Tyr Pro Pro Val Glu Lys Glu
195 200 205
tgg gat ttg cat cat ttt ctg ttg gcc ggg tgg gga gtg ccg att ggg 726
Trp Asp Leu His His Phe Leu Leu Ala Gly Trp Gly Val Pro Ile Gly
210 215 220 225
gag atg ttt gat ctg gag ggg ttg aag gag gtt tgt gag agg ttg ggc 774
Glu Met Phe Asp Leu Glu Gly Leu Lys Glu Val Cys Glu Arg Leu Gly
230 235 240
agg 777
Arg
<210>80
<211>242
<212>PRT
<213>Aspergillus niger
<400>80
Asn Trp Asp Leu Glu Lys Leu Asn Pro Pro Gly Phe Gly Arg Lys Pro
1 5 10 15
Phe Ala His Gln Val Lys Trp Val Ser Glu Gly His Ala Phe Asp Asp
20 25 30
Glu Tyr His Phe Asn Pro Gln Gln Ser Ser Gln Trp Asp Gly Leu Arg
35 40 45
His His Asn Ala Pro Als Pro Thr Pro Asp Asp Pro Asp Arg Arg Val
50 55 60
Phe Tyr Gly Gly Thr Thr Ser Thr Glu Ile Leu Asp Pro Ser Ser Ala
65 70 75 80
Arg Ile Gly Ile Ala His Trp Ala Lys Lys Gly Ile Ala Gly Arg Gly
85 90 95
Val Leu Ile Asp Tyr Ala Ser Tyr Ile Gln Arg Thr Lys Gly Ile Pro
100 105 110
Val Asn Ala Leu Thr Arg His Thr Val Ser Leu Asp Asp Val Leu Thr
115 120 125
Ile Ala Lys Glu Cys Asn Ile Thr Phe Gln Pro Gly Asp Ile Leu Phe
130 135 140
Leu Arg Val Gly Leu Pro Thr Thr Trp Asp Asn Met Ser Asp Asp Glu
145 150 155 160
Lys Val Lys Tyr Ser Gln Gln Glu Met Pro Gln His Ala Gly Leu Glu
165 170 175
Gln Ser Glu Arg Val Val Arg Phe Leu Trp Asp Gln His Phe Ala Ala
180 185 190
Val Ala Gly Asp Ala Val Ser Phe Glu Val Tyr Pro Pro Val Glu Lys
195 200 205
Glu Trp Asp Leu His His Phe Leu Leu Ala Gly Trp Gly Val Pro Ile
210 215 220
Gly Glu Met Phe Asp Leu Glu Gly Leu Lys Glu Val Cys Glu Arg Leu
225 230 235 240
Gly Arg
<210>81
<211>12
<212>PRT
<213>Aspergillus niger
<220>
<221>MISC_FFATURE
<222>(10)..(10)
<223>undefined amino acid
<400>81
Lys Pro Phe Ala His Gln Val Lys Thr Xaa Glu Asp
1 5 10
<210>82
<211>8
<212>PRT
<213>Aspergillus niger
<400>82
Ile Gly Ile Ala His Trp Ala Lys
1 5
<210>83
<211>13
<212>PRT
<213>Aspergillus niger
<400>83
Trp Thr Phe Phe Val Ser Ser Ser Pro Leu Asn Cys Lys
1 5 10
<210>84
<211>15
<212>PRT
<213>Aspergillus niger
<220>
<221>MISC_FEATURE
<222>(5)..(5)
<223〉amino acid can't clearly be determined
<220>
<221>MISC_FEATURE
<222>(14)..(14)
<223〉undetermined amino acid
<400>84
Val Cys Leu Asn Trp Asp Leu Glu Lys Leu Asn Pro Pro Xaa Phe
1 5 10 15
<210>85
<211>15
<212>PRT
<213>Aspergillus niger
<400>85
Glu Cys Asn Ile Thr Phe Gln Pro Gly Asp Ile Leu Phe Leu Arg
1 5 10 15
<210>86
<211>11
<212>PRT
<213>Aspergillus niger
<220>
<221>MISC_FEATURE
<222>(8)..(8)
<223〉undetermined amino acid
<400>86
Ala Glu Thr Thr Thr Asn Pro Xaa Tyr Phe Phe
1 5 10
<210>87
<211>8
<212>PRT
<213>Aspergillus niger
<400>87
Tyr His Leu Leu Gln Ala Glu Asp
1 5
<210>88
<211>10
<212>PRT
<213>Aspergillus niger
<400>88
Leu Glu Ser Leu Val Glu Glu Val Tyr Lys
1 5 10
<210>89
<211>16
<212>PRT
<213>Aspergillus niger
<220>
<221>MISC_FEATURE
<222>(15)..(15)
<223〉undetermined amino acid
<400>89
Leu Phe Glu Asp Val Tyr Ala Gln Lys Pro Glu Thr Ala Pro Xaa Asp
1 5 10 15
<210>90
<211>9
<212>PRT
<213>Aspergillus niger
<220>
<221>MISC_FEATURE
<222>(7)..(7)
<223〉amino acid can't clearly be determined
<400>90
Phe Leu Phe Asn Val Pro Tyr Thr Ser
1 5
<210>91
<211>8
<212>PRT
<213>Aspergillus niger
<220>
<221>MISC_FEATURE
<222>(8)..(8)
<223〉amino acid can't clearly be determined
<400>91
Gly Val Met Gly Gly Leu Gly Gly
1 5
<210>92
<211>1005
<212>DNA
<213>Aspergillus niger
<220>
<221>CDS
<222>(1)..(1002)
<223>
<400>92
atg aga gga tcg cat cac cat cac cat cac gcc gac tcc ctc ccg aaa 48
Met Arg Gly Ser His His His His His His Ala Asp Ser Leu Pro Lys
1 5 10 15
acc tac gac gac ctc ccc gac aag cgg cgc tac tgg ccc gca acc ccc 96
Thr Tyr Asp Asp Leu Pro Asp Lys Arg Arg Tyr Trp Pro Ala Thr Pro
20 25 30
aac tcc gcc gac gag gga ctg ggg atg ctc cgt ctc ctc act cca gaa 144
Asn Ser Ala Asp Glu Gly Leu Gly Met Leu Arg Leu Leu Thr Pro Glu
35 40 45
att gtc gcc aac gca gca cgc acc cag atc cag acc ggc gag cgc gta 192
Ile Val Ala Asn Ala Ala Arg Thr Gln Ile Gln Thr Gly Glu Arg Val
50 55 60
tgc ctg aac tgg gac ctg gag aag ctg aac cca cca ggc ttc ggc cgc 240
Cys Leu Asn Trp Asp Leu Glu Lys Leu Asn Pro Pro Gly Phe Gly Arg
65 70 75 80
aaa ccc ttc gcc cac cac gta aaa tgg gtc tcc gaa ggc cac gcc ttc 288
Lys Pro Phe Ala His His Val Lys Trp Val Ser Glu Gly His Ala Phe
85 90 95
gac gac gaa tac cac ttc aac ccg caa caa tcc tcc caa tgg gac ggt 336
Asp Asp Glu Tyr His Phe Asn Pro Gln Gln Ser Ser Gln Trp Asp Gly
100 105 110
ctg cga cac cac aac gcc ccg gct cca acc ccc gac gac cct aac cgc 384
Leu Arg His His Asn Ala Pro Ala Pro Thr Pro Asp Asp Pro Asn Arg
115 120 125
cgg gtc ttc tac ggc ggc acc acc tcc acc gag atc ctc gac ccc tcg 432
Arg Val Phe Tyr Gly Gly Thr Thr Ser Thr Glu Ile Leu Asp Pro Ser
130 135 140
tcc acc cga atc ggc ata gcc cac tgg gcc aag aaa ggc atc gcc ggc 480
Ser Thr Arg Ile Gly Ile Ala His Trp Ala Lys Lys Gly Ile Ala Gly
145 150 155 160
cgc ggc gtc ctc atc gac tac gcc tcc tac gtg caa cga acc aag ggc 528
Arg Gly Val Leu Ile Asp Tyr Ala Ser Tyr Val Gln Arg Thr Lys Gly
165 170 175
gtc aca gta aac gcc cta acc cgc cac acc gtc tcc ctg gac gac gtc 576
Val Thr Val Asn Ala Leu Thr Arg His Thr Val Ser Leu Asp Asp Val
180 185 190
ctc acc atc gcg aag gaa tgc aac atc acc ttc gaa cca ggc gac att 624
Leu Thr Ile Ala Lys Glu Cys Asn Ile Thr Phe Glu Pro Gly Asp Ile
195 200 205
ctc ttc ctg cgc gtc ggt cta ccg act aca tgg gat aac atg acc gat 672
Leu Phe Leu Arg Val Gly Leu Pro Thr Thr Trp Asp Asn Met Thr Asp
210 215 220
gag gag agg gtc aag tat agt cag cag gaa acg ccc aac cat gca gga 720
Glu Glu Arg Val Lys Tyr Ser Gln Gln Glu Thr Pro Asn His Ala Gly
225 230 235 240
tta gag cag agt gag cgt gtg gtg cgg ttc ctt tgg gat cag cat ttc 768
Leu Glu Gln Ser Glu Arg Val Val Arg Phe Leu Trp Asp Gln His Phe
245 250 255
gcc gct gta gcg ggt gat gcg gtc agc ttt gag gtg tat ccg ccg gta 816
Ala Ala Val Ala Gly Asp Ala Val Ser Phe Glu Val Tyr Pro Pro Val
260 265 270
gag aag gag tgg gat tta cat cat ttt ttg ctg gct ggg tgg gga cta 864
Glu Lys Glu Trp Asp Leu His His Phe Leu Leu Als Gly Trp Gly Leu
275 280 285
ccg att ggg gag atg ttt gat ctt gag ggg ttg aag gag gtg tgt gag 912
Pro Ile Gly Glu Met Phe Asp Leu Glu Gly Leu Lys Glu Val Cys Glu
290 295 300
agg ttg gga agg tgg acg ttt ttc gtt agt tct agt ccg ttg aac tgt 960
Arg Leu Gly Arg Trp Thr Phe Phe Val Ser Ser Ser Pro Leu Asn Cys
305 310 315 320
ggg aga ggt gtg tcg agt ccg ccg aat tgt atg gca att ttt taa 1005
Gly Arg Gly Val Ser Ser Pro Pro Asn Cys Met Ala Ile Phe
325 330
<210>93
<211>334
<212>PRT
<213>Aspergillus niger
<400>93
Met Arg Gly Ser His His His His His His Ala Asp Ser Leu Pro Lys
1 5 10 15
Thr Tyr Asp Asp Leu Pro Asp Lys Arg Arg Tyr Trp Pro Ala Thr Pro
20 25 30
Asn Ser Ala Asp Glu Gly Leu Gly Met Leu Arg Leu Leu Thr Pro Glu
35 40 45
Ile Val Ala Asn Ala Ala Arg Thr Gln Ile Gln Thr Gly Glu Arg Val
50 55 60
Cys Leu Asn Trp Asp Leu Glu Lys Leu Asn Pro Pro Gly Phe Gly Arg
65 70 75 80
Lys Pro Phe Ala His His Val Lys Trp Val Ser Glu Gly His Ala Phe
85 90 95
Asp Asp Glu Tyr His Phe Asn Pro Gln Gln Ser Ser Gln Trp Asp Gly
100 105 110
Leu Arg His His Asn Ala Pro Ala Pro Thr Pro Asp Asp Pro Asn Arg
115 120 125
Arg Val Phe Tyr Gly Gly Thr Thr ser Thr Glu Ile Leu Asp Pro Ser
130 135 140
Ser Thr Arg Ile Gly Ile Ala His Trp Ala Lys Lys Gly Ile Ala Gly
145 150 155 160
Arg Gly Val Leu Ile Asp Tyr Ala Ser Tyr Val Gln Arg Thr Lys Gly
165 170 175
Val Thr Val Asn Ala Leu Thr Arg His Thr Val Ser Leu Asp Asp Val
180 185 190
Leu Thr Ile Ala Lys Glu Cys Asn Ile Thr Phe Glu Pro Gly Asp Ile
195 200 205
Leu Phe Leu Arg Val Gly Leu Pro Thr Thr Trp Asp Asn Met Thr Asp
210 215 220
Glu Glu Arg Val Lys Tyr Ser Gln Gln Glu Thr Pro Asn His Ala Gly
225 230 235 240
Leu Glu Gln Ser Glu Arg Val Val Arg Phe Leu Trp Asp Gln His Phe
245 250 255
Ala Ala Val Ala Gly Asp Ala Val Ser Phe Glu Val Tyr Pro Pro Val
260 265 270
Glu Lys Glu Trp Asp Leu His His Phe Leu Leu Ala Gly Trp Gly Leu
275 280 285
Pro Ile Gly Glu Met Phe Asp Leu Glu Gly Leu Lys Glu Val Cys Glu
290 295 300
Arg Leu Gly Arg Trp Thr Phe Phe Val Ser Ser Ser Pro Leu Asn Cys
305 310 315 320
Gly Arg Gly Val Ser Ser Pro Pro Asn Cys Met Ala Ile Phe
325 330
<210>94
<211>992
<212>DNA
<213>Aspergillus niger
<220>
<221>CDS
<222>(9)..(983)
<223>
<400>94
gaattcaa atg gcc gac tcc ctc ccg aaa acc tac gac gac ctc ccc gac 50
Met Ala Asp Ser Leu Pro Lys Thr Tyr Asp Asp Leu Pro Asp
1 5 10
aag cgg cgc tac tgg ccc gca acc ccc aac tcc gcc gac gag gga ctg 98
Lys Arg Arg Tyr Trp Pro Ala Thr Pro Asn Ser Ala Asp Glu Gly Leu
15 20 25 30
ggg atg ctc cgt ctc ctc act cca gaa att gtc gcc aac gca gca cgc 146
Gly Met Leu Arg Leu Leu Thr Pro Glu Ile Val Ala Asn Ala Ala Arg
35 40 45
acc cag atc cag acc ggc gag cgc gta tgc ctg aac tgg gac ctg gag 194
Thr Gln Ile Gln Thr Gly Glu Arg Val Cys Leu Asn Trp Asp Leu Glu
50 55 60
aag ctg aac cca cca ggc ttc ggc cgc aaa ccc ttc gcc cac cac gta 242
Lys Leu Asn Pro Pro Gly Phe Gly Arg Lys Pro Phe Ala His His Val
65 70 75
aaa tgg gtc tcc gaa ggc cac gcc ttc gac gac gaa tac cac ttc aac 290
Lys Trp Val Ser Glu Gly His Ala Phe Asp Asp Glu Tyr His Phe Asn
80 85 90
ccg caa caa tcc tcc caa tgg gac ggt ctg cga cac cac aac gcc ccg 338
Pro Gln Gln Ser Ser Gln Trp Asp Gly Leu Arg His His Asn Ala Pro
95 100 105 110
gct cca acc ccc gac gac cct aac cgc cgg gtc ttc tac ggc ggc acc 386
Ala Pro Thr Pro Asp Asp Pro Asn Arg Arg Val Phe Tyr Gly Gly Thr
115 120 125
acc tcc acc gag atc ctc gac ccc tcg tcc acc cga atc ggc ata gcc 434
Thr Ser Thr Glu Ile Leu Asp Pro Ser Ser Thr Arg Ile Gly Ile Ala
130 135 140
cac tgg gcc aag aaa ggc atc gcc ggc cgc ggc gtc ctc atc gac tac 482
His Trp Ala Lys Lys Gly Ile Ala Gly Arg Gly Val Leu Ile Asp Tyr
145 150 155
gcc tcc tac gtg caa cga acc aag ggc gtc aca gta aac gcc cta acc 530
Ala Ser Tyr Val Gln Arg Thr Lys Gly Val Thr Val Asn Ala Leu Thr
160 165 170
cgc cac acc gtc tcc ctg gac gac gtc ctc acc atc gcg aag gaa tgc 578
Arg His Thr Val Ser Leu Asp Asp Val Leu Thr Ile Ala Lys Glu Cys
175 180 185 190
aac atc acc ttc gaa cca ggc gac att ctc ttc ctg cgc gtc ggt cta 626
Asn Ile Thr Phe Glu Pro Gly Asp Ile Leu Phe Leu Arg Val Gly Leu
195 200 205
ccg act aca tgg gat aac atg acc gat gag gag agg gtc aag tat agt 674
Pro Thr Thr Trp Asp Asn Met Thr Asp Glu Glu Arg Val Lys Tyr Ser
210 215 220
cag cag gaa acg ccc aac cat gca gga tta gag cag agt gag cgt gtg 722
Gln Gln Glu Thr Pro Asn His Ala Gly Leu Glu Gln Ser Glu Arg Val
225 230 235
gtg cgg ttc ctt tgg gat cag cat ttc gcc gct gta gcg ggt gat gcg 770
Val Arg Phe Leu Trp Asp Gln His Phe Ala Ala Val Ala Gly Asp Ala
240 245 250
gtc agc ttt gag gtg tat ccg ccg gta gag aag gag tgg gat tta cat 818
Val Ser Phe Glu Val Tyr Pro Pro Val Glu Lys Glu Trp Asp Leu His
255 260 265 270
cat ttt ttg ctg gct ggg tgg gga cta ccg att ggg gag atg ttt gat 866
His Phe Leu Leu Ala Gly Trp Gly Leu Pro Ile Gly Glu Met Phe Asp
275 280 285
ctt gag ggg ttg aag gag gtg tgt gag agg ttg gga agg tgg acg ttt 914
Leu Glu Gly Leu Lys Glu Val Cys Glu Arg Leu Gly Arg Trp Thr Phe
290 295 300
ttc gtt agt tct agt ccg ttg aac tgt ggg aga ggt gtg tcg agt ccg 962
Phe Val Ser Ser Ser Pro Leu Asn Cys Gly Arg Gly Val Ser Ser Pro
305 310 315
ccg aat tgt atg gca att ttt taagaattc 992
Pro Asn Cys Met Ala Ile Phe
320 325
<210>95
<211>325
<212>PRT
<213>Aspergillus niger
<400>95
Met Ala Asp Ser Leu Pro Lys Thr Tyr Asp Asp Leu Pro Asp Lys Arg
1 5 10 15
Arg Tyr Trp Pro Ala Thr Pro Asn Ser Ala Asp Glu Gly Leu Gly Met
20 25 30
Leu Arg Leu Leu Thr Pro Glu Ile Val Ala Asn Ala Ala Arg Thr Gln
35 40 45
Ile Gln Thr Gly Glu Arg Val Cys Leu Asn Trp Asp Leu Glu Lys Leu
50 55 60
Asn Pro Pro Gly Phe Gly Arg Lys Pro Phe Ala His His Val Lys Trp
65 70 75 80
Val Ser Glu Gly His Ala Phe Asp Asp Glu Tyr His Phe Asn Pro Gln
85 90 95
Gln Ser Ser Gln Trp Asp Gly Leu Arg His His Asn Ala Pro Ala Pro
100 105 110
Thr Pro Asp Asp Pro Asn Arg Arg Val Phe Tyr Gly Gly Thr Thr Ser
115 120 125
Thr Glu Ile Leu Asp Pro Ser Ser Thr Arg Ile Gly Ile Ala His Trp
130 135 140
Ala Lys Lys Gly Ile Ala Gly Arg Gly Val Leu Ile Asp Tyr Ala Ser
145 150 155 160
Tyr Val Gln Arg Thr Lys Gly Val Thr Val Asn Ala Leu Thr Arg His
165 170 175
Thr Val Ser Leu Asp Asp Val Leu Thr Ile Ala Lys Glu Cys Asn Ile
180 185 190
Thr Phe Glu Pro Gly Asp Ile Leu Phe Leu Arg Val Gly Leu Pro Thr
195 200 205
Thr Trp Asp Asn Met Thr Asp Glu Glu Arg Val Lys Tyr Ser Gln Gln
210 215 220
Glu Thr Pro Asn His Ala Gly Leu Glu Gln Ser Glu Arg Val Val Arg
225 230 235 240
Phe Leu Trp Asp Gln His Phe Ala Ala Val Ala Gly Asp Ala Val Ser
245 250 255
Phe Glu Val Tyr Pro Pro Val Glu Lys Glu Trp Asp Leu His His Phe
260 265 270
Leu Leu Ala Gly Trp Gly Leu Pro Ile Gly Glu Met Phe Asp Leu Glu
275 280 285
Gly Leu Lys Glu Val Cys Glu Arg Leu Gly Arg Trp Thr Phe Phe Val
290 295 300
Ser Ser Ser Pro Leu Asn Cys Gly Arg Gly Val Ser Ser Pro Pro Asn
305 310 315 320
Cys Met Ala Ile Phe
325
<210>96
<211>1019
<212>DNA
<213>Aspergillus niger
<220>
<221>CDS
<222>(9)..(1010)
<223>
<400>96
gaattcaa atg aga gga tcg cat cac cat cac cat cac gcc gac tcc ctc 50
Met Arg Gly Ser His His His His His His Ala Asp Ser Leu
1 5 10
ccg aaa acc tac gac gac ctc ccc gac aag cgg cgc tac tgg ccc gca 98
Pro Lys Thr Tyr Asp Asp Leu Pro Asp Lys Arg Arg Tyr Trp Pro Ala
15 20 25 30
acc ccc aac tcc gcc gac gag gga ctg ggg atg ctc cgt ctc ctc act 146
Thr Pro Asn Ser Ala Asp Glu Gly Leu Gly Met Leu Arg Leu Leu Thr
35 40 45
cca gaa att gtc gcc aac gca gca cgc acc cag atc cag acc ggc gag 194
Pro Glu Ile Val Ala Asn Ala Ala Arg Thr Gln Ile Gln Thr Gly Glu
50 55 60
cgc gta tgc ctg aac tgg gac ctg gag aag ctg aac cca cca ggc ttc 242
Arg Val Cys Leu Asn Trp Asp Leu Glu Lys Leu Asn Pro Pro Gly Phe
65 70 75
ggc cgc aaa ccc ttc gcc cac cac gta aaa tgg gtc tcc gaa ggc cac 290
Gly Arg Lys Pro Phe Ala His His Val Lys Trp Val Ser Glu Gly His
80 85 90
gcc ttc gac gac gaa tac cac ttc aac ccg caa caa tcc tcc caa tgg 338
Ala Phe Asp Asp Glu Tyr His Phe Asn Pro Gln Gln Ser Ser Gln Trp
95 100 105 110
gac ggt ctg cga cac cac aac gcc ccg gct cca acc ccc gac gac cct 386
Asp Gly Leu Arg His His Asn Ala Pro Ala Pro Thr Pro Asp Asp Pro
115 120 125
aac cgc cgg gtc ttc tac ggc ggc acc acc tcc acc gag atc ctc gac 434
Asn Arg Arg Val Phe Tyr Gly Gly Thr Thr Ser Thr Glu Ile Leu Asp
130 135 140
ccc tcg tcc acc cga atc ggc ata gcc cac tgg gcc aag aaa ggc atc 482
Pro Ser Ser Thr Arg Ile Gly Ile Ala His Trp Ala Lys Lys Gly Ile
145 150 155
gcc ggc cgc ggc gtc ctc atc gac tac gcc tcc tac gtg caa cga acc 530
Ala Gly Arg Gly Val Leu Ile Asp Tyr Ala Ser Tyr Val Gln Arg Thr
160 165 170
aag ggc gtc aca gta aac gcc cta acc cgc cac acc gtc tcc ctg gac 578
Lys Gly Val Thr Val Asn Ala Leu Thr Arg His Thr Val Ser Leu Asp
175 180 185 190
gac gtc ctc acc atc gcg aag gaa tgc aac atc acc ttc gaa cca ggc 626
Asp Val Leu Thr Ile Ala Lys Glu Cys Asn Ile Thr Phe Glu Pro Gly
195 200 205
gac att ctc ttc ctg cgc gtc ggt cta ccg act aca tgg gat aac atg 674
Asp Ile Leu Phe Leu Arg Val Gly Leu Pro Thr Thr Trp Asp Asn Met
210 215 220
acc gat gag gag agg gtc aag tat agt cag cag gaa acg ccc aac cat 722
Thr Asp Glu Glu Arg Val Lys Tyr Ser Gln Gln Glu Thr Pro Asn His
225 230 235
gca gga tta gag cag agt gag cgt gtg gtg cgg ttc ctt tgg gat cag 770
Ala Gly Leu Glu Gln Ser Glu Arg Val Val Arg Phe Leu Trp Asp Gln
240 245 250
cat ttc gcc gct gta gcg ggt gat gcg gtc agc ttt gag gtg tat ccg 818
His Phe Ala Ala Val Ala Gly Asp Ala Val Ser Phe Glu Val Tyr Pro
255 260 265 270
ccg gta gag aag gag tgg gat tta cat cat ttt ttg ctg gct ggg tgg 866
Pro Val Glu Lys Glu Trp Asp Leu His His Phe Leu Leu Ala Gly Trp
275 280 285
gga cta ccg att ggg gag atg ttt gat ctt gag ggg ttg aag gag gtg 914
Gly Leu Pro Ile Gly Glu Met Phe Asp Leu Glu Gly Leu Lys Glu Val
290 295 300
tgt gag agg ttg gga agg tgg acg ttt ttc gtt agt tct agt ccg ttg 962
Cys Glu Arg Leu Gly Arg Trp Thr Phe Phe Val Ser Ser Ser Pro Leu
305 310 315
aac tgt ggg aga ggt gtg tcg agt ccg ccg aat tgt atg gca att ttt 1010
Asn Cys Gly Arg Gly Val Ser Ser Pro Pro Asn Cys Met Ala Ile Phe
320 325 330
taagaattc 1019
<210>97
<211>334
<212>PRT
<213>Aspergillus niger
<400>97
Met Arg Gly Ser His His His His His His Ala Asp Ser Leu Pro Lys
1 5 10 15
Thr Tyr Asp Asp Leu Pro Asp Lys Arg Arg Tyr Trp Pro Ala Thr Pro
20 25 30
Asn Ser Ala Asp Glu Gly Leu Gly Met Leu Arg Leu Leu Thr Pro Glu
35 40 45
Ile Val Ala Asn Ala Ala Arg Thr Gln Ile Gln Thr Gly Glu Arg Val
50 55 60
Cys Leu Asn Trp Asp Leu Glu Lys Leu Asn Pro Pro Gly Phe Gly Arg
65 70 75 80
Lys Pro Phe Ala His His Val Lys Trp Val Ser Glu Gly His Ala Phe
85 90 95
Asp Asp Glu Tyr His Phe Asn Pro Gln Gln Ser Ser Gln Trp Asp Gly
100 105 110
Leu Arg His His Asn Ala Pro Ala Pro Thr Pro Asp Asp Pro Asn Arg
115 120 125
Arg Val Phe Tyr Gly Gly Thr Thr Ser Thr Glu Ile Leu Asp Pro Ser
130 135 140
Ser Thr Arg Ile Gly Ile Ala His Trp Ala Lys Lys Gly Ile Ala Gly
145 150 155 160
Arg Gly Val Leu Ile Asp Tyr Ala Ser Tyr Val Gln Arg Thr Lys Gly
165 170 175
Val Thr Val Asn Ala Leu Thr Arg His Thr Val Ser Leu Asp Asp Val
180 185 190
Leu Thr Ile Ala Lys Glu Cys Asn Ile Thr Phe Glu Pro Gly Asp Ile
195 200 205
Leu Phe Leu Arg Val Gly Leu Pro Thr Thr Trp Asp Asn Met Thr Asp
210 215 220
Glu Glu Arg Val Lys Tyr Ser Gln Gln Glu Thr Pro Asn His Ala Gly
225 230 235 240
Leu Glu Gln Ser Glu Arg Val Val Arg Phe Leu Trp Asp Gln His Phe
245 250 255
Ala Ala Val Ala Gly Asp Ala Val Ser Phe Glu Val Tyr Pro Pro Val
260 265 270
Glu Lys Glu Trp Asp Leu His His Phe Leu Leu Ala Gly Trp Gly Leu
275 280 285
Pro Ile Gly Glu Met Phe Asp Leu Glu Gly Leu Lys Glu Val Cys Glu
290 295 300
Arg Leu Gly Arg Trp Thr Phe Phe Val Ser Ser Ser Pro Leu Asn Cys
305 310 315 320
Gly Arg Gly Val Ser Ser Pro Pro Asn Cys Met Ala Ile Phe
325 330
<210>98
<211>975
<212>DNA
<213>Aspergillus niger
<220>
<221>CDS
<222>(1)..(975)
<223>
<400>98
atg gcc gac tcc ctc ccg aaa acc tac gac gac ctc ccc gac aag cgg 48
Met Ala Asp Ser Leu Pro Lys Thr Tyr Asp Asp Leu Pro Asp Lys Arg
1 5 10 15
cgc tac tgg ccc gca acc ccc aac tcc gcc gac gag gga ctg ggg atg 96
Arg Tyr Trp Pro Ala Thr Pro Asn Ser Ala Asp Glu Gly Leu Gly Met
20 25 30
ctc cgt ctc ctc act cca gaa att gtc gcc aac gca gca cgc acc cag 144
Leu Arg Leu Leu Thr Pro Glu Ile Val Ala Asn Ala Ala Arg Thr Gln
35 40 45
atc cag acc ggc gag cgc gta tgc ctg aac tgg gac ctg gag aag ctg 192
Ile Gln Thr Gly Glu Arg Val Cys Leu Asn Trp Asp Leu Glu Lys Leu
50 55 60
aac cca cca ggc ttc ggc cgc aaa ccc ttc gcc cac cac gta aaa tgg 240
Asn Pro Pro Gly Phe Gly Arg Lys Pro Phe Ala His His Val Lys Trp
65 70 75 80
gtc tcc gaa ggc cac gcc ttc gac gac gaa tac cac ttc aac ccg caa 288
Val Ser Glu Gly His Ala Phe Asp Asp Glu Tyr His Phe Asn Pro Gln
85 90 95
caa tcc tcc caa tgg gac ggt ctg cga cac cac aac gcc ccg gct cca 336
Gln Ser Ser Gln Trp Asp Gly Leu Arg His His Asn Ala Pro Ala Pro
100 105 110
acc ccc gac gac cct aac cgc cgg gtc ttc tac ggc ggc acc acc tcc 384
Thr Pro Asp Asp Pro Asn Arg Arg Val Phe Tyr Gly Gly Thr Thr Ser
115 120 125
acc gag atc ctc gac ccc tcg tcc acc cga atc ggc ata gcc cac tgg 432
Thr Glu Ile Leu Asp Pro Ser Ser Thr Arg Ile Gly Ile Ala His Trp
130 135 140
gcc aag aaa ggc atc gcc ggc cgc ggc gtc ctc atc gac tac gcc tcc 480
Ala Lys Lys Gly Ile Ala Gly Arg Gly Val Leu Ile Asp Tyr Ala Ser
145 150 155 160
tac gtg caa cga acc aag ggc gtc aca gta aac gcc cta acc cgc cac 528
Tyr Val Gln Arg Thr Lys Gly Val Thr Val Asn Ala Leu Thr Arg His
165 170 175
acc gtc tcc ctg gac gac gtc ctc acc atc gcg aag gaa tgc aac atc 576
Thr Val Ser Leu Asp Asp Val Leu Thr Ile Ala Lys Glu Cys Asn Ile
180 185 190
acc ttc gaa cca ggc gac att ctc ttc ctg cgc gtc ggt cta ccg act 624
Thr Phe Glu Pro Gly Asp Ile Leu Phe Leu Arg Val Gly Leu Pro Thr
195 200 205
aca tgg gat aac atg acc gat gag gag agg gtc aag tat agt cag cag 672
Thr Trp Asp Asn Met Thr Asp Glu Glu Arg Val Lys Tyr Ser Gln Gln
210 215 220
gaa acg ccc aac cat gca gga tta gag cag agt gag cgt gtg gtg cgg 720
Glu Thr Pro Asn His Ala Gly Leu Glu Gln Ser Glu Arg Val Val Arg
225 230 235 240
ttc ctt tgg gat cag cat ttc gcc gct gta gcg ggt gat gcg gtc agc 768
Phe Leu Trp Asp Gln His Phe Ala Ala Val Ala Gly Asp Ala Val Ser
245 250 255
ttt gag gtg tat ccg ccg gta gag aag gag tgg gat tta cat cat ttt 816
Phe Glu Val Tyr Pro Pro Val Glu Lys Glu Trp Asp Leu His His Phe
260 265 270
ttg ctg gct ggg tgg gga cta ccg att ggg gag atg ttt gat ctt gag 864
Leu Leu Ala Gly Trp Gly Leu Pro Ile Gly Glu Met Phe Asp Leu Glu
275 280 285
ggg ttg aag gag gtg tgt gag agg ttg gga agg tgg acg ttt ttc gtt 912
Gly Leu Lys Glu Val Cys Glu Arg Leu Gly Arg Trp Thr Phe Phe Val
290 295 300
agt tct agt ccg ttg aac tgt ggg aga ggt gtg tcg agt ccg ccg aat 960
Ser Ser Ser Pro Leu Asn Cys Gly Arg Gly Val Ser Ser Pro Pro Asn
305 310 315 320
tgt atg gca att ttt 975
Cys Met Ala Ile Phe
325
<210>99
<211>325
<212>PRT
<213>Aspergillus niger
<400>99
Met Ala Asp Ser Leu Pro Lys Thr Tyr Asp Asp Leu Pro Asp Lys Arg
1 5 10 15
Arg Tyr Trp Pro Ala Thr Pro Asn Ser Ala Asp Glu Gly Leu Gly Met
20 25 30
Leu Arg Leu Leu Thr Pro Glu Ile Val Ala Asn Ala Ala Arg Thr Gln
35 40 45
Ile Gln Thr Gly Glu Arg Val Cys Leu Asn Trp Asp Leu Glu Lys Leu
50 55 60
Asn Pro Pro Gly Phe Gly Arg Lys Pro Phe Ala His His Val Lys Trp
65 70 75 80
Val Ser Glu Gly His Ala Phe Asp Asp Glu Tyr His Phe Asn Pro Gln
85 90 95
Gln Ser Ser Gln Trp Asp Gly Leu Arg His His Asn Ala Pro Ala Pro
100 105 110
Thr Pro Asp Asp Pro Asn Arg Arg Val Phe Tyr Gly Gly Thr Thr Ser
115 120 125
Thr Glu Ile Leu Asp Pro Ser Ser Thr Arg Ile Gly Ile Ala His Trp
130 135 140
Ala Lys Lys Gly Ile Ala Gly Arg Gly Val Leu Ile Asp Tyr Ala Ser
145 150 155 160
Tyr Val Gln Arg Thr Lys Gly Val Thr Val Asn Ala Leu Thr Arg His
165 170 175
Thr Val Ser Leu Asp Asp Val Leu Thr Ile Ala Lys Glu Cys Asn Ile
180 185 190
Thr Phe Glu Pro Gly Asp Ile Leu Phe Leu Arg Val Gly Leu Pro Thr
195 200 205
Thr Trp Asp Asn Met Thr Asp Glu Glu Arg Val Lys Tyr Ser Gln Gln
210 215 220
Glu Thr Pro Asn His Ala Gly Leu Glu Gln Ser Glu Arg Val Val Arg
225 230 235 240
Phe Leu Trp Asp Gln His Phe Ala Ala Val Ala Gly Asp Ala Val Ser
245 250 255
Phe Glu Val Tyr Pro Pro Val Glu Lys Glu Trp Asp Leu His His Phe
260 265 270
Leu Leu Ala Gly Trp Gly Leu Pro Ile Gly Glu Met Phe Asp Leu Glu
275 280 285
Gly Leu Lys Glu Val Cys Glu Arg Leu Gly Arg Trp Thr Phe Phe Val
290 295 300
Ser Ser Ser Pro Leu Asn Cys Gly Arg Gly Val Ser Ser Pro Pro Asn
305 310 315 320
Cys Met Ala Ile Phe
325
Claims (10)
1. the nucleotide sequence of the gene of the pantolactone hydrolase of encoding, described pantolactone hydrolase is from horse liver, A.niger ATCC 9142, A.niger awamori ATCC 38854 or A. niger MacRae ATCC 46951.
2. nucleotide sequence as claimed in claim 1 wherein comprises: when from the horse liver, and the nucleotide sequence shown in SEQ ID NO:1; When from A.niger MacRae ATCC 46951, the nucleotide sequence shown in SEQ ID NO:5; When from A.niger ATCC 9142, the sequence shown in SEQ ID NO:7; And when from A.niger awamori ATCC 38854, the sequence shown in SEQ ID NO:9.
3. expression vector, the nucleotide sequence that wherein comprises the gene of the pantolactone hydrolase of encoding, described pantolactone hydrolase is from horse liver, Bacillus subtilis, A.niger ATCC 9142, A.niger awamori ATCC 38854 or A.niger MacRae ATCC 46951.
4. the host cell that transformed with expression vector as claimed in claim 3.
5. pantolactone hydrolase is from horse liver, A.niger ATCC 9142, A.niger awamori ATCC 38854 or A.niger MacRae ATCC 46951.
6. pantolactone hydrolase, its amino acid sequence comprises: when from the horse liver, the amino acid sequence shown in SEQ ID NO:2; When from A.niger MacRae ATCC 46951, the amino acid sequence shown in SEQ ID NO:6; When from A.niger ATCC 9142, the amino acid sequence shown in SEQ ID NO:8; And when from A.niger awamori ATCC 38854, the amino acid sequence shown in SEQ ID NO:10.
7. such as claim 5 or 6 described pantolactone hydrolases, wherein said pantolactone hydrolase is fixed.
8. pantolactone hydrolase as claimed in claim 6 or the pantolactone hydrolase that obtains from Bacillus subtilis shown in SEQ ID NO:4 are in the purposes of R-or S-pantolactone being carried out the selective hydrolysis.
9. method of producing R-pantothenic acid or its salt or R-panthenol, described method comprises the steps: in the situation of pantolactone hydrolase as claimed in claim 6 or the pantolactone hydrolase existence that obtains from Bacillus subtilis shown in SEQ ID NO:4 R-or S-pantolactone to be carried out selective hydrolysis.
10. the method for the nucleotide sequence of a clone and known array direct neighbor, described method comprises pcr amplification, described amplification comprises:
A) carry out PCR second time with the single stranded DNA of PCR for the first time as template, in described second time PCR with the primer that can hybridize at random with the single stranded DNA of the PCR generation first time; And
B) thus, still use the at random hybridized primer of step in a), produce self as the antisense strand of the template of second chain.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45922003P | 2003-03-28 | 2003-03-28 | |
US60/459,220 | 2003-03-28 | ||
PCT/EP2004/002902 WO2004085651A2 (en) | 2003-03-28 | 2004-03-19 | Pantolactone hydrolase |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1768141A true CN1768141A (en) | 2006-05-03 |
CN1768141B CN1768141B (en) | 2012-10-10 |
Family
ID=33098294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2004800085042A Expired - Lifetime CN1768141B (en) | 2003-03-28 | 2004-03-19 | Pantolactone hydrolase |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP4571936B2 (en) |
KR (1) | KR101156882B1 (en) |
CN (1) | CN1768141B (en) |
GB (1) | GB2413329B (en) |
WO (1) | WO2004085651A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105669837A (en) * | 2015-06-03 | 2016-06-15 | 苏州大学 | Vascular endothelial cadherin epitope, antibody and application thereof |
CN110358687A (en) * | 2018-12-19 | 2019-10-22 | 安徽瑞达健康产业有限公司 | One plant of gibberella for producing D pantoic acid lactone hydrolase and application, fermentation process |
CN112048537A (en) * | 2019-06-07 | 2020-12-08 | 帝斯曼知识产权资产管理有限公司 | Synthesis of (R) -pantolactone acetate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411875A (en) * | 1991-11-01 | 1995-05-02 | University Of Iowa Research Foundation | Method for retrieval of unknown flanking DNA sequence |
WO1993011261A1 (en) * | 1991-11-25 | 1993-06-10 | Keygene N.V. | A novel pcr method with a single primer for nucleic acid analysis |
US6406898B1 (en) * | 1995-09-13 | 2002-06-18 | Daiichi Fine Chemical Co., Ltd. | D-pantolactone hydrolase and gene encoding the same |
DE19849348A1 (en) * | 1998-10-26 | 2000-04-27 | Univ Ludwigs Albert | Identification and/or sequencing of an unknown DNA or RNA sequence adjacent to a known DNA or RNA region comprises linker-mediated PCR following amplification by linear PCR |
JP2003530080A (en) * | 1999-10-29 | 2003-10-14 | ビーエーエスエフ アクチェンゲゼルシャフト | Method for producing L-pantolactone hydrolase and D-pantolactone |
-
2004
- 2004-03-19 KR KR1020057018207A patent/KR101156882B1/en active IP Right Grant
- 2004-03-19 WO PCT/EP2004/002902 patent/WO2004085651A2/en active Application Filing
- 2004-03-19 CN CN2004800085042A patent/CN1768141B/en not_active Expired - Lifetime
- 2004-03-19 JP JP2006504751A patent/JP4571936B2/en not_active Expired - Fee Related
- 2004-03-19 GB GB0516602A patent/GB2413329B/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105669837A (en) * | 2015-06-03 | 2016-06-15 | 苏州大学 | Vascular endothelial cadherin epitope, antibody and application thereof |
CN110358687A (en) * | 2018-12-19 | 2019-10-22 | 安徽瑞达健康产业有限公司 | One plant of gibberella for producing D pantoic acid lactone hydrolase and application, fermentation process |
CN110358687B (en) * | 2018-12-19 | 2020-12-04 | 安徽瑞达健康产业有限公司 | Gibberellin for producing D-pantolactone hydrolase and application and fermentation method thereof |
CN112048537A (en) * | 2019-06-07 | 2020-12-08 | 帝斯曼知识产权资产管理有限公司 | Synthesis of (R) -pantolactone acetate |
Also Published As
Publication number | Publication date |
---|---|
CN1768141B (en) | 2012-10-10 |
KR20050119151A (en) | 2005-12-20 |
KR101156882B1 (en) | 2012-07-05 |
GB2413329B (en) | 2007-09-19 |
WO2004085651A2 (en) | 2004-10-07 |
GB0516602D0 (en) | 2005-09-21 |
GB2413329A (en) | 2005-10-26 |
JP4571936B2 (en) | 2010-10-27 |
JP2006521103A (en) | 2006-09-21 |
WO2004085651A3 (en) | 2005-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1196789C (en) | Modified cytochrome P450 monooxygenases | |
CN1151252C (en) | Method for producing microbiological transglutaminase | |
CN1229499C (en) | Phosphodiesterase 8A | |
CN1993377A (en) | Alanine 2,3,aminomutase | |
CN1622998A (en) | Fungus-origin lysyl oxidases | |
CN1571843A (en) | Nitrile hydratase and a method for producing amides | |
CN1836044A (en) | Cephalosporin c(CPC) acylase mutant having improved reactivity at cpc substrate and improved resistance to 7-aca productand method for preparing 7-aca using same | |
CN1175104C (en) | Endo-beta-N-acetyl glucosaminidase gene | |
CN1195058C (en) | Oxaloacetae hydrolase deficient fungal host cells | |
CN1216988C (en) | Process for production of secretory kexz derivatives | |
CN1656225A (en) | Novel carbonyl reductase, gene encoding it and process for producing optically active alcohols using the same | |
CN101061222A (en) | Gene for encoding methylated catechin biological synthetase | |
CN1950501A (en) | AMP deaminase originating in streptomyces and utilization thereof | |
CN1529756A (en) | Steroselective preparation of cyclic L-amino acids | |
CN1768135A (en) | Stable lipase variants | |
CN1183248C (en) | Cyclic depsipeptide synthases, genes thereof and mass production system of cyclic depsipeptide | |
CN1617931A (en) | Esteralse with lipase activity | |
CN1891820A (en) | Cholesterol oxidase stable in the presence of surfactant | |
CN1934250A (en) | Novel alcohol dehydrogenase | |
CN1517436A (en) | Oxide-reductase | |
CN1768141A (en) | Pantolactone hydrolase | |
CN1250726C (en) | Thermotolerant ribonuclease H | |
CN1497046A (en) | Alpha ketonic acid reductase and its preparation method, and method of preparing optical active alpha hydroxy acid using said reductase | |
CN1761742A (en) | Process for producing lactonase and utilization thereof | |
CN1639340A (en) | Method of controlling ethanol production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CX01 | Expiry of patent term |
Granted publication date: 20121010 |
|
CX01 | Expiry of patent term |